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PENCIRIAN FITOKIMIA, PENGARUHAN APOPTOSIS DAN 
PENGAKTIFAN SEL PEMBUNUH SEMULAJADI  (NK) OLEH EKSTRAK 




 Kanser masih merupakan salah satu masalah global yang mengancam populasi 
dunia secara amnya. Pencarian penawar untuk kanser masih lagi dijalankan dengan 
pesat. Walaupun perubatan konvensional masih merupakan pilihan nombor satu dalam 
rawatan kanser, perubatan secara tradisi tetap juga menjadi pilihan oleh pesakit kanser. 
Pendekatan rawatan tradisional yang menggunakan tumbuhan ubatan masih lagi 
diamalkan secara meluas sejak berpuluh dan ratusan tahun yang lampau. Kebolehan 
tumbuhan berubat untuk menghalang pembiakan sel kanser berserta kemampuannya 
untuk mengaktifkan sistem imun tubuh badan merupakan salah satu strategi yang 
paling ideal untuk melawan kanser. Oleh itu, pemahaman dan pembuktian secara 
saintifik berkenaan mekanisma keupayaan tumbuhan berubat untuk melawan kanser 
akan mengurangkan jurang ilmu pengetahuan yang belum lagi diterokai berkenaan 
tumbuhan tersebut. Dalam kajian ini, satu tumbuhan berubat yang dikenali sebagai 
Abrus precatorius atau pokok saga, diselidiki. Daun tumbuhan ini digunakan secara 
tradisional untuk merawat pelbagai penyakit termasuk kanser. Daun tumbuhan ini 
dipilih dan diekstrak menggunakan beberapa teknik pengekstrakan dengan pelarut 
yang berbeza. Analisis fitokimia dilakukan menggunakan GC-MS. Keupayaan ekstrak 
tumbuhan ini untuk menghalang pembiakan sel kanser dianalisis menggunakan asai 
MTT. Ekstrak terbaik yang menunjukkan IC50 paling rendah ke atas sel kanser terpilih 
seterusnya dipilih untuk analisis selanjutnya untuk melihat mekanisma induksi 
 
 xviii 
kematian sel. Ini diukur dengan analisis penghentian kitaran sel, pewarnaan apoptosis 
dengan AnnexinV/PI, dan akhir sekali dengan mengukur ekspresi protein p53, Bax, 
Bcl-2 dan Caspase-3. Keupayaan ekstrak ini untuk merangsang tindakbalas sistem 
imun dengan mengaktifkan sel pembunuh semula jadi (NK) dinilai melalui uji kaji 
yang melibatkan proses pengkulturan sel NK bersama dengan sel kanser sasaran, 
MDA-MB-231. Ini diamati dengan analisis kematian sel sasaran dan kuantifikasi 
rembesan sitokin interleukin-2 (IL-2) dan interferon gamma (IFN-g)  berserta perforin 
(PRF-1) dan granzyme B (GzmB). Hasil kajian mendapati, ekstrak yang diperoleh 
melalui kaedah Soxhlet menggunakan pelarut etil asetat dan metanol mempunyai 
sebatian finolik dan terpenoid yang paling tinggi berbanding ekstrak yang lain. Ekstrak 
metanol yang diperolehi secara kaedah Soxhlet (APME) menunjukkan IC50 paling 
rendah ke atas sel kanser MDA-MB-231. Analisis selanjutnya menggunakan sitometri 
aliran, menunjukkan kemampuan APME untuk mengaruh kematian sel secara 
apoptosis  melalui perencatan DNA di fasa G0/G1 dalam kitaran sel, peningkatan 
ekspresi protein p53, Bax dan Caspase-3; dan diregulasi protein Bcl-2. APME juga 
mampu mengaktifkan sel NK (daripada penderma sihat) untuk menjadi sitotoksik dan 
mengakibatkan apoptosis ke atas sel kanser. Peningkatan rembesan IFN-g dan PRF-1 
dapat dilihat dari eksperimen ko-kultur ini. Penemuan ini menunjukkan keupayaan A. 
precatorius untuk bertindak sebagai agen anti proliferasi ke atas sel kanser dan 
perangsang ke atas sel NK dari penderma yang sihat.  Ini mungkin diakibatkan oleh 
kehadiran pelbagai sebatian kimia dalam profil tumbuhan tersebut yang bertindak 







PHYTOCHEMICAL CHARACTERIZATION, INDUCTION OF APOPTOSIS 
AND ACTIVATION OF NATURAL KILLER (NK) CELLS BY  Abrus 
precatorius LEAVES EXTRACT ON HUMAN BREAST CANCER CELL 
 
ABSTRACT 
 Cancer is still one of the global menace and poses a threat to the general world 
population. The search for cancer cure is also still on the race. Although conventional 
medicine remains the number one choice in cancer treatment, traditional approach is 
also still one of the favourable choices made by cancer patients to deal with this 
horrible disease. Traditional approaches, mainly by utilising medicinal plants are 
widely sought after in many countries since centuries ago. The ability of medicinal 
plants to exhibit their anti-proliferative activity, together with the ability to activate 
immune responses would be the ideal strategy to beat the disease. Therefore, 
understanding the mechanisms of medicinal plants displaying their anticancer 
properties scientifically would fill the gap of unknown knowledge about them. A 
medicinal plant known as Abrus precatorius or  ‘saga’ were used in this study.  This 
plant has been utilised traditionally to cure various ailments including cancer. The 
leaves of A. precatorius were selected to be extracted by different extraction 
techniques which employed different types of solvent. GC-MS was employed to 
provide the phytochemical analysis of the extracts. The ability of those extract to 
inhibit proliferation in cancer cells were measured using MTT assay. The best extract 
exhibiting the lowest inhibitory concentration (IC50) on the selected cancer cell, was 
selected to determine the mechanisms of action in inducing the cell death. Cell cycle 
arrest analysis, apoptosis staining with AnnexinV/PI and quantification of the 
expression of p53, Bac, Bcl-2 and Caspase-3 proteins were used to determine the 
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mechanism of cell deaths. Finally, the ability of the extract to induce immune response 
by activating NK cells was determined in a co-culture experiment of the NK cells with 
the target cell,  MDA-MB-231 cells. This was observed by the analysis of target cell 
deaths and quantification of the secretion of cytokines, interleukin-2 (IL-2) and 
interferon gamma (IFN-g); and the degranulation of the cytotoxic granules by 
quantifying the perforin (PRF-1) and granzyme B (GzmB). The results showed that 
the ethyl acetate and methanol extracts prepared using Soxhlet contained the highest 
phenolic and terpenoid compounds comparing to the other extracts. The methanol 
extract obtained by Soxhlet, APME (A. precatorius methanol extract), exhibited the 
lowest IC50 value on MDA-MB-231 cells. Further analysis by flow cytometry revealed 
APME induced cell death on MDA-MB-231 cells via apoptosis, through DNA arrest 
at G0/G1 cycle, coupled with an increase of p53, Bax and Caspase-3 expression and 
decrease of Bcl-2 expression. APME was also found to activate NK cells (from healthy 
donor) by causing NK cell cytotoxic activity via apoptosis in the target cells. Increased 
levels of INF-g and PRF-1 were also observed in this co-culture experiment. These 
findings reflect the ability of A. precatorius leaves extract to exhibit the anti-
proliferative effect on cancer cells and stimulatory effect on NK cells from the healthy 
donors. This might be due to the presence of various phytochemical compounds in the 












 Cancer is one of the leading causes of death worldwide. Choices of cancer 
treatments are bone marrow transplantation, chemotherapy, hormone therapy, 
immunotherapy, radiotherapy and surgery. Cancer chemotherapy employing cytotoxic 
drugs targeting the apoptosis pathway still remains as the main choice to eradicate 
cancer cells in medical oncology. However, the non-specificity of the drugs might also 
cause toxicity to the neighbouring normal healthy cells. Prolong exposure to these 
drugs lead to severe toxicity effects including drug resistance, infertility and 
carcinogenicity. This limitation makes the search for alternative anticancer agents that 
are not toxic to normal and healthy cells, in demand. Therefore, using the guide from 
folklore medicinal practices (Ulung and Studi, 2014), a medicinal plant,  Abrus 
precatorius, was chosen for this current study. This medicinal plant works wonder in 
traditional medicinal practices where it is widely used for many ailments such as 
coughs, diarrhoea, wound healing and even including as anticancer and anti virus 
(Ulung and Studi, 2014). The investigation started with the phytochemical analysis of 
the plant extract, ability of the plant extract to promote cell death, and finally the ability 
of the extract to activate the natural killer (NK) cells activity.  
1.1 Medicinal plants as potential anticancer agent  
Herbal medicine or medicinal plants or also referred as botanical medicine or 
phytomedicine, is broadly defined as the use of part or whole plants for illness 
prevention or treatment. Traditionaly, plants have always been the main source of 
continuous remedies for mankind since thousand years ago. Their therapeutic 
potentials were based on the observations and findings they made throughout those 
years. This knowledge of practising traditional medicinal plant is known as wisdom. 
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It led to the continuous use of the medicinal plants, and has become the basis of many 
studies that led to the discovery of drugs for many diseases including cancer.  
Most of the drugs available currently, are obtained from medicinal plants, such 
as reserpine from Rauvolfia sepentina, atropine from Atropa belladonna and 
morphine, obtained from the unripe seedpods of Papaver somniferum dried latex 
(Mondal et al., 2016). Aspirin, the analgesic drug is also one of the important example 
of drug discoveries from willow bark tree (Gonzalez and Morer, 2017). Different plant 
extracts have been proven to exert different biological activities among others include 
anticancer. Medicinal plants known to exhibit anticancer properties are generally 
comprised of a large collection of phenolic compounds. These compounds are found 
to inhibit carcinogenesis by interfering at the specific stages of the event (David et al., 
2016). Therefore identification of the composition of phytochemicals in those plants 
helped us to understand and discover more about the medicinal properties of those 
plants, besides laying out the information needed to support the traditional wisdom of 
the use of medicinal plants. 
1.2 Anti-proliferative Activity and Apoptosis effect of Medicinal Plants 
 Many studies have been carried out to investigate the effectiveness of a 
medicinal plant extracts to induce apoptosis in cancer cells. The effectiveness of the 
plant extracts to exhibit the anti-proliferative activity on cancer cells was firstly 
investigated, then ‘how’ or the mechanism of the cell death was determined. This is 
often involved the determination of the IC50 of the extract, followed by analysis of the 
apoptosis proteins expression. IC50 is the half maximal of the inhibitory concentration 
to evaluate the performance of a test substance or drug (Sebaugh, 2011). Apoptosis is 
an orchestrated programmed cell death that is characterized by specific biochemical 
and morphological properties.  
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Apoptosis is a regulated and controlled pathway of multicellular organisms to 
eliminate unwanted cells. Failure of apoptosis leads to uncontrolled cell proliferation 
that may lead to cancer. One of the ways for cancer treatment is targeting the apoptosis 
pathway, either stimulating the pro-apoptotic proteins or inhibiting anti-apoptotic 
proteins. These apoptotic proteins are known to regulate the event of the cell death. 
Among the widely investigated proteins are p53, Bcl-2 family proteins and the 
caspases (Roy et al., 2018). These proteins create a network of communication among 
each other as a response to the stimuli of initiating cell deaths. The stimuli includes 
DNA damage or stressed cells due to heat, radiation or cytotoxic exposure. Medicinal 
plants have been promoted as potential chemoprevention agents due to the human 
consumption as dietary supplement and health maintenance purposes since decades 
ago. Many scientific evidence have demonstrated that medicinal plants can inhibit the 
carcinogenesis process effectively (Singh et al., 2019). As an alternative therapy, 
medicinal plants were also administered to cancer patients to prevent and treat cancer 
in recent years (Gezici and Şekeroğlu, 2019). Therefore, the understanding of a 
medicinal plant extract ability to cause cell death through apoptosis will open up to 
possibilities of new cancer therapy or chemoprevention. 
1.3 Medicinal plants and Natural Killer Cells 
 Another area of interest in the medicinal plants research is the study on immune 
response towards the introduction of the plant extract. Furthermore, this information 
would answer if certain medicinal plants would stimulate the immune response in 
order to promote cancer cell deaths. The immune system consists of cells that prevent, 
detect and eliminate pathogens and unwanted cells in the body. Natural killer (NK) 
cells are unique innate immune cells that are important in cancer immune surveillance. 
NK cells kill target cells by recognition of the target cells surface proteins mainly the 
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lacking of MHC class I protein. However, cancer cells have their own mechanisms to 
evade this immune - surveillance. Some natural compounds have demonstrated the 
ability to act as NK cells stimulator. Vitamins are known to be useful for our body, 
and vitamins such as vitamin A, B, C, D and E also have been found to help the 
stimulation of NK cells. As reviewed by Grudzien and Rapak (2018),  phytochemicals 
that were found to act as NK cells stimulator are genistein, curcumin, ginseng extract, 
garlic extract, resveratrol, poison gooseberry extract, kumquat pericarp extract, 
prostratin, lectin and polysaccharides.  
1.4 Abrus precatorius as potential anticancer agent 
A. precatorius is native to India and mostly grows in tropical and subtropical 
areas of the world. In traditional Hindu medicine, it has been used since ancient times 
where in some regions the leaves were chewed to treat mouth ulcer. These similar 
practices were also found in other ancient cultures including China. The leaves are also 
used as nerve tonic and are useful for its anti-inflammatory properties to treat wounds 
and swellings. Oil extracted from the A. precatorius seeds are used to promote hair 
growth while the roots are used for jaundice, gonorrhoea and haemoglobinuria (Samy 
et al., 2008).  
Traditionally in Malaysia, the leaves of Abrus precatorius are used to treat 
ailments such as fever, ulcer and mouth cancer (Ulung and Studi, 2014). These 
traditional practices however have never been documented and the usage of the plant 
is only based on popular folklore among the local people. Decoction of the leaves is 
widely practised as the treatment for cold, coughs and colic. Juice from the leaves is 
applied to swellings by mixing with oil (Bamola et al., 2018). Mixture of rice starch 
and the leaf paste are consumed orally for anthrax treatment (Pokharkar et al., 2011). 
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Powdered leaves paste is used for conjunctivitis and convulsion in children (Joshi and 
Tyagi, 2011).  
Abrus precatorius is one of the medicinal plants listed to exhibit many types 
of biological activities including anticancer (Ghosh et al., 2017; Gul et al., 2018; Lebri 
et al., 2015; Oladimeji et al., 2016; Sofi et al., 2018). M. Gul et al., (2013, 2018) 
reported anti-proliferative activities of A. precatorius against human acute monocytic 
leukemia cell line (THP-1), while Sofi et al., (2013, 2018) reported the anti-
proliferative activities on MDA-MB-231. However, Sofi et al., (2013, 2018) used the 
aqueous extract and fractions prepared from gradient elution of ethyl acetate extract. 
Therefore, A. precatorius serves as a promising plant as the possible candidate for 
cancer therapy. However, deeper understanding and fundamental information needed 
to be gathered about this medicinal plant.  
1.5 Rationale & Objectives of this study 
 Many people nowadays are looking for an alternative or complementary 
treatment to chemotherapy that is not only effective to eradicate cancer cells but also 
harmless to  other healthy and normal functioning cells and tissues. Previous studies 
of A. precatorius have shown the ability of the plant to exhibit anticancer properties 
and it has been used in traditional settings since many years ago. However, most of 
these studies are from India and Africa. Less is known about the ability of our home 
grown species. In traditional setting, medicinal plants are mostly taken raw in crude 
extract form. Synergistic actions among phytocompounds in the crude extract might 
contribute to the medicinal properties of these plants (Ma et al., 2009), furthermore, 
few studies have suggested that the crude extract usages were more effective compared 
to using isolated single compound (Aiyelaagbe et al., 2011; Rasoanaivo et al., 2011).  
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A deeper understanding of the ability of A.precatorius to induce cytotoxicity and 
promote immune stimulation were investigated, in order to provide beneficial 
fundamental pharmacological information on this medicinal plant. Therefore, the 
objectives of this study are as follows: 
General Objective: 
 To study the ability of Abrus precatorius leaves as an anticancer agent through 
its ability to induce apoptosis and to promote the activation of natural killer cell.  
 
Specific Objectives: 
1. To employ different extraction strategies on A. precatorius leaves employing 
different extraction processes and solvents and analyse the presence of the 
phytochemical compounds by gas chromatography mass spectometry (GC-
MS) 
2. To determine the effects of the extracts as anti-proliferative agents on the 
selected normal and cancer cell lines and to investigate the mechanism of cell 
death imposed by the selected extract on the corresponding cancer cell.  
3. To observe the ability of the selected extract to induce Natural Killer (NK) 
cells activation in co-culture experiment with the selected cancer cells, using 












The word ‘cancer’ is originated from the word ‘carcinoma’ from Latin that 
means, crab.  Cancer is the most feared disease and it refers to the malignant tumours 
resulted from abnormal cell growth. Cancer is one of the leading causes of death 
globally with 9.6 millions mortalities in 2018 (World Health Organization, 2018). The 
prevalence is increasing in both men and women where one in every six deaths is due 
to cancer.  Among the top leading cancer fatalities are colorectal, stomach, lung and 
breast. In Malaysia, out of 43, 837 new cases reported in 2018, 7593 of them were 
breast cancer cases (World Health Organization, 2019a). Prevalence of cancer cases 
reported in Malaysia is presented in Figure 2.1.  Most of the cancers affect the age 
group of 50 – 60, however the incident of the disease is not affected by sex. 
Conversely, the site of growth differs between men and women, which cause men to 
be associated with intestine, prostate and lung cancer, while women are mostly 




Figure 2.1: Cancer cases reported in Malaysia in the year 2018  
The chart is recreated from the data published by  
(World Health Organization, 2019a) 
 
 
2.1.1 Hallmark of Cancer 
 Normal cells have many factors controlling their growth and proliferation. 
Their growth are normally regulated by growth factors. If the cells are damaged, there 
will be another regulatory mechanisms that will stop their growth and division until 
they are repaired. If the damage is irreparable, the cells will “self destruct”. Therefore, 
in order for cancer cells to survive, they have to overcome these regulatory factors 
controlling the normal cells mechanisms. Hanahan and Weinberg (2016) has outlined 
eight hallmark capabilities of most forms of cancers. Each capability has a different 



























1. “Sustaining proliferating signalling”. 
Generally, one of the known criteria of cancer is the uncontrollable cell proliferation. 
The inappropriate cell proliferation is resulted from disrupt cellular regulatory 
network. Induction and repressive signals control cell proliferation. The inductive 
signals are chronically sustained, causing inappropriate stimuli for cell proliferation. 
This often involves gene mutations that drive the cancer cell proliferation. These 
mutated genes are known as oncogenes.  
2.  “Evading growth suppressors”  
Cancer occurs when tumour suppressor genes (TSGs) failed to stop initiation of cancer 
cell-division process. In the cells internal system, p53, one of the TSGs, mediates the 
cells regulation to ensure they only proceed to their growth and division cycle after 
appropriate state of cell physiological is achieved. In a stressful event in the cell, p53 
will be activated and induce programmed cell death, thus stopping cell proliferation. 
However, mutation or defect in p53 pathway were identified in majority of human 
cancers that allows continuous cancer cell proliferation.  
3. “Resisting cell death” 
Normal and healthy cells have the ability to “kill themselves” in an orchestrated cell 
death program known as apoptosis. Besides apoptosis, cell death also occurs by 
autophagy, and necroptosis. Cancer cells lose this ability to self-destruct thus 
promoting continous proliferation. Proper signalling to induce cell death is disrupted 
causing cancer cells to resist cell death.  
4. “Enabling Replicative Immortality” 
Normal cells are able to die after several cell division processes however cancer cells 
are able to escape this and become immortal, where they can not divide (senescence) 
 
 10 
or die. This is due to the length of the telomeres in cancer cells DNA that has been 
manipulated to increase at each division time, therrefre avoiding senescence.  
5. “Inducing angiogenesis” 
Angiogenesis is a process that demonstrates the formation of new blood vessels. 
Cancer cells are able to initiate angiogenesis to ensure that they receive continuous 
oxygen and other nutrients supply. Cancer cells need to activate their “angiogenic 
switch” which reduce the factors inhibiting the formation of new blood vessels and 
increase the factors promoting formation of new blood vessels.  
6. “Activating invasion and metastasis” 
Established cancer cells can become invasive and migratory. Cancer cells are able to 
invade neighbouring tissues including the blood and lymphatic vessel that provide a 
pathway for the cells to disseminate to other anatomical sites. This is where the tumour 
will be categorized as being benign or malignant.  
7. “Deregulating Cellular Energetics and Metabolism” 
Cancer cells utilize the abnormal metabolic pathway to create energy to support their 
proliferation and survival. This is a concept introduced almost a century ago by Otto 
Warburg where the cancer cells uptook glucose and demonstrated glycolysis, even in 
the presence of oxygen. This aerobic glycolysis produces building blocks and ATP 
required for cell growth and division.  
8. “Avoiding Immune Destruction” 
Cancer cells must find ways to  avoid the immune surveillance. They are able to avoid 
the immune surveillance because of most of the antigens expressed on cancer cells are 
most likely shared by their normal cell-of-origin. Antigens on the cells are being 
ignored by the immune system and reflecting immune self-tolerance of the cancer 
cells. Some of the cancer cells are also able to express antigens that are not tolerateable 
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by the immune system, such as new antigens produced due to the genome mutation 
and embryonic antigens.  
2.1.2 Cancer therapy 
 Upon diagnosis with cancer, patients will be subjected to different types of 
treatments based on the type of cancer, locality, and stage. Cancer treatments available 
today are surgery, chemotherapy, radiotherapy, immunotherapy, vaccination, 
photodynamic therapy, stem cell transformation or any combination of the 
aforementioned treatments. These treatments are normally accompanied by side 
effects including toxicity, non-specificity, restriction in metastasis and fast clearance 
(Mukherjee and Patra, 2016; Patra et al., 2014).  A lot of efforts were made to reduce 
the side effects of cancer therapy such as preventing damage of the chemotherapy 
drugs on neighbouring cells, aggregate drug accumulation and lesion efficiency, 
acquiring novel drug delivery and targeting system (Vinogradov and Wei, 2012). 
Chemotherapeutic agents work on different molecular targets, such as: 
1) topoisomerase inhibitors such as irinotecan and doxorubicin 
2)  alkylating agents such as oxaliplatin, melphalan, carboplatin, and 
cisplatin 
3)  microtubule acting agents such as vincristine, vinblastine, paclitaxel 
and docetaxel 
These drugs give side effects such as neutropenia, diarrhoea, cardiotoxicity, 
nephrotoxicity, gastrointestinal toxicity, hematologitoxicity and many more (Caruso 
et al., 2000; Iqbal et al., 2017; Weaver, 2014). The aforementioned drugs are very 
effective on a broad range of cancers however, their limitations are not disregardable, 
among others include the high price-tag, not eco-friendly, besides having the side 
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effects and toxicity.  Cancer cells might develop drug resistant as they progress 
through mutation. For example, MCF-7, breast cancer cells exhibit over-expressed 
drug resistant genes (ABCA12 and ABCA4) when docetaxel was applied. However, 
downregulation of those genes was observed when application of docetaxel was 
applied alongside with curcumin, a phytocompound found in tumeric (Aung et al., 
2017). Therefore, applying single-target anticancer agent is not the only option for 
efficacy of cancer treatment. Thus, employing phytochemicals and their analogues 
serve as alternative promising options for cancer treatment for better and lesser toxicity 
treatment (Singh et al., 2016).  
2.2 COMPLEMENTARY AND ALTERNATIVE MEDICINE 
A huge reservoir of bioactive compounds exists in over 400 000 species of 
plants on Earth, but only a small percentage have been examined in research studies. 
Plants have been and continue to be an important source for therapeutic uses.  In many 
developed countries, plant products use in complementary and alternative medicine 
(CAM) are popular. Approximately, more than 80% of the population worldwide 
depend on the traditional medicine or folk medicine as their primary healthcare needs 
as reported by WHO (Qi, 2013).  
Herbal medicine usages in Asia embodies the history of the interaction between 
human and the environment. In Africa, the ratio of traditional healers to population is 
1:500, however, the ratio of medical doctors to the population is broader at 1:40 000. 
This might be due to the locality of majority of the African population that lives in the 
rural areas. On that note, even in well-developed countries equipped with advanced 
conventional healthcare system like Singapore and Korea, 76-86% of their respective 
population still relies on traditional medicine (Qi, 2013). About 62.9% of cancer 
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patients in non-Asian countries reported to have used CAM (Saghatchian et al., 2014). 
Approximately 40% of the cancer patients in Australia, New Zealand, Europe, Canada 
and the United States were reported to use CAM (Horneber et al., 2012).  
Findings from the 2015 National Health Morbidity Survey showed that 29.95% 
of Malaysian used CAM with consultation in their lifetime (World Health 
Organization, 2019b). Report from WHO (2019) also stated that 9 million users of 
CAM were reported among the Malaysian estimated population of 30 million. In 
Malaysia, the reported use of CAM was USD 500 million, annually, comparing to 
about USD 300 million spent on the use of conventional medicines (World Health 
Organization, 2002). Among CAM practices available in Malaysia and recognized by 
the Traditional and Complementary Medicine (Recognized Practice Areas) Order 
2017, are traditional Malay medicine, traditional Indian medicine, traditional Chinese 
medicine, Islamic medical practice, homeopathy, chiropractic and osteopathy (World 
Health Organization, 2019b).  
CAM users among cancer patients in Asian countries were reported as follows: 
97.2% - China (Chen et al., 2008), 79.3% - Taiwan (Ku and Koo, 2012), 60.9% - 
Thailand (Puataweepong et al., 2012), 55.0% - Singapore (Chow et al., 2010) and 
57.4%-Korea (Kang et al., 2012). According to the study by Siti et al. (2009), the 
usage of CAM among Malaysian’s adult was estimated about 67.6-71.2% during their 
lifetime. They also highlighted the main CAM used were biological-based therapies 
(88.9%), manipulative and body-based therapies (27.0%), mind-body medicine 
(11.1%) and traditional medicine (1.9%) (Siti et al., 2009). The usage of CAM among 
Malaysian breast cancer patients were 64.0% (Shaharudin et al., 2011) and 88.3% 
(Gopal et al., 2013), while the prevalence of CAM usage among breast cancer 
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survivors in Peninsular Malaysia was 51.0% (Saibul et al., 2012). And in recent 
studies, CAM users among Malaysian breast cancer patients was 70.7% (Chui et al., 
2018) and 34.8% (Zulkipli et al., 2018). Dietary supplementation was reported as the 
most frequent use of CAM.  
High demand on CAM usages indicates that more information is needed to be 
explored and disseminate to the mass especially on the efficacy of the utilization of 
medicinal plants as well as the toxicity dosage of the plant. Most CAM practices are 
based on cultural and historical influences and this knowledge was passed on from one 
generation to another generation, however, scientific evidence supporting their usages 
are lacking.  Malaysia has been actively regulating the traditional medicine practices 
in order to control the usages and practices in this country. Efforts were made in order 
to document all information as a reference for practitioners and consumers. Traditional 
medicine units were also being set up in 15 hospitals around Malaysia. Integrative 
traditional medicine and practices are practised in addition to the conventional 
allopathic medicine and many patients have benefited from this integrative programme 
since its introduction in 2007 (Meow, 2018).  
2.3 MEDICINAL PLANTS AND CANCER 
 Medicinal plants have always centred around the traditional medicine 
practices. These plants have also continuously providing resources for mankind in 
search of remedies to various diseases and ailments. Historically, the initial usage of 
medicinal plants originated from China in 5000 BC. Tyler (1999) reported that natural 
medicines were widely used up until the first half of twentieth century, when after that 
synthetic medicine took the front seat. Natural products such as vegetables, fruits, tea, 
grains, spices, nuts, herbs, and medicinal plants are rich in phenolic, flavonoids, 
alkaloids, carotenoids, vitamins, minerals and other organic materials. Therapeutics 
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capabilities of these plants, especially the medicinal plants include antiviral, 
antitumour, antimalarial, and anti-inflammatory activity.  
One of strategy to combat cancer is through chemoprevention using natural 
product to suppress, prevent and reverse pre-malignancy before the cancer become 
aggressive. Scientific interest towards medicinal plants to combat cancer has recently 
gained popularity. 35 000 plant species were screened by The National Cancer 
Institute, USA (NCI) for the anticancer activities and among that about 3000 plants 
were able to demonstrate reproducible anticancer activity (Desai et al., 2008; Roy et 
al., 2018).  
Anticancer medicinal plants are known to contain a huge reservoir of 
polyphenolic components (David et al., 2016) and other phytocompounds that are able 
to inhibit progression and development of cancer (Aung et al., 2017). Table 2.1 listed 
some medicinal plants with reported anticancer activity in the year 2018 and 2019.  
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Table 2.1 : Medicinal plants with anticancer activities reported in the year 2018 & 2019 







Induction of apoptosis and anti-proliferative activities against 
breast cancer cell, monocytic leukemia (THP-1), and 
chemopreventive effect in mice model experiment 
 
 
Sofi et al. (2018), Gul et al. 
(2018), Wan-Ibrahim et al. 
(2019) 
 
Alangium salviifolium Sage Induction of apoptosis and anti-proliferative activity against 
melanoma and non-melanoma cancer cells 
 
Dhruve et al. (2019) 
Allium cepa Onion Cytotoxic effect on colon cancer cells (WiDr) 
 
Fadholly et al. (2019) 
Allium sativum Garlic  Anticancer effect on MKN74 cell line  
 
Korga et al. (2019) 
Alpinia galanga Galangal Induced cytotoxicity and apoptosis in human lung cancer cells 
and murine lymphoma 
Anticancer effect in T47D cells 
 
Lakshmi et al. (2019), 
Dai et al. (2018), 
 
Annona muricata Soursop Induced apoptosis in breast cancer cells Kim et al. (2018a), Arif et 
al. (2018) 
 
Bacopa monnieri Indian pennywort 
 
Inhibited growth of colon cancer cells by inducing cell cycle 
arrest and apoptosis 
 
Smith et al. (2018) 
Brassica oleoracea Cabbage Anticancer effect of ethanol extract on hepatotocellular 
carcinoma 
 




Table 2.1 Continued    
Plant Scientific Name Common Name Reported Activity Reference 
Caralluma retrospiciens  Bitter cress Apoptosis in breast cancer cell lines Alallah et al. (2018) 
 




In vitro and in vivo protective effect against oxidizing agent in 
cancer experimental models 
 
 
Siddique et al. (2018) 
Coriandrum sativum Coriander Anticancer effects on prostate cancer cell lines  Elmas et al. (2019) 
 
Crinum amobile Spider lily Anticancer activity of chloroform leaves extract on MCF-7, 
MDAMB-231, HCT-116 and HT-29 cells 
 
Lim et al. (2019) 
Curcuma longa Turmeric Anti-proliferative activity in cancer cells 
 
Sheikh et al. (2018) 
 
Cymbopogon citratus Lemongrass Decreases prostate cancer and glioblastoma cell survival 
 
Bayala et al. (2018) 
Eurycoma longifolia ‘Tongkat Ali’ Anticancer efficacy against lung carcinoma (A-549 cells) and 
breast cancer (MCF-7 cells), through upregulation of p53 and 
Bax, down regulation Bcl-2 
 
Thu et al. (2018) 
Diosphyros kaki L. Persimmon Inhibited liver tumour growth in vivo via enhancement of 
immune function in mice  
 
Chen et al. (2018) 
Ficus deltoidea 
 
Mistletoe fig / 
‘Mas cotek’ 
Ethyl acetate extract demonstrated anti-proliferative activity 
on MCF-7, MDA-MB-231, HCT 116 
 
Abolmaesoomi et al. (2019) 
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Table 2.1 Continued    
Plant Scientific Name Common Name Reported Activity Reference 






Downregulation of histone demethylase JMJD5 prevent the 
progression of breast cancer cells 
 
 
Wang et al. (2018b) 
Lawsonia inermis  Henna tree Branch methanolic extract inhibited the invasion of HT1080 
cells strongly 
 
Nakashima et al. (2018) 
Moringa oleifera Moringa 
 
Induction of apoptosis and downregulation of AKT pathway in 
human prostate cancer 
 
Ju et al. (2018) 
Murraya koenigii 
 
Curry tree Exhibited anticancer activity on various cancer cell lines Samanta et al. (2018) 
Nigella sativa Black seed Inhibited proliferation and angiogenesis, induced apoptosis in 
Hela and HepG2  
 
(Maqbool et al., 2019) 
Ocimum tenuiflorum Holy basil Anticancer activity of methanol leaves extract on MCF-7 cells 
 
Lam et al. (2018) 
Orthosiphon stamineus Java Tea /  
‘Misai Kucing 
Inhibit proliferation and induced apoptosis in uterine fibroid 
cells 
(Pauzi et al., 2018) 
Perekia bleo Rose cactus 
/‘Duri 7’ 
Induced cell death by cell cycle arrest and apoptosis in HeLa Mohd-Salleh et al. (2019) 
 
Syzgium polyanthum Bay leaf Low cytotoxic effect against breast cancer cells MCF-7 
 




Medicinal plants are generally known because of the medicinal properties that 
they exhibited through their biological activity. Active compounds or substances refers 
to the constituents produced or stored in the plants that have physiological effects on 
living organisms (Rafieian-Kopaei, 2012). Most medicinal plants used for treatment 
contain properties including compounds that give synergistic actions. These 
compounds are beneficial as a source of drugs discoveries (Rasool Hassan, 2012). 
Different parts of the plants are utilized for the medicinal purposes including root, 
seed, leaves, flowers, stem, bark, fruits, or even the whole plant. Active compounds 
from these organs may have indirect or direct therapeutic effect that make them 
suitable as medicinal agents.  
Phytochemicals are any of biologically active compounds found naturally 
occurring in plants. The term ‘bioactive compound’ is defined by the ability of the 
compound to interact with one or more component of a living tissue to generate 
probable effects (Guaadaoui et al., 2014). Some of these compounds interact with each 
other and gives synergistic actions and this interaction might be beneficial or harmful 
to either of the components that contribute to their biological activities. These 
compounds are also characterized by their ability to prevent certain disease 
development including cancer.  
Plants contain thousands of phytochemicals that are generally classified into 
primary and secondary metabolite. Primary metabolites are compounds that are 
responsible for plant growth, development and reproduction. Secondary metabolites 
referes to compounds that do not involve in those processes (Singh, 2015). Some 
classified these secondary metabolites as non-nutrient compounds that have been 
found to exert biological activity in human and link with reductions of 
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noncommunicable chronic diseases (Liu, 2013).  Out of that only a few belongs to the 
primary group while the rest are classified as secondary metabolites which are 
subdivided based on their chemical structures. Phytochemicals are also classified 
based on their biosynthesis pathways, botanical origins, or biological properties. 
Figure 2.2 exhibit the phytochemical classifications which consist of carbohydrate, 
lipids, terpenoids, phenolic acids and alkaloid or other nitrogen containing 
metabolites.  
Phenolics are compounds with at least one aromatic ring containing hydroxyl 
group. This compound is easily found in vegetables, fruits, legumes, cereals, wine, 
chocolate, tea and coffee which contributed to more than 8000 of phenolic compounds 
have been isolated (Gao and Hu, 2010). Phenolics exhibited anti-proliferative effect 
on several cancer cells by inhibition of topoisomerase or phosphatidylinositol-3-kinase 
and also cell cycle arrest. Phenolic compounds can also accelerate oxidative damage 
either to the proteins, carbohydrates or to the DNA (Vaghora and Shukla, 2016). 
Another phytochemical group belongs to the phenolic is known as flavonoid. In a 
study using animal models, flavonoids were found to give protective effect against 
tumour initaiton and progression (Batra and Sharma, 2013). Alkaloids also have 
demonstrated the anti-proliferative effects on different types of cancers in vivo and in 
vitro (Lu et al., 2012). Some of the anticancer agents found from alkaloids groups are 







Figure 2.2: Phytochemical classifications.  
Adapted from (Huang et al., 2012; Mondal et al., 2019; Nizami and Sayyed, 2018; 
Sharma et al., 2017; Vermerris and Nicholson, 2007) 
 
2.3.2 Plant extraction 
 Human depends on raw plant materials to access the medical needs in health 
maintenace and to cure diseases and ailment. Natural products extracted from 
medicinal plants either as crude extract or pure isolated compounds gives endless 
opportunity for novel drug discoveries since abundance of chemical diversity existed 
from plants on our planet. Historically, in most household, medicinal plants were used 
as a whole plant rather as a single pure compound (Cos et al., 2006).  Definition of 









flavanoids, phenolic acids, stillbenoids, 
tannins, lignans, xanthones, quinones, 
coumarins, phenylpropanoids, 
benzofurans





indole, isoquinoline, lycopodium peptide,
pyrrolidine, piperidine, quinolizidine,
amino acids, amine, peptides, proteins
monounsaturated fat, polyunsaturated fat,






Extraction is a crucial process in analysis of medicinal plants to obtain 
bioactive compound from biomass materials. The extraction process is performed to 
increase the amount of target compound. This will increase the chance of obtaining 
maximum biological activities from the extract.  This process starts with plant 
collection and identification, washing, drying, and grinding. Grinding to homogenize 
sample is important to increase surface contact area of the plant material with solvents. 
If the plant of interest is chosen based on traditional uses, therefore it is important that 
the preparation of the plant should be prepared as closely as possible mimicking the 
traditional preparation.  
 Maceration is a technique used widely in medicinal plant research and it is 
adapted from the art of wine making. This process involve soaking of the plant 
materials with a solvent in a closed container for a period of time, with frequent 
agitation (Chemat et al., 2017). Basic principle of maceration is to soften the cell wall 
of the plant and then releasing the soluble phytochemicals. After the soaking period is 
over, the mixture is filtrated, and the flow-through is then collected and dried to obtain 
the extract. This process uses a large amount of solvent and a longer period of time.  
 
Decoction is a method that uses similar principle as maceration except that the 
plant is boiled in a specific volume of water. This extraction process is normally done 
on hard plant materials such as root and barks and suitable for heat stable compound. 
Another extraction method is known as Soxhlet extraction. A porous bag known as 
“thimble” is used to place finely ground sample. Thimble is made of a strong cellulose 
or filter paper and it is placed in a thimble chamber of the Soxhlet apparatus (Figure 
2.3). This is a hot continuous process. Solvent is placed in the bottom flask, boiled and 
the vapour arises will reach the sample thimble and condenses at the condensation 
chamber and finally drip back into the bottom flask. Contrary to maceration, Soxhlet 
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uses lesser quantity of solvent , however the solvent used must be high-purity and that 
could be costly (Azwanida, 2015). Figure 2.3 shows the conventional systems used for 
medicinal plants extraction.  
Extraction efficacy is highly depending on the extraction method, temparature, 
time length and the solvent choice. Extraction yield obtained after an extraction 
process and its biologocial activity, does not only relies on the extraction technique 
but also the choice of the solvent used. In the same extraction condition, the most 
important paramenter that need to be consider is the solvent choice (Ngo et al., 2017). 
Different types of solvents can be use in addition to water which include hexane, ethyl 
acetate, ethanol, methanol, chlorofom and many more. Choice of the solvent depends 
on each plant and the target compound (Ajanal et al., 2012; Mahdi-Pour et al., 2012).   
Hexane is normally used to dissolve non-polar compounds such as wax, lipid, 
lignin and aglycon (Indarti et al., 2019). Ethyl acetate is a semi polar solvent, used to 
dissolve semi and non polar compounds (Kasitowati et al., 2019) such as sterol, 
alkaloid, terpenoid, and flavanoid. Methanol is able to extract polar compounds such 
as amino acids, sugar, glycoside, low and medium molecular weight phenolic 
compound, flavanoid, terpenoid, saponin, tannin and polyphenols (Solomon et al., 





Figure 2.3: The conventional extraction methods for medicinal plant extraction. Modified from Belwal et al. (2018) 
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2.4 The medicinal plant: Abrus precatorius 
 
Figure 2.4:  Abrus precatorius plant twining around a tree.  




Abrus precatoriu, as shown in Figure 2.4, is a flowering plant that belongs to 
legume family, Fabaceae. The common names of A. precatorius include: jequirity, 
Crab’s eye, Rosary pea, precatory pea or bean, John crow bead, Indian licorice, Akar 
saga, and jumble bead. Phenotypically this plant is characterized as a slender, perennial 
climber that twines around trees, shrubs and hedges Abrus can be found in different 




Table 2.2: Different varieties of Abrus genus.  
Abrus Varieties Countries Reference 
Abrus aureus Madagascar  Solanki and Zaveri (2012) 
Abrus baladensis Somalia  Thulin (1994) 
Abrus bottae Saudi Arabia, Yemen Al-Safadi (1994) 
Abrus canescens Africa Agbagwa and Okoli (2005) 
Abrus cantoniensis China Zhang et al. (2015) 
Abrus diversifoliatus Madagascar Okhale and Nwanosike (2016) 
Abrus fruticulosus India, Brazil de Vasconcelos et al. (2018) 
Abrus gawenensis Somalia Thulin (1994) 
Abrus kaokensis Africa Swanepoel and Kolberg 
(2011) 
Abrus laevigatus South Africa Pandhure et al. (2010) 
Abrus longibracteatus Laos, Vietnam Mondal and Parui (2014) 
Abrus madagascariensis Madagascar Quattrocchi (2012) 
Abrus parvifolius Madagascar Quattrocchi (2012) 
Abrus precatorius India, Malaysia, Sri Lanka, Africa, Florida, Hawaii, South America, 
Australia, all tropical region  
(Pavithra et al., 2019) 
Abrus pulchellus Africa, China Zhang et al. (2015) 
Abrus sambiranensis Madagascar Verdcourt (1970) 
Abrus schimperi Africa Rahman et al. (2011) 
Abrus somalensis Somalia Quattrocchi (2012) 
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2.4.1 Traditional uses of Abrus precatorius 
 Aerial, leaves, stem and roots are all parts of A. precatorius used in the 
traditional system. Leaves are generally used to cure fever, stomach pain, headaches, 
asthma and skin diseases including itching and wound healing. Maceration of the 
leaves in warmed mustered oil is used to relieve pain of rheumatism affected area. 
Similarly, the juice of the leaves, blended in some oil is also used to relieve local pain 
(Joshi, 2019). In case of leukoderma and menorrhagia, powdered leaves mixed with 
sugar are consumed. Some practices take the leaves for managing diarrhoea, gastritis, 
insomnia, kidney diseases and cancer  (Attal et al., 2010). 
 Roots of A. precatorius is known to be emetic and alexiteric. Aqueous extract 
of the root is beneficial to relieve bad cough. It is used as substitute for liquorice and 
taken orally for sore-throat reliever.  The roots also useful in treatment of gonorrhoea, 
jaundice and infections (Daniel, 2016). The seeds are used for nervous system remedy, 
and applied externally for skin diseases, ulcers and on hair. Seed paste can be applied 
for muscle stiffness, sciatica, shoulder pain, paralysis and other nervous disorder. For 
contraception, the seeds are taken orally to prevent conception by interfering the 
uterine function .  
The traditional uses of A. preactorius also differ from one ethnic background 
to another. Not only differ on the choice of plant parts, but also methods in preparing 
them. Table 2.3 listed the traditional way of how A. precatorius is utilised in different 





Table 2.3: Ethnomedicinal use of A. precatorius summarized from Ross (2003) 
Part of the plant Preparation Acclaimed medicinal use Country 
Leaves Powder Antidote Brazil 
Decoction (dried) Nerve tonic 
Juice Gonorrhoea, stomach-aches 
East Africa 
 
Powder Swellings, cuts 
Decoction Inflamed eyes, chest pain 
Decoction Coughs and flu Haiti 
Decoction  Eye disease India 
Decoction Aphrodisiac, facilitate in childbirth Ivory coast 
Juice Coughs Africa 
Paste Antifertility Sudan 
Juice Antiinflammatory Thailand 
Decoction Coughs Tanzania 
    
Seeds Powder Aphrodisiac Afghanistan 
 Decoction Malaria Cambodia 
 Powder Intestinal worms, oral contraceptive Africa 
 Powder Aphrodisiac Egypt 
 Decoction Antifertility, contraceptive, for tuberculosis treatment and painful swelling India 
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Table 2.3 Continued  
Part of the plant Preparation Acclaimed medicinal use Country 
 Decoction Aphrodisiac Nepal 
 Decoction Aphrodisiac, abortion Pakistan 
 Decoction Coughs Virgin Island 
 Decoction Purgative West Indies 
    
Roots Decoction Asthma, aphrodisiac Tanzania 
 Decoction Bronchitis, hepatitis Taiwan 
 Decoction Antimalarial, anticonvulsant Nigeria 
 Decoction Aphrodisiac Mozambique 
 Juice Abortion India 
 Chewed Aphrodisiac Africa 
 Chewed Snake bite Africa 
 Decoction Nerve tonic Africa 
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2.4.2 Phytochemistry of Abrus precatorius 
 Roots from A. precatorius have documented presence of compounds such as 
abrol, abrasine, pre-casine and precol. Meanwhile the mostly studied and potent 
bioactive compound from the seed is abrin. Abrin is toxic, containing poisonous 
protein,  which could be fatal when ingested. However, the seed coat protects human 
from the toxin (Das et al., 2016).  
A review written by Ross (2003) listed all the compounds identified in the leaf 
of A. precatorius from the early years (1968 – 1981) include; arabinose, galactose, 
glycyrrhizin, hemiphloin, hypaphorine, inositol, montanyl alcohol, myricyl alcohol, 
pinitol, precatorine, trigonelline and xylose. Sweet tasting compounds were discovered 
in the leaves of A. precatorius. These compounds are asabrusoside, which is a 
triterpene glucoside;  and glycyrrhizin. They are low in calorie but taste sweeter than 
normal sucrose. The level of sweetness is 30-100 times more than sucrose.  
Compounds that have been discovered from the leaves are abrusoside- (A-E) 
(Choi et al., 1989; Kinghorn and Soejarto, 2002), pterocarpan (Malele et al., 2015); 
abrusprecatins A-C, medicarpin, maackiain and 4-hydroxy-3-methoxy-8,9-
methylenedioxypterocarpan (Li et al., 2019); stigmasterol and b-monolinolein (Sofi et 
al., 2018). Other compounds that were also discovered from the leaves are flavonoids 
(vitexin, liquirtiginin-7-mono- and diglycosided), triterpene (abrusgenic acid, 
abruslactone A, and mehyl abrusgenate) and toxifolin-3-glucosides (Attal et al., 2010; 





2.4.3 Reported Pharmacological activities of Abrus precatorius 
 Anticancer activity of A. precatorius leaves has been previous mentioned at 
section 1.4. Here, the other pharmacological activities of A. precatorius in seeds, roots, 
aerial and leaves, are listed.  
2.4.3(a) Seeds 
 The microglial cells (MCG) activation from the Alzheimer’s Disease (AD) 
patients’ brain was able to be identified by A. precatoirius agglutinin. It was able to 
identify the MCG in the white matter of the cerebral from all AD patients studied. 
Identification of novel markers in MCG research is crucial in order to understand better 
the role of these cells in  the metabolic/ dysmetabolic control of AD (Zambenedetti et 
al., 1998). Anti-diabetic activity of the chloroform and methanol extract of A. 
precatorius was reported in diabetic rabbits (Monago and Alumanah, 2005).  The 
chloroform and methanol seed extract also showed anti-fertility in rats (Bhutia et al., 
2009). Ethanolic seed extract was found to cause DNA damage in spermatozoa that 
lead to teratogenic effect which exhibit the antifertility activity of A. precatorius 
(Jahan et al., 2009). Anti-spermatogenic effect was shown by the A. precatorius 
hydraalcoholic extract (Soni et al., 2015). Aborfacient and anti-implantation effect was 
also observed in pregnant rats (Solakhia et al., 2019). A. precatorius seeds extract also 
showed potent antimicrobial activity (Bobbarala and Vadlapudi, 2009). The 
antibacterial and antifungal activity was because of the presence of certain compounds 
such as falvanoids, alkaloids and saponin (Vinayaka et al., 2010). Cytotoxic effects on 
HepG2 cells was observed in the experiment using the hydroalcoholic seed extract 
(Gautam, 2017). Significant immunomodulating activity was observed on cellular 





 Alcoholic extract  and ethanol extract from fresh roots showed anti-convulsant 
activity and anti-depressant activity in mice, respectively (Moshi et al., 2005; Okhale 
and Nwanosike, 2016).  
2.4.3(c) Aerial and Leaves 
 Petroleum ether extract of the aerial part of the A. precatorius reported 
neuroprotective activity in hypoxic neurotoxicity rats (Premanand and Ganesh, 2010). 
The aqueous extract exhibited nephrotective effect on nephrotoxicity-induced 
HEK293 (Sohn et al., 2009). Isoflavanquinone and abruquinone, isolated for the aerial 
part demonstrated antimalarial activity (Limmatvapirat et al., 2004). Crude ethanol 
extract of the leaves exerted significant neuromascular effect by blocking the phrenic 
nerve diaphragm in the rat (Wambebe and Amosun, 1984). Antiepileptic activity was 
reported from the aqueous extract of the leaves (Moshi et al., 2005). A recent study 
showed that the ethanolic extract exhibited analgesic and neuropharmacological 
activities that proposed the utilization of A. precatorius in pain management, 
psychiatric and neurological conditions (Mondal et al., 2017). In another study, the 
methanolic leaves extract showed antidiabetic, antimicrobial and cytotoxic effect in 
brine shrimp lethality assay (Adekunle Alayande et al., 2017).  
2.5 APOPTOSIS 
 The first visualized human cell death was observed in a report on yellow fever 
in 1890 (Councilman, 1890), where he discovered vacuolated acidophilic bodies from 
hepatic tissue of yellow fever patients. This bodies were sometimes referred to as the 
Councilman bodies. Despite the early discovery of those bodies, it took about 70 years 
to reveal that the Councilman bodies were actually dying or dead cells with the help 
of the electron microscope (Bosurgi et al., 2017; Kerr, 1969). It turned out that those 
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dying cells were not only unique in liver damage observation but also in other tissues 
and later, a detailed morphological and description of these cell deaths were published. 
This phenomenon was then termed as apoptosis (Kerr, 1971; Kerr et al., 1972). 
One of the causes of cancer is the failure of the cells to undergo apoptosis. 
Failure of apoptosis in cells lead to tumorigenesis by inhibition of the signals and 
activation of proteins involved in the apoptosis pathway. Apoptosis is process known 
for a programmed cell death or “cellular suicide”. It is a key event in many biological 
processes, such as removal of the webbing between fingers and toes in embryos. This 
is known as programmed cell death because the death is specific and at the defined 
times during development (Hassan et al., 2014). Another example of apoptosis is the 
resumption of the tadpoles’ tails when they undergo metamorphosis. In human, 
apoptosis occurs continually. When cells are infected by pathogens or when the white 
blood cells reach the end of their lifespan, they are eliminated through apoptosis.  
Apoptosis also occurs in a hormone-dependant physiologic involution such as 
the involution of endometrium lining during the menstrual cycle. Cell deletions in 
proliferation cell population such as in the intestinal crypt epithelium also demonstrate 
the event of apoptosis. Among pathological causes that lead to apoptosis are stimuli of 
mild injuries such as heat, radiation, or cytotoxic exposure that result in irreparable 
DNA damage, which ends with the suicidal pathway. The event of apoptosis is also 
beneficial in cell injuries cause by pathogens, besides it is mainly important in 
programming the cell death in tumours. Millions of cells die every minute in human 
body and being eliminated. However, mutations in some of the proteins that are 
involved in apoptosis pathway, may lead to tumour formation and cancer (Cao and 
Tait, 2018).  
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The first cell death programme was demonstrated in the nematode 
(Caenorhabditis elegans), where the key genes involved in apoptosis were identified 
(Malin and Shaham, 2015). Subsequent studies showed that many other organisms, 
including mammals, use similar proteins to commit cellular suicidal. Apoptosis is 
different from necrosis, another type of cell death. Necrosis involves swelling and 
rupture of the injured cells, while apoptosis involves a specific series of events that 
leads to cell death. Apoptosis is characterized by morphological changes including 
membrane blebbing, chromatin condensation, and nuclear fragmentation (Figure 2.6).  
During the early stage of apoptosis in a cell, DNA segregates near the periphery 
of the nucleus thus the volume of the cytoplasm decreases. After that, cell begin to 
produce small bubble-like cytoplasmic extensions known as “blebs” and the nucleus 
and organelles begin to fragment into membrane-bound vesicles knows as apoptotic 
bodies. The apoptotic bodies are eliminated through phagocytosis by macrophages or 

























2.5.1 Apoptosis pathway  
All of these morphological changes leading to apoptosis are the results of the 
activation of a cascade of intracellular factors known as caspases (cysteine aspartyl-
specific proteases). It can occur by activation, up regulation and/or downregulation of 
many types of protein. There are two main routes where caspases can be activated and 
enters the apoptotic pathway.  
The first pathway is known as the extrinsic pathway where cells receive death 
signals produced by cytotoxic-T cells in response of damaged or infected cells that 
initiate the apoptotic cascade (Zaman et al., 2014). Two well-known death signals are 
received by the tumor necrosis factor (TNF) receptor and the Fas receptor or CD95. 
The CD95 ligand (Fas Ligand) will bind to the CD95/Fas receptors of the infected cell. 
This aggregation will result in the attachment of FADD (Fas associated death domain), 
an adaptor protein, to the cluster. This will activate the procaspase-8, a protease, to 
assemble at the site of the cluster and thus cleave into an active caspase-8 protein. 
Procaspase-8 also cleaved procaspase-3 into caspase-3 protein. Activation of caspase-
8 and caspase-3 are important in order to activate subsequent steps in the apoptosis 
event such as the activation of Bid, a cell death protein, by interacting with the proteins 
at the surfaces of the mitochondria. This pathway may be inhibited by FLIP (FLICE-
like inhibitory protein) protein that binds to procaspase-8, thus inhibit the proteins 
cleavage (Cao and Tait, 2018).  
The second pathway of apoptosis involves the mitochondria and it is also called 
as the intrinsic pathway. In this pathway, apoptosis occurs in absence of cell death 
signals. This pathway is triggered by signals including the deprivation of growth 
factor, DNA damage, and cytokine deprivation (Zaman et al., 2014). At the 
mitochondria, the balance between death-promoting (proapoptotic) proteins and 
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death-preventing (antiapoptotic) proteins determine whether cell will undergo 
apoptosis. Among known proapoptotic proteins are Bax, Bid, Bak or Bad, while the 
antiapoptotic proteins are Bcl-2 and Bcl-x.  In the case where a cell’s DNA is injured 
by radiation, for example, apoptosis will be initiated by the activation of a protein 
knows as p53. The p53 protein will activate Bax, a proapoptotic protein. Mitochondrial 
permeability increases and cytochrome c molecules are released into the cytoplasm 
and recruits proteins such as Apaf-1, an apoptosis activating factor, and procaspase-9, 
which form a complex known as apoptosome. This assembly cleaved procaspase-9 to 
caspase-9 and activates the caspase-3, which then leads to the activation of caspases 




Figure 2.6: Apoptosis pathway schematic diagram.  
Extrinsic pathway starts with external stimuli which induces the cell death signals; 
andintrinsic pathway starts with internal stimuli such as DNA damage. Adapted from 





















2.5.2 Apoptosis proteins   
2.5.2(a) Tumour suppressor protein, p53 
 Tumour suppressor proteins are important in regulating cell division. Once 
damaged DNA is detected in a cell, these proteins will halt the cell proliferation until 
the damage is repaired. In some instances, specific tumour suppressor proteins will 
encourage damaged cell to cell death. However, when the genes encoding these 
proteins are malfunction, the cell with the damaged DNA will continue to proliferate 
which may cause further DNA damage or eventually leads to the formation of cancer. 
Tumour suppressor protein p53 is encoded by TP53 gene and approximately 
50-55% of cancers loss this wild type activity of p53, making it the most silenced or 
mutated gene in cancer (Wang et al., 2015). p53 activation causes responses such as 
apoptosis or cell cycle arrest thus preventing the development of tumour. Cell stresses 
such as DNA damage, hypoxia and oncogene activation increase p53 cellular level by 
phosphorylation and acetylation. However, in tumour bearing wild type p53, p53 
function is downregulated thus inhibiting p53 responses, as shown in estrogen-
receptor positive breast cancer, that directly interact with p53 and therefore prevent 
the p53-mediated apoptosis response (Bailey et al., 2012b).  
Scientists have demonstrated that p53 protein function also regulates 
metabolism and homeostasis in cells and tissues without causing cell cycle arrest or 
apoptosis (Schwartzenberg-Bar-Yoseph et al., 2004; Wang et al., 2015).  A number of 
proteins are involved in regulation of p53 activity to sustain energy homeostasis and 
cell metabolism under normal and stresses physiological condition. p53 is an important 
protein engaging in controlling the changes in tumour cell metabolisms. Mutation in 
genes such as p53, leads to cancers in human. The p53 protein ensures response to 
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appropriate signals in order to decide the fate of the cell; therefore, known as “guardian 
of the genome” (Lane 1992), that plays a protective role in the whole body.   
2.5.2(b) Bcl-2 Family Proteins 
Bcl-2 family consist of 18 members which are categorised into three functional 
group based on their activities in apoptosis or their BH (Bcl-2 homology) domain. 
Anti-apoptotic Bcl-2 proteins are Bcl-2, Bcl-xL, Bcl-w, Mc11 and A1. These proteins 
contain four BH domains and prevent cell death by binding to the pro-apoptotic protein 
of the Bcl-2 family (Bax, Bak, or Bid) (Chipuk et al., 2010). In order to maintain cell 
homeostasis or balance between pro- and anti- apoptotic proteins and control of the 
apoptosis, these proteins bind to each other and create a complex interaction network, 
therefore determine whether a cell lives or dies (Peña‐Blanco and García‐Sáez, 2018).  
An example of a pro-apoptotic protein is Bid. Bid belongs to the Bcl-2 
superfamily (Degli Esposti, 2002). Once in active form, Bid will initiate the action of 
mitochondria which will release the cytochrome c. Similar to the intrinsic pathway, 
Bax, another pro-apoptotic protein also belonging to the Bcl-2 superfamily also will 
initiate the action of mitochondria. Bax is activated by p53 protein and deactivated by 
Bcl-2 anti-apoptotic protein (McCurrach et al., 1997; Peña‐Blanco and García‐Sáez, 
2018).  
2.5.2(c) Caspases 
Caspase was first discovered as designated interleukin-1b converting enzyme 
and cytokine-processing enzyme (Cerretti et al., 1992). Caspases belong to the 
cysteine proteases family and involved in protein hydrolysis (Lopez and Tait, 2015), 
which is the key event in apoptosis. Caspases are highly specific proteases synthesized 
as zymogens and activated by cleavage at aspartate, which generates large and small 
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units of mature enzyme (McIlwain et al., 2015). Caspases are produced as inactive 
precursors known as procaspases. Once activated, caspases cleaved proteins within 
cells, resulting in precise and efficient killing of the cell in which they are activated.  
Caspases are a group of proteins responsible for cleaving target proteins, 
especially in apoptosis. Two types of caspases classified based on their roles in 
apoptosis are known as the initiator caspases (caspase-2,-8,-9, and -10) and 
executioner caspases (caspase-3, -6 and -7) (Pfeffer and Singh, 2018). Caspase -8 and 
-9 are normally inactive pro-caspases and will be activated by dimerization instead of 
cleavage and this process is known as an “induced proximity model” (McIlwain et al., 
2015; Muzio et al., 1998). In the model, the dimerization and activation of these 
caspases are reliable on the upstream signals. Activation of the executioner caspases 
are in controlled by their inactive pro-caspase dimers which needed the initiator 
caspases to cleave them. This mechanism prevents from inappropriate activation of 
the executioner caspases. Initiator caspases will cleave the executioner caspases 
between the large and small subunit that allows a conformational change on the active 
sites of the executioner caspase, and finally create a functional active mature caspase 
(McIlwain et al., 2015). Once activated, caspase-8 will directly initiate apoptosis or 
cleave few other proteins including caspase-3, that eventually will initiate apoptosis 
after a series of proteins activation events occured.  
2.5.3 Targeting apoptosis for Cancer treatment 
A smart way discovered to treat cancer is to become the driver in controlling 
and possibly end the uncontrollable proliferating cancer cells. This can be achieved by 
using their own mechanism of programmed cell death, the apoptosis. Apoptosis plays 
a major role in cancer by inhibiting the tumour growth. Targeting apoptosis can be 
applied on various types of cancers as apoptosis evasion is one of the hallmarks of 
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cancer which is not specific to the type or the cause of cancer. Many anticancer drugs 
work by targeting different types of proteins or stages in either intrinsic pathway or 
the extrinsic pathway (Bao et al., 2017; Liu and Zhu, 2017). The most common 
approaches reported are inhibition of anti-apoptotic proteins and stimulation of pro-
apoptotic proteins (Hassan et al., 2014). The research that has been done include Bcl-
2 inhibitors (Zaman et al., 2014), death-receptors ligands (Lopez and Tait, 2015), 
alkylphospholipid analogs (apoptosis signals) and inhibiton of XIAP (Hassan et al., 
2014). Though more researches are currently underway, there is no indication as of 
which target is the best. As we progress, more anticancer drugs inducing apoptosis will 
be determined.  
2.6 CANCER AND IMMUNE RESPONSE 
Cancer is often diagnosed long after it is initially formed. In 1909, Ehrlich 
(1909) believed that the immune system is able to protect host from cancer. However, 
his hypothesis was not experimentally proven because of the experimental tools and 
knowledge were inadequate at that time. He said,  
“in the enormously complicated course of fetal and post-fetal 
development, aberrant cells become unusually common. Fortunately, 
they remain completely latent thanks to the organism’s positive 
mechanisms” 
(Ehrlich, 1909) 
A resilient immune system is needed to eliminate or control the development 
of cancer. In other words, Burnet and Thomas postulated the immune surveillance 
hypothesis of cancer, which stated that sentinel thymus-dependent cells of the body 
constantly surveyed host tissues for emerging transformed cells. This hypothesis has 
 
 42 
been supported by animal model experiment where mice with an immune-compromise 
status are susceptible to develop cancers compared to immune-competent mice 
(Burnet, 1957; Burnet, 2014; Mosier et al., 1988; Thomas and Lawrence, 1959). 
Patients receiving organ transplants that were under treatment of prolong 
immunosuppressive drugs were developing tumours such as renal cancer, non-
Hodgkin lymphoma, Kaposi sarcoma and other carcinomas (Burra and Rodriguez-
Castro, 2015; Penn, 1993).  
Over the years, treatments of cancers involved both ionizing radiation and 
chemotherapeutic agents were used to eradicate the mass of tumour. These treatments 
are beneficial and effective however there are cases of tumour relapse due to drug 
resistance of the tumour cells. Cancer immunotherapies are alternatives to the 
conventional treatments to enhance the ability of the immune system to kill-and-
destroy cancer cell and control the advancement of tumour growth. Since the 
knowledge of the immune system is developing and slowly understood, various 
immune pathways are identified as candidates to potentiate anti-tumour responses in 
cancer patients. Several types of immunotherapy include monoclonal antibodies, non-
specific immunotherapies, oncolytic virus therapy, T-cell therapy, cancer vaccines and 
other interventions (Hu et al., 2019).  
The immune system responses involved both adaptive long-lived responses 
and memory (T cells and B cells), and the innate cells that give short-lived responses, 
which involved the monocytes, macrophages, dendritic cells, and natural killer (NK) 
cells. The innate cells are the immediate responses that release the cytokines to lyse 
the abnormal cells or capturing debris from dead cells that resulted in specific foreign 
antigens peptide fragments, which are then identified by the adaptive T and B cells to 
generate antigen-specific responses. Major effector cells that target cancer cells 
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specifically are NK cells, dendritic cells, polymorphonuclear (PMN) leukocytes, 
macrophages, cytotoxic T lymphocytes (CTL) and mast cells (Yang et al., 2019).  
2.6.1 Natural Killer Cells 
Natural Killer cells or also known as NK cells are a large granular lymphocyte 
(LGL) important to the innate immune system. NK cells was first discovered in 1970s 
(Pross and Jondal, 1975) through a series of experimentation on cancer patients with 
regards to cytotoxicity. NK cells are capable of killing virus-infected and cancer cells 
without initial activation thus the term “Natural Killer” cells were used. NK cells are 
originated from common lymphoid progenitor cells located in the bone marrow. NK 
cells live in the primary and secondary lymphoid tissue, including in the non-lymphoid 
tissue and also within the liver, lungs and peripheral blood (Freud et al., 2014).  
Ten to 15% of the circulating lymphocytes are the NK cells. NK cells are 
cytotoxic lymphocyte and can be characterised by the presence of surface marker 
protein expressing CD56 and CD16. They are also identified by CD56+/CD3-, where 
CD3 is specific for T-lymphocytes and is not expressed by NK cells (Grudzien and 
Rapak, 2018). Ten percent (10%) of the NK cells found in the peripheral blood are 
immature NK cells (CD56bright / CD16dim) that produce cytokine which is important in 
the immunomodulation. CD56bright NK cells do not contain cytotoxic granules but are 
able to respond to target cells by producing the TH1 cytokine IFNg. While more than 
90% of NK cells in peripheral blood are mature NK (CD56dim/ CD16bright), which is 
important in mediating immune response of NK cells (Daher and Rezvani, 2018). They 
carry cytotoxic granules and are effective killers. NK cells in the liver, lymph nodes 
and lung are less cytotoxic comparing to the blood NK. Although, NK cells from the 
uterus contain cytotoxic granules, they do not respond to target cells. They are mainly 
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functioning to produce angiogenic factors and mediating in placenta formation (Sojka 
et al., 2019).  
Lymphocytes activation, survival, proliferation and differentiation are 
regulated by cytokines. Interleukin in particular IL-2, IL-15, IL-12, IL-18 and IL-21 
are known to promote NK cells proliferation and improve their anti-tumour ability 
(Floros and Tarhini, 2015; Hu et al., 2019; Srivastava et al., 2013). A 15 000-kDa a-
helix cytokines known as IL-2 is produced predominant by activated CD4+ and CD8+ 
T cells. IL-2 is also produced by activated dendritic cells (DCs), NK cells, and NKT 
cells (Granucci et al., 2001). IL-2 effects two important immune cell population, the 
T and NK cells. It is known that IL-2 plays a role in the these cells proliferation and 
not only that, it also enhances the NK cells cytotoxic ability aginst tumour cells (Floros 
and Tarhini, 2015; Srivastava et al., 2013; Wang et al., 1999). Recently, IL-2 is 
administered to induce NK proliferation in patient undergoing immunotherapy. 
However, IL-2 caused side effects including nausea, flu and dizziness, therefore 
limiting its application widely (Surayot and You, 2017). Furthermore, high dosage of 
IL-2 also can result in toxicity in patients (Suck and Koh, 2010).  
NK cells have the ability to promote cytotoxic activity and cytokine production 
following immune system stimulation (Grossenbacher et al., 2016). Recently, NK 
cells are classified as cytotoxic, interferon-g (IFNg)-producing innate lymphocytes 
(ILC) (Elemam et al., 2017).  IFNg is responsible in modulating immune response in 
particular towards defence against intracellular pathogens and cancers. It is produced 
by NK cells, NKT cells, CD8+ T cells and T-helper 1 (TH1) CD4+ cells (Schoenborn 
and Wilson, 2007). IFNg supports TH1 differentiation, enhancing the function of 
macrophages, encouraging leukocyte migration to the infection site, and exerting the 
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MHC expression for better T-cells recognition of infected or malignant cells (Farrar 
and Schreiber, 1993; Schroder et al., 2004). Deficiency in IFNg signalling in mice and 
humans contributes to the susceptibility to tumours and intracellular pathogens 
infections such as mycobacteria (Bustamante et al., 2014; Ikeda et al., 2002).  
NK cells induce apoptosis in their targets by producing the TNF family 
molecules, cytokines and cytotoxic granules (Paul and Lal, 2017). NK cells respond 
to target cells, either virus infected or malignant cells that are lacking MHC class I 
molecules. NK cells activation is regulated by signals, either inhibitory or activating, 
from target cells in the pro- and anti- inflammatory microenvironment. Once activated, 
cytotoxic proteins are released from the pre-formed cytoplasmic granules of the NK 
cells by exocytosis at the NK-target cell interface (Lotzova and Herberman, 2019). 
This process is knows as degranulation which relase pore-forming protein, perforin 
and granzyme B.  
NK cells directly kill their target cells by mediation of perforin/granzyme or 
by FasL mechanism (Lee et al., 2018b). These cytotoxicity granules proteins critically 
drive direct cytotoxicity on target cells (Backes et al., 2018). Once activated, NK cells 
release these proteins on the target cells. Perforin is the protein function to disrupt the 
cell membrane and granzymes are protein belonging to the serine proteases (Sabry and 
Lowdell, 2017). Perforin binds to the phospholipid on the components of the 
membrane lipid bilayer in a calcium dependent manner and finally, facilitate the 
entrance of the granzymes into the cytosol of the target cell. Granzymes will induce 
apoptosis once they are inside the target cell.  
As mentioned earlier, NK cells also kill target cell by engagement of cell 
surface death receptors with the expression of Fas ligand (FasL) and TNF-related 
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apoptosis-inducing ligand (TRAIL). Once bound to the receptors on the target cells, 
these proteins will induce apoptosis. Another direct killing method of NK cells 
cytotoxicity involves antibody dependent cell mediated cytotoxicity (ADCC) and this 
is usually mediated by immunoglobulin G (IgG) in humans. NK cells also kill their 
target cells indirectly by producing cytokines and chemokines to destroy abnormal 
cells and restore the regulation of innate and acquired immune responses (Fauriat et 
al., 2010). 
2.6.2 Phytocompounds and Natural Killer cells 
 Medicinal plants contain phytocompounds that can stimulate NK cells effect. 
Vitamins are among the natural compound known to stimulate NK cells. Fat-soluble 
vitamin A such as retinol, retinal, retinoic acid (RA) and carotenoids were able to 
reduce tumour growth in several animal models. Administration of retinol in BALB/c 
mice (with breast cancer) resulted in increased splenic NK cells activity and the highest 
activity was recorded after 1 hour of the treatment (Fraker et al., 1986). Vitamin B is  
important for cell metabolism and it a water soluble vitamins. Significant decrease of 
NK cells cytotoxicity was observed in the spleen of the mice with vitamin B12 
defeciency (Partearroyo et al., 2013). The water soluble vitamin C also have 
demonstrated stimulatory NK cells activities. In an experiment conducted in vivo, 
blood from healthy individuals were collected before and after administration of 
vitamin C and aloe vera juice. NK cells cytotoxicity was significantly increased after 
the vitamin C supplementation (Toliopoulos et al., 2012). Vitamin D is a insoluble 
vitamin belonging to the steroid group. In experiment comparing between control mice 
and high-fat diet mice showed that supplementation of vitamin D increased the NK 
cells actvity in lean mice but not in obese diet mice (Lee et al., 2018a). Vitamin E is 
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another water insoluble vitamin that have demonstrated immunomodulatory effects in 
animals and human models (Mutalip, 2018).  
 Some other reported phytochemicals promoting NK cells acitivity are  
genistein, curcumin and ginseng. Genistein is an isoflavone compound identified in 
soybean. The investigation of genistein and NK cells activation started with the 
observation of lower incident rates of breast, colon and prostate cancer in countries 
with higher dietary consumption of soybean (Tse and Eslick, 2016). Genistein (0.1-
0.5µmol/l)  showed increased NK cells activity, however the activity declined with 
concentration more than 0.5µmol/l (Zhang et al., 1999). Curcumin, form Curcumin 
longa showed that the increased dosage was able to increase NO production by NK 
cells therefore promoting apoptosis on the target cell (Bhaumik et al., 2000). Ginseng 
plant was also able to significantly augment NK cells cytotoxicity (Takeda and 
Okumura, 2019) and treatment of polysaccharide from ginseng berry also showed NK 








GC-MS ANALYSIS OF PHYTOCHEMICAL COMPOUNDS of Abrus 
precatorius LEAVES EXTRACT 
3.1 INTRODUCTION 
 Medicinal plants are gaining worldwide recognitions because of their diversity 
and have broad pharmacological activities from their therapeutic phytochemicals. 
Phytochemicals are extracted from different parts of plants like seeds, seed coats, 
barks, leaves, flowers, pulps, roots, and shoots. The extraction of the phytochemical 
compounds is significant in the exploration of new therapeutic biomolecules that are 
potential as medicinal agents.  Plant contains a variety of chemical compounds that 
can be utilised to treat chronic and infectious diseases (Duraipandiyan et al., 2006). 
Phenolic compounds and flavonoids, for instance, have a great impact on health and 
cancer prevention (Venugopal and Liu, 2012). To date, thousands of phytochemical 
compounds have been reported to have beneficial biological activities such as 
antimicrobial, antioxidant, anticancer, and many more.  
 
The important part in studying the medicinal plants is the extraction procedure. 
Extraction is a standard procedure to separate phytochemical compounds using 
selective solvents. Decoction and maceration are commonly used in traditional 
practices while the Soxhlet extraction is more familiar in the industrial settings. Other 
modern extraction techniques include, microwave-assisted extraction (MAE) and 
ultrasound-assisted extraction (UAE), which aim to increase yield with a minimal cost, 
while superficial fluid extraction (SFE) and accelerated solvent extraction are less 




Decoction is a method of extraction by means of boiling the plant materials to 
extract volatile compounds, oils, and various other phytochemical compounds. 
Maceration on the other hand is a technique adopted from wine making where plant 
materials are soaked in a closed container with a solvent for at least three days at room 
temperature (Handa, 2008). Soxhlet extraction or also known as continuous hot 
extraction uses the Universal Extraction System (Buchi), where heated solvent in a 
flask, vaporizes into the thimble containing grounded plant material, condenses in the 
condenser and drip back into the hot flask.  This process is repeated until the colour of 
the solvents becomes clear. Decoction of the Abrus precatorius leaves is widely 
practised as the treatment for cold, coughs and colic. Juice from the leaves is applied 
to swellings by mixing with oil. Mixture of rice starch and the leaf paste are consumed 
orally for anthrax treatment (Pokharkar et al., 2011). Powdered leaves paste are used 
for conjunctivitis and convulsion in children (Joshi and Tyagi, 2011). 
 
Plant extracts encompass of numerous phytochemical compounds, which pose 
a challenge in order to separate and identify them due to their polarity. 
Chromatography is a process to separate any molecules based on their shape, size and 
charge. With the advancement of research and technologies, different separation 
techniques have been introduced to identify and isolate these compounds such as gas 
chromatography (GC), paper chromatography, thin layer chromatography (TLC), 
high-performance thin layer chromatography (HPTLC), column chromatography, 
overpressure layer chromatography (OPLC), and high-performance liquid 
chromatography (HPLC). GC is a technique used to separate volatile compounds, 
where the liquid phase is separated from the gas phase. It is one of the most important 
analytical methods in organic chemical analysis to determine individual substances in 
complex mixtures. Mass-spectrometry is an analytical method that measure masses 
within a sample by ionizing the chemical species and sort their ions based on the mass-
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to-charge ration. This detection method provides meaningful data by determining the 
substance molecules or fragments directly. Therefore, the integration of gas-
chromatography and mass-spectrometry into a single GC-MS system has been a great 
platform for many laboratories to run a quantified detection analysis due to its high 
selectivity and very high sensitivity (Belwal et al., 2018).  
 
Phytochemical analysis of the leaves and roots of A. precatorius demonstrated 
the presence of glycyrrhizin (Karwasara et al., 2010), an important compound of 
liquorice (Killacky et al., 1976), which is widely used in the food and pharmaceutical 
industry. A known triterpenoid and three novel triterpenoids were identified from the 
acid hydrolyzed methanol-soluble leaves extract (Kim et al., 2002) of A. precatorius. 
From the n-butanol leaves extract of A. precatorius, other compounds identified were 
abrusoside A (Choi et al., 1989), abrusosides B, C, D, plus three other sweet glycosides 
based on the novel cycloartane-type aglycone, abrusogenin (Kinghorn and Soejarto, 
2002). This chapter described the phytochemicals identified in the leaves extracts of 
A. precatorius. Different extraction methods were performed and their phytochemicals 
were characterised in order to possibly identify all phytochemicals in the leaves of A. 
precatorius.  
3.2 MATERIALS & METHODOLOGY 
3.2.1 Plant collections 
A. precatorius matured leaves (Figure 3.1) were collected from Kampung Sabak, 
Pengkalan Chepa, Kelantan, Malaysia, around the months of August till September.  
The plant was authenticated by Assoc. Prof. Dr. Rahmad Zakaria from the Herbarium 
Unit, School of Biological Sciences, Universiti Sains Malaysia and the voucher 
specimen (USM 11730) was submitted for future references. 
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3.2.2 Preparation of leaves sample 
The leaves of A. precatorius were collected, cleaned and oven-dried at 50oC, and 
then later ground to fine powder with a mechanical grinder.  
3.2.3 Aqueous decoction of Abrus precatorius leaves 
Decoction method was used in traditional medicine and hence was applied in 
this experiment. For aqueous extract, 11g of dried fine powdered leaves were soaked 
in 450 ml water at 50°C until the water reduced to one-third of the initial volume  
(Wan-Ibrahim et al., 2018). The extract was then freeze-dried for the subsequent 
analysis.   
3.2.4 Maceration extraction of the leaves by hexane, ethyl acetate and methanol 
solvents 
Three successive extractions of the A. precatorius leaves by maceration were 
performed following the method by Irshad et al. (2012) with modifications. 
Approximately 18g of dried powdered leaved were soaked in three different solvents 
successively for about one month each. Initially the leaves were macerated in 250ml 
of hexane (99%), followed by 250ml of ethyl acetate (99%) and lastly in 250ml of 
methanol (99%). During the maceration period, the mixture was manualy agitated in 
every other three days. After each solvent, the mixture of the leaves and solvent was 
filtered then the filtrate was left to dry under the fume hood to obtain the dried crude 
extract. The remaining leaves were also left under the fume hood to evaporate the 
remaining solvent before macerating with the following solvent.  
3.2.5 Successive solvent Soxhlet Extraction  
About 22g of ground A. precatorius was subjected to successive Soxhlet 
(Buchi) extraction with 250ml hexane, -ethyl acetate and -methanol, performed with 
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modification according to Kaneria and Chanda (2012) . Upon completion of the first 
extraction with hexane, the solution was dried using a rotary evaporator. The 
remaining powdered leaves in the thimble was left to dry overnight in fume hood to 
evaporate residual hexane. Then subsequent extraction with ethyl acetate was 
performed in the same manner and followed by methanol. All extracts were kept in -
20°C until further used.  
3.2.6 Gas Chromatography – Mass Spectrometry (GC-MS)  
Hewlett Packard 6890 Gas Chromatograph with 5973N Mass Selective 
Detector was used to carry out the GC-MS. The column was fused silica capillary, HP-
5 column (30 m x 0.25 mm i.d x 0.25 µm film thickness) (Agilent Technologies, USA). 
The carrier gas was helium with flow rate at 1.0 ml/min with the oven temperature was 
programmed from 50°C (held for 2 min) to 280°C (held for 10 min) at a rate of 
20°C/min. The injection and interface temperatures were set at 250°C and 280°C, 
respectively. One microliter sample was injected in splitless mode and was analysed 
in MS full scan mode (m/z 40-650). The electron ionisation was fixed at 70eV. 
Acquisition of data was performed using Chemsation software. 
3.2.7 Identification of phytochemical compounds 
The mass spectrum of the GC-MS was interpreted against the database of the 
National Institute of Standards and Technology (NIST02) and Wiley275 libraries with 








3.3 RESULTS  
3.3.1 Abrus precatorius plant 
 
Figure 3.1: Abrus precatorius leaves used in this study. 
 
 
3.3.1(a) Yield  of all extracts after each extraction  
 Figure 3.1 showed the leaves collected for this study. The yield obtained after 
each extractions of the A. precatorius leaves are as follows: aqueous extract (31.8%), 
hexane extract by maceration (5.55%), ethyl acetate extract by maceration (6.10%), 
methanol extract by maceration (8.67%), hexane extract by Soxhlet (4.67%), ethyl 






3.3.2 Aqueous Extract by decoction 
The GC-MS analysis showed that the classes of compounds identified in 
aqueous extracts of A. precatorius leaves were phenolic compounds, terpenoids and 
steroids..  Seventeen chemical compounds were identified as shown in Table 3.1. The 
main class of compounds identified was phenolic compounds (2.82%).  Four phenolic 
compounds were identified, and the major phenolic compound was 4-vinylphenol 
(1.17%). Other major compounds that found in A. precatorius leaves are methyl 
jasmonate (1.89%), decylenic alcohol (1.46%) and cis-11-Tetradecen-1-ol (1.41%). 
Methyl jasmonate is categorised as fragrance that belongs to structural group ketones 
cyclopentanones and cyclopentenones (Scognamiglio et al., 2012). Decylenic alcohol 











Name of Compound Area 
(%) 
 Phenolic compound 
 
8.4 4-vinylphenol 1.17 
8.9 p-Vinylguaiacol 0.68 
10.1 β-Phenoxyethyl iso-butyrate 0.47 
11.2 Cinnamaldehyde, β-hexyl- 0.50 
 Terpenoids  
9.9 β-lonone 0.17 
12.6 Phytol 0.39 
 Steroids  
16.5 Stigmasterol 0.31 
 Others  
7.8 4H-Pyran-4-one,2,3-dihydro-3,5-dihydroxy-6-methyl- 0.66 
9.8 6-Tridecene 0.13 
10.7 Methyl dihydrojasmonate 1.89 
10.9 Propanoic acid,2-methyl-3-[4-t-butyl]phenyl- 0.68 
11.5 Decylenic alcohol 1.46 
11.5 3-Decen-1-ol, (E)- 1.07 
11.6 cis-11-Tetradecen-1-ol 1.41 
13.7 Palmitic acid á-monoglyceride 0.19 
15.7 1-Heneicosanol 0.72 






3.3.3 Maceration extraction of the leaves (Hexane) 
36 compounds were identified in this extract. The main compounds in this 
hexane leaves extract by maceration are 1-Octscosanol (24.09%), 1-heptacosanol 
(21.80%) and oxirane heptadecyl- (20.85%). Twelve compounds were identified under 
the terpenoids group as listed in Table 3.2. 
 
Table 3.2: Compounds Present in The Leaves Hexane Extracts (Maceration) of 
Abrus Precatorius Using GC-MS 
Retention 
Time (min) 




7.114 Dihydromyrcenol 0.01 
7.387 Linalool 0.02 
8.417 Citronellol 0.01 
8.109 m-methylacetophenone 0.01 
8.368 b-cyclocitral 0.01 
8.627 b -cyclohomocitral 0.01 
9.243 Naphtalene,1,2,3,4-tetrahydro-1,1,6-trimethyl- 0.02 
9.733 Geranyl acetone 0.02 
9.936 β-lonone 0.07 
11.512 Neophytadiene 1.23 
14.894 Squalene 0.91 
14.957 Geranylgeraniol 0.13  
Others 
 
5.938 3-octanone 0.01 
10.195 2(4h)-benzofuranone,5,6,7,7a-tetrahydro-4,4,7aa-trimethyl 0.15 
10.734 Methyl dihydrojasmonate 0.20 
11.162 Octanal, 2-(phenylmethylene)- 0.08 
13.339 Ethyl eicosanoate 0.18 
13.451 4,8,12,16-tetramethylheptadecan-4-olide 0.20 
13.563 Tetracosane 1.00 
13.815 Butyl 9,12-octadecadienoate 0.14 
13.885 Eicosane 0.32 
13.955 2- Monopalmitin 0.66 
14.151 4-methyl-1-anthracenamine 0.08 
14.305 16-heptadecenal 0.16 
14.495 Heptadecane 1.55 
14.586 Tetracosanoic acid, methyl ester 0.80 
15.076 Octadecane, 1-chloro- 1.98 
15.363 Tridecane 0.86 
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Table 3.2 Continued  
Retention 
Time (min) 
Name of Compound Area 
(%) 
15.531 1,19-eicosadiene 7.98 
15.839 1-heptacosanol 21.80 
15.923 Octadecanal 0.78 
15.972 16-octadecenal 1.07 
16.441 Oxirane heptadecyl- 20.85 
16.868 1-octacosanol 24.09 
17.582 Dl-a-tocopherol 0.62 
19.585 Cyclotriacontane 0.20 
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3.3.4 Maceration extraction of the leaves (Ethyl acetate) 
21 compounds were identified. The main compounds in this extract are 2-
hexadecene,3,7,11,15-tetramethyl-(R-(R*,R*-E)- (16.02%), octacosyl acetate 
(8.67%) and phytol (7.6%).  
Table 3.3: Compounds Present in The Leaves Ethyl acetate Extracts (Maceration) of 




Name of Compound Area 
(%) 
 Phenolic compounds  
8.984 2-Methoxy-4-vinylphenol 0.72 
 Terpenoids  
12.59 Phytol 7.60 
14.886 Squalene 0.73 
 Steroids  
16.28 7-ergosterol 2.06 
16.805 b-Sitosterol 1.78 
 Others  
7.121 1-Ethyl-2-pyrrolidinone 0.01 
8.41 Coumaran 0.12 
9.229 Naphthalene,1,2-dihydro-2,5,8-trimethyl- 0.09 
9.474 1-(3,6,6-Trimethyl-1,6,7,7a-tetrahydrocyclopenta[c]pyran-1-yl)ethanone 0.06 
11.519 2-hexadecene,3,7,11,15-tetramethyl-(R-(R*,R*-E)- 16.02 
11.855 Methyl hexadecanoate 1.70 
12.786 Ethyl linolenate 0.18 




15.055 Cyclotriacontane 2.52 
15.244 D-d-tocopherol 2.54 
15.902 Vitamin E 2.05 
16.133 Z-14-Nonacosane 2.48 
16.574 Octacosyl acetate 8.67 
17.141 Triacontyl acetate 2.44 
17.764 Cyclotriacontane 1.08 
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3.3.5 Maceration extraction of the leaves (Methanol) 
21 compounds were identified. The main compounds group in this extract are 
the phenolic compounds (3.44%), consisted of phenol, 4-Vinylguaiacol, syringol, 
methylparaben, and 4-methyl-2,5-dimethoxybenzaldehyde. Cyclotetracosane was the 
most abundant compound in this extract (3.00%).  
 
Table 3.4: Compounds Present in The Leaves Methanol Extracts (Maceration) of 
Abrus precatorius Using GC-MS 
Retention 
Time (min) 
Name of Compound Area 
(%) 
 Phenolic compounds  
6.246 Phenol 0.22 
8.984 4-Vinylguaiacol 0.72 
9.201 Syringol 0.95 
9.831 Methylparaben 0.34 
10.328 4-methyl-2,5-dimethoxybenzaldehyde 1.21 
 Steroids  
16.805 b-Sitosterol 0.48 
 Terpenoids  
8.872 Indolizine 0.25 
 Others  
7.681 Butanedioic acid, hydroxy-,dimethyl ester 0.60 
8.185 Methyl salicylate 0.10 




10.734 Cyclopentaneacetic acid, 3-oxo-2-pentyl-, methyl ester 0.91 
11.210 2-Propenoic acid,3-(4-hydroxyphenyl)-, methyl ester 2.58 
11.862 Hexadecanoic acid, methyl ester 2.08 
13.948 2-Monopalmitin 2.82 
15.054 Cyclotetracosane 3.00 
15.601 g-Tocopherol 0.80 
15.706 Cyclooctacosane 1.12 
15.902 Vitamin E 0.55 
16.574 Triacontyl acetate 2.01 






3.3.6 Soxhlet Extraction of the leaves (Hexane) 
 22 compounds were identified from this extract. Main compound identified 
from this extract is oxirane, hexadecyl- at 15.72%, followed by 1-eicosanol at 10.53%. 




Name of Compound Area 
(%) 
 Phenolic compounds  
11.870 Phenol, 3-isopropoxy-5-methyl 0.05 
 Terpenoids  
10.722 Dihydroactinidiolide 0.12 
12.003 Neophytadiene 1.54 
11.814 (-)-Loliolide 0.35 
18.151 Alnulin 0.23 
 Steroids  
17.437 Campesterol 0.33 
 Others  
2.621 Octane 0.10 
4.924 Nonane 1.00 
10.57 Dodecanoic acid 0.05 
10.834 3-Mercapto-2(1H)-pyridinone 0.04 
11.660 Myristic acid 0.08 
11.682 1-Methylbicyclo(6.3.0)undec-5-en-9-one 0.09 
12.185 3,7,11,15-Tetramethyl-2-hexadecen-1-ol 0.57 
12.354 Hexadecanoic acid, methyl ester 0.05 
12.564 Hexadecanoic acid 5.63 
13.031 2-Pentadecanone,6,10,14-trimethyl- 0.11 
13.047 9,12,15-Octadecatrienoic acid, methyl ester 0.18 
13.096 Octadecanoic acid 5.24 
14.477 2-Monopalmitin 0.23 
15.035 9,12,15-Octadecatrienoic acid 0.18 
15.077 
Octadecanoic acid,2-hydroxy-1-( hydroxymethyl)ethyl 
ester 0.35 
15.378 Cyclooctacosane 0.13 
15.792 Bicyclo (10.8.0)eicosane, (E)- 0.37 
16.415 Stigmasta-5,22-dien-3-ol, acetate, (3.beta.,22Z)- 0.46 
16.541 1-Eicosanol 10.53 
16.744 Vitamin E 0.37 
18.067 (23S)-ethylcholest-5-en-3.beta.-ol 0.49 
18.403 1-Tetracosanol 0.69 
18.788 Oxirane, hexadecyl- 15.72 
19.152 Stigmast-4-en-3-one 0.08 
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3.3.7 Soxhlet Extraction of the leaves (Ethyl acetate) 
 Neophytadiene (32.56%) was the main compound idetified in this extract. 37 
compounds were identified from this extract.  
 
Table 3.6: Compounds identified in the leaves of A. precatorius ethyl acetate 
extracts (Soxhlet)  
Retention 
Time (min) 
Name of Compound Area 
(%) 
 Phenolic compounds  
8.531 Benzoic acid 0.30 
8.860 4-vinyl-phenol 3.26 
9.834 2-Methoxy-4-vinylphenol 0.99 
15.75 Naringenin 0.91 
16.688 3-Methoxy-4,5,7-trihydroxyflavone 0.43 
17.479 Cirsimaritin 4.48 
 Terpenoids  
10.722 Dihydroactinidiolide 0.54 
11.822 (-)-Loliolide 2.16 
12.011 Neophytadiene 32.56 
13.089 Phytol 1.71 
 Steroids  
17.99 b-Sitosterol 0.64 
 Others  
2.705 2-Propenoic acid, 2-methyl-,methyl ester 0.41 
3.657 2-Pentanone,4-hydroxy-4-methyl- 0.35 
8.089 2-Pentene,(Z)- 0.46 
8.713 Benzoic acid, 2-hydroxy-, methyl ester 0.12 
8.958 1H-Pyrrole-2,5-dione,3-ethyl-4-methyl- 0.25 
9.378 Benzonitrile, 2-methyl- 0.19 




10.561 2,5-Cyclohexadiene-1,4-dione,2,6-bis(1,1-dimethyl)- 0.57 
10.750 Dodecanoic acid 0.57 
10.820 2,6-Dimethyl-3-(methoxymethyl)-p-benzoquinone 1.16 
11.660 Myristic acid 2.30 
11.569 1,2-Benzenediol,3,5-bis(1,1-dimethylethyl)- 0.40 
11.709 1-Methylbicyclo(6.3.0)undec-5-en-9-one 1.05 
12.508 Hexadecanoic acid 4.76 
12.620 Ethyl palmitate 0.22 
12.872 Margaric acid 0.19 
13.201 Linolenic acid 5.59 
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Table 3.6 Continued 
Retention 
Time (min) 
Name of Compound Area 
(%) 
13.264 Stearic acid 2.97 
13.362 Ethyl stearate 0.25 
14.363 Heptacosanol 0.41 
15.028 Nonanoic Acid,9-(3-Hexenylidenecyclopropylidene)- 1.71 
15.351 4,5'-Dihydroxy-7-methoxyflavanone 0.44 
15.841 Stigmastan-6,22-dien,3,5-dehydro- 0.29 
16.408 Stigmastan-3,5,22-trien 0.90 
16.744 Vitamin E 0.76 
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3.3.8 Soxhlet Extraction of the leaves (Methanol) 
 A total of 29 compounds found in this extract. 4-vinylphenol and 
neophytadiene were the two main compounds indentified.  
 




Name of Compound Area 
(%) 
 Phenolic compounds  
6.787 Phenol 0.09 
8.867 4-vinylphenol 12.18 
9.483 2-Methoxy-4-vinylphenol 0.71 
10.820 4-vinyl-syringol 0.37 
17.472 Cirsimaritin 0.53 
 Terpenoids  
11.822 (-)-Loliolide 1.59 
11.941 Neophytadiene 12.18 
13.089 Phytol 0.31 
 Steroids  
17.598 Stigmasterol 0.54 
 Others  
2.545 2-Furancarboxaldehyde 0.22 
5.555 Butyrolactone 0.08 
5.856 2-Hydroxy-2-cyclopenten-1-one 0.80 
7.928 Benzoic acid, methyl ester 0.56 
8.159 Octanoic acid, methyl ester 0.13 
8.783 Benzoic acid,2-methyl-, methyl ester 0.17 
9.735 Capric acid 0.29 
10.568 Lauric acid, methyl ester 0.22 
10.764 Dodecanoic acid 1.16 
11.506 Tetradecanoic acid, methyl ester 3.02 
11.660 Myristic acid 2.77 
12.032 2-Pentadecanone 1.32 
13.040 Methyl,8,11,14-heptadecatrienoate 0.51 
13.187 Linolenic acid 0.55 
13.25 Stearic acid 0.56 
13.53 Methanone, (4-chlorophenyl)(4-hydroxyphenyl)- 0.11 
14.440 Hexadecanoic acid, 2-hydroxy-1-(hydroxymethyl)ethyl 
ester 
0.44 






15.813 Glycerol tricaprylate 0.43 
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3.3.9 Comparison of the obtained between Maceration and Soxhlet by each 
solvent 
3.3.9(a) Hexane 
Comparison of the compounds present in from both henaxe- Soxhlet and 
maceration techniques are as shown in Table 3.9. Both extracts shared eight same 
compounds. 1-Octacosanol appeared the highest with 24.31% (Soxhlet) and 24.09% 
(Maceration).  
 
Table 3.9: Comparison of phytocompounds in A. precatorius leaves extracted with 
hexane by Soxhlet and maceration.  
 Soxhlet Maceration  
24.31% 1-Octacosanol 24.09% 
0.24% 1-Heptacosanol 21.80% 
2.17% 16-Octadecenal 1.07% 
1.54% Neophytadiene 1.23% 
0.02% a-inone 0.02% 
0.31% Octadecanal 0.78% 




15.72% Oxirane, hexadecyl- Oxirane heptadecyl- 20.85% 
10.53% 1-Eicosanol 1,19-Eicosadiene 7.98% 
5.63% Hexadecanoic acid Octadecane,1-chloro- 1.98% 
5.24% Octadecanoic acid Heptadecane 1.55% 
1.01% Celidoniol, deoxy- Tetracosane 1.00% 






Tetracosanoic acid, methyl 
ester 
0.80% 




0.37% Vitamin E Cyclopentaneacetic acid, 3-
oxo-2-pentyl-,methyl ester 
0.20% 
0.37% Bicyclo (10.8.0)eicosane, (E)- Cyclotriacontane 0.20% 
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Table 3.9 Continued 







Eicosanoic acid, ethyl ester 0.18% 





0.18% 9,12,15-Octadecatrienoic acid, 
methyl ester 
Butyl 9,12-octadecadienoate 0.14% 
0.18% 9,12,15-Octadecatrienoic acid Geranylgeraniol 0.13% 
0.13% Cyclooctacosane Octanal, 2-
(phenylmethylene)- 
0.08% 








0.08% Stigmast-4-en-3-one 3-Octanone 0.01% 
0.08% Myristic acid Dihydromyrcenol 0.01% 






0.05% Hexadecanoic acid, methyl 
ester 
Citronellol 0.01% 
0.04% 3-Mercapto-2(1H)-pyridinone b -cyclohomocitral 0.01% 

















3.3.9(b) Ethyl acetate 
Comparison of the compounds present in from both Ethyl acetate- Soxhlet and 
maceration techniques are as shown in Table 3.10. Both extracts shared seven similar 
compounds. Phytol appeared the highest with 1.71% (Soxhlet) and 7.60% 
(Maceration). Neophytadiene was the highest compound in the extract by Soxhlet and 
it was not identified in the extract by maceration.  
 
Table 3.10: Comparison of phytocompounds in A. precatorius leaves extracted with 
ethyl acetate by Soxhlet and maceration. 
 
  Soxhlet Maceration   
1.71% Phytol 7.60% 
0.31% Nonanoic Acid,9-(3-Hexenylidenecyclopropylidene)- 5.03% 
0.41% Heptacosanol 4.45% 
0.76% Vitamin E 2.05% 
0.64% b-Sitosterol 1.78% 
0.99% 2-Methoxy-4-vinylphenol 0.13% 
0.26% Naphtalene,1,2-dihydro-1,1,6-trimethyl- 0.09% 
   
32.56% Neophytadiene 2-hexadecene,3,7,11,15-tetramethyl-(R-(R*,R*-E)- 16.02% 
5.59% Linolenic acid Octacosyl acetate 8.67% 
4.76% Hexadecanoic acid Cyclotriacontane 2.52% 
4.48% Cirsimaritin  D-d-tocopherol 2.54% 
3.26% 4-vinyl-phenol Z-14-Nonacosane 2.48% 
2.97% Stearic acid Triacontyl acetate 2.44% 









Hexadecanoic acid, methyl 
ester 1.70% 
1.05% 1-Methylbicyclo(6.3.0)undec-5-en-9-one Cyclotriacontane 1.08% 
0.91% Naringenin Squalene 0.73% 
0.90% Stigmastan-3,5,22-trien 
9,12,15-Octadecatrienoic 
acid, ethyl ester, (Z,Z,Z)- 0.18% 
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Table 3.10  Continued 
  Soxhlet Maceration   
0.57% 2,5-Cyclohexadiene-1,4-dione,2,6-bis(1,1-dimethyl)- Coumaran 0.12% 




0.54% Dihydroactinidiolide 1-Ethyl-2-pyrrolidinone 0.01% 
0.46% 2-Pentene,(Z)-     
0.44% 
4,5'-Dihydroxy-7-
methoxyflavanone     
0.43% 3-Methoxy-4,5,7-trihydroxyflavone     
0.41% 
2-Propenoic acid, 2-methyl-
,methyl ester     
0.40% 1,2-Benzenediol,3,5-bis(1,1-dimethylethyl)-     
0.35% 
2-Pentanone,4-hydroxy-4-
methyl-     
0.30% Benzoic acid     
0.29% Stigmastan-6,22-dien,3,5-dehydro-     
0.25% 1H-Pyrrole-2,5-dione,3-ethyl-4-methyl-     
0.25% Ethyl stearate     




1-yl)ethanone     
0.19% Benzonitrile, 2-methyl-     
0.19% Margaric acid     
0.12% 
Benzoic acid, 2-hydroxy-, 








Comparison of the compounds present in from both methanol- Soxhlet and 
maceration techniques are as shown in Table 3.11. Both extracts shared only four 
similar compounds. They are hexadecenoic acid, methyl ester; 2-methoxy-4-
vinylphenol, hexadecanoic acid, 2-monopalmitin and phenol. Hexadecanoic acid, 
methyl ester appeared the highest with 13.09% (Soxhlet) and 2.08% (Maceration).  
 
Table 3.11: Comparison of phytocompounds in A. precatorius leaves extracted with 
methanol by Soxhlet and maceration.  
  Soxhlet Maceration   
13.09% Hexadecanoic acid, methyl ester 2.08% 
0.71% 2-Methoxy-4-vinylphenol 0.72% 
0.44% 2-Monopalmitin 2.82% 
0.09% Phenol 0.22% 
   
12.18% Neophytadiene 2-Propenoic acid,3-(4-
hydroxyphenyl)-, methyl ester 
2.58% 
3.02% Tetradecanoic acid, methyl 
ester 
Coumaran 2.35% 
2.77% Myristic acid Triacontyl acetate 2.01% 




1.32% 2-Pentadecanone Cyclooctacosane 2.12% 




oxo-2-pentyl-, methyl ester 
0.91% 
0.56% Benzoic acid, methyl ester g-Tocopherol 0.80% 
0.56% Stearic acid Butanedioic acid, hydroxy-,dimethyl ester 
0.60% 
0.55% Linolenic acid Vitamin E 0.55% 
0.54% Stigmasterol b-Sitosterol 0.48% 







0.43% Glycerol tricaprylate Indolizine 0.25% 
0.37% 4-vinyl-syringol Methyl salicylate 0.10% 
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0.31% Phytol     
0.29% Capric acid     
0.24% 4-amino-5-tert-butyl-4'-
(dimethylamino)biphenyl-3-
carbonitrile     
0.22% Lauric acid, methyl ester     
0.22% 2-Furancarboxaldehyde     
0.17% Benzoic acid,2-methyl-, 
methyl ester     
0.13% Octanoic acid, methyl ester     
0.11% Methanone, (4-
chlorophenyl)(4-
hydroxyphenyl)-     





3.3.10 Compounds with reported biological activity 
 
 Known anticancer compounds identified from each A. precatorius extracts are listed in Table 3.12. The extracts are aqueous (AQ), hexane 
by maceration (HM), ethyl acetate by maceration (EAM), methanol by maceration (MM), hexane by Soxhlet (HS), ethyl acetate by Soxhlet (EAS), 
and methanol by Soxhlet (MS).  
Table 3.12: Compunds identified in GCMS analysis with reported biological activity. 
 Compound Name A. precatorius 
Extract  
Reported Activity Reference 
 4-vinylphenol AQ, MS In vivo and in vitro antiangiogenic activities, 
reducing the blood vessel number and tumour 
size 
 
Yue et al. (2015) 
 p-Vinylguaiacol 
 
AQ Antioxidant and antibacterial Ao et al. (2009) 
 2-Methoxy-4-vinylphenol EAS, MS, EAM Anti-inflammatory Effect of 2-Methoxy-4-
Vinylphenol via the Suppression of NF-κB 
and MAPK Activation, and Acetylation of 
Histone H3 
 
Jeong et al. (2011) 
 Phytol AQ, EAM, EAS, 
MS 
Cytotixicity and antitumour activity de Alencar et al. (2019) 
 
 Citronellol HM Anti-inflammatory, analgesic Santos et al. (2018) 
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 Table 3.12 Continued    
 Compound Name A. precatorius 
Extract  






HM, HS, EAS, MS 
 
A good analgesic, antipyretic, anti-




Kumbum and Sivarao 
(2012) 
 Squalene HM, EAM Cardioprotector, antioxidant, antibacterial and 
antifungal, anticancer, detoxifying agent.  
 
Lozano-Grande et al. 
(2018) 
 
 Dihydroactinidiolide HS, EAS Antioxidative and anti aggregation agent,  
Inhibit acetylcholinesterase, demostrated 
anticancer activity 
 
Das et al. (2018) 
 Geranylgeraniol HM Anti-inflammatory, anti-tumorigenic, 
neroprotective, enhanced testoteron and 
progesteron level 
 
Synergistic effect with d-d-tocotrienol on 
prostate carninoma cells by cell cycle arrest at 
G1 




 b-Sitosterol EAM, EAS, MM Anti-proliferative effects and induced 
apoptosis in MCF7, HVT116 and HeLa 
Antidiabetic 
Alvarez-Sala et al. 
(2019) 




 Table 3.12 Continued    
 Compound Name A. precatorius 
Extract  
Reported Activity Reference 
 Stigmasterol AQ, MS Membrane stabilizing activity in human red 
blood cell, axhibitng anti-inflammatory effect 
 
Zeb et al. (2017) 
 β-lonone 
 
AQ, HM Anribacteria and anti-inflammatory Kurashov et al. (2016) 
 
 Tetracosane HM Cytotoxic against MDA-MB-231, HT-29, and 
NIH(3T3). Induced apoptosis in AGS cells  
Uddin et al. (2012) 
 3-octanone HM Role as a human urinary metabolite, an insect 
attractant, a fungal metabolite, an antifeedant, 
a plant metabolite and a biomarker.  
 
Berendsen et al. (2013) 
 Vitamin E  HS, EAS, EAM, 
MM 
 
Antioxidant Mutalip (2018) 
 D-d-tocopherol 
 
EAM Anticancer Duke (1992-2019) 
 Dl-a-tocopherol  
 
HM Antioxidant Bharati (2019) 
 g-Tocopherol MM Protect cells from NO damage 
Potential biomarker in response to 
pathological condition, as general marker for 
mortality risk in populations 
Sjöholm et al. (2000) 
Chai et al. (2019) 
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 Compound Name A. precatorius 
Extract  
Reported Activity Reference 
 Linolenic EAS, MS Antibacterial activity Chandrasekaran et al. 
(2008) 
 Myristic acid HS, EAS, MS Enhanced plasma activity, increased 
immunemodulating activity 
 
Tan et al. (2017) 
 (-)-loliolide HS, EAS, MS Inhibit cellular senecence in human dermal 
fibroblast (HDFs) 
Antibacterial, antitumour, anticancer 
Yang et al. (2015) 
Grabarczyk et al. 
(2015) 
 2-pentadecanone MS Wound healing and antibacterial acitivity, 
collagen depostion, fibroblast proliferation 
 





HM Antifungal, antialgal, antioxidant, anbacterial 
activity 
Akhbari et al. (2012) 
 9,12,15-Octadecatrienoic acid, 
methyl ester 
HS Anticancer, Antimicrobial, Antioxidant and 
Hyperchloesteralemic  
 
Kumar et al. (2010) 
 Eicosane HM, HS Antifungal, antibacterial, antitumor and 
cytotoxic effects  
 
Hsouna et al. (2011) 




HS Cytotoxic to human leukemic cells 
 
 
Lai et al. (2010) 
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 Compound Name A. precatorius 
Extract  
Reported Activity Reference 
 Hexadecanoic acid, methyl ester HS, EAM, MM, MS Antifungal, Antioxidant, hypocholesterolemic 
nematicide, pesticide, antiandrogenic flavour, 
haemolytic, 5-Alpha reductase inhibitor, 
potent antimicrobial activity. 
 
Hema et al. (2011) 
 Naringenin EAS Cytotoxic effect on colon carninoma 
Inihibit migration of lung cancer (A549) cells 
by inhibing Akt activities and reduction of 
MMP-2 and MMP-9 activities  
 
Song et al. (2016) 
Chang et al. (2017) 
 Linalool HM Antifungal, anti-inflammatory Dias et al. (2018) 
 
 Geranyl acetone HM Antimicrobial activity Bonikowski et al. 
(2015) 
 Methyl dihydrojasmonate AQ, HM Antitumour drug compound 
 
da Silva et al. (2015) 
 4,8,12,16-
tetramethylheptadecan-4-olide 
HM Against for PPARg Perumal et al. (2014) 
 2-Monopalmitin HS, MM, MS Members of MAG. MAG is important critical 
nodein lipid signaling pathways. MAG lipase 
inhibitor controls FA release of the sysnthesis 
protumorigenic sigaling lipids.  
 




 Table 3.12 Continued    
 Compound Name A. precatorius 
Extract  
Reported Activity Reference 
 Tetradecanoic acid, methyl ester MS 
 
Inhibit production of uric acid Duke (1992-2019) 
 Tetracosanoic acid, methyl ester  HM Inhibit production of uric acid 
 
Duke (1992-2019) 
 Octadecanal HM Main compound found in crude extract of 
Nostoc linckia, algae, exhibited antimicrobial 
activity against S, aureus and S. sonnei 
Al-Wathnani et al. 
(2012) 




 1-Octacosanol HM, HS, MM  90% of antioxidant activity from rice with 
high level of octacosanol 
 
Cho et al. (2017) 
 Coumaran EAM, MM Antitubercular, anti-HIV, anticancer, 
cytotoxic, antiprotozoal 
Ilya et al. (2018) 
 Methyl hexadecanoate EAM COMT inhibitors – decrease off time in 
Parkinson’s desease patients 
 
Duke (1992-2019) 
 Indolizine  MM Medicinal moeity, anticancer Sharma and Kumar 
(2014) 
 
 Butanedioic acid, hydroxy-
,dimethyl ester  
MM Testosterone-hydroxylase-inducer 




 Table 3.12 Continued    
 Compound Name A. precatorius 
Extract  
Reported Activity Reference 
 Methyl salicylate MM Anti-inflammatory, analgesic, antipyretic and 
antithrombotic 
 
Mao et al. (2014) 
 Cyclopentaneacetic acid, 3-oxo-
2-pentyl-, methyl ester  
 
MM COMT inhibitors – decrease off time in 
Parkinson’s desease patients 









 Cirsimaritin  EAS, MS Inhibited NO production 
Anti-inflammatory activity by inhibtion of c-
fos and STAT3 phosphorylation in 
RAW264.7 cells 
 
Shin et al. (2017a) 
 3-Methoxy-4,5,7-
trihydroxyflavone  
EAS Antioxidant, anti-inflammatory activities 
 
Cytotoxic effect in human lung carcinoma  
Limboonreung et al. 
(2019) 
Wei et al. (2019) 
 
 4-vinyl-syringol  
 
 
MS Inhibit gastric tumours initiation Cao et al. (2015) 
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 Table 3.12 Continued    
 Compound Name A. precatorius 
Extract  
Reported Activity Reference 
 Octanoic acid, methyl ester  
 
MS COMT inhibitors – decrease off time in 
Parkinson’s desease patients 




 Capric acid  MS Bactericidal, anti-inflammatory activity Huang et al. (2014) 
 
 Dodecanoic acid  MS, EAS Bactericidal, anti-inflammatory activity Huang et al. (2014) 
 
 Linolenic acid  EAS, MS Anti-inflammatory activity on human corneal 
epithelial cells 
Erdinest et al. (2012) 




0.24 carbonitrile  
MS Anti-inflammatory activity Duke (1992-2019) 
     
Legends: 
(HM) -hexane maceration; (HS) – hexane Soxhlet; (EAM) – ethyl acetate maceration; (EAS)- ethyl acetate Soxhlet; (MM) – methanol 
maceration; (MS) – methanol Soxhlet; (AQ) – aqueous extract; (MMP) – matrix metalloproteinases;  (PPARg) - peroxisome proliferator-
activated receptor gamma; (NF-κB) – nuclear factor kappa b; (MAPK) – mitogen activated protein kinase;  (MAG)- monoacylglycerol; (FA)-






Medicinal plants contain organic compounds, which include phenolic 
compounds, alkaloids, tannins, carbohydrates, flavonoids, terpenoids, and steroids. 
These compounds existed as a result from being synthesized by the primary or 
secondary metabolism of living thing. 
Phytochemical studies of aqueous leaves extract of A. precatorius are still 
limited as it only identifies the polar compounds. The composition of the compounds 
identified in aqueous extracts of A. precatorius leaves is a complex mixture of several 
classes of components, mainly phenolic compounds, terpenoids and steroids. Phenolic 
compounds are identified by the presence of a phenol structure such as an aromatic 
benzene ring with at least a hydroxyl substituent (Patra and Saxena, 2009; Robbins, 
2003; Vermerris and Nicholson, 2006). Study by Hussain and Kumaresan (2014) 
showed that only phenolic compounds and steroids were present in aqueous leaves 
extract of A. precatorius. The aqueous extract was obtained via Soxhlet extraction 
method, hence the prolonged heat exposure may resulted in the loss of terpenoids 
compounds in their extract.  
4-vinylphenol is the main phenolic compound identified in aqueous, ethyl 
acetate (maceration) and methanol (Soxhket) extracts of A. precatorius leaves. Recent 
study of 4-vinylphenol showed that this compound has anti-angiogenic activities (Yue 
et al., 2015). Other identified compounds that have some therapeutic activities were 
β-lonone, phytol and stigmasterol. β-lonone was found to have anti-proliferative 
(Faezizadeh et al., 2016),  antibacterial (Kubo et al., 1993; Patra et al., 2015) and 
antitumor activities (Cho et al., 2016; Liu et al., 2008; Sharma et al., 2013; Yu et al., 
1995) besides it also can be used as fungicide, pesticide, and trichomonicide. Phytol 
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has antimicrobial (Pejin et al., 2014), anticancer (Song and Cho, 2015) and anti-
inflammatory activities (Silva et al., 2014). Stigmasterol is listed as antihepatotoxic 
(El-Domiaty et al., 2009), anti-inflammatory (Gabay et al., 2010), antinociceptive 
(Kamurthy et al., 2013), antiophidic, antiviral, cancer-preventive agent (Ali et al., 
2015; Kasahara et al., 1994), hypocholesterolemic agent (Barriuso et al., 2015), 
ovulant agent (Zaman et al., 2015) and sedative agent (Habib et al., 2007).  
The therapeutic activity of the aqueous leaves extract from A. precatorius, 
which in traditional practices obtained by decoction, might be due to the presence of 
phytol, stigmasterol and β-lonone. Individually, these phytochemical compounds have 
exhibited their bioactivities, however, it does not answer how it works as a whole crude 
extract as being practiced traditionally. Other studies indicated that other solvent 
extracts from A. precatorius leaves are rich in alkaloids, carbohydrates, steroids, 
phenolic compounds and terpenoids (Gul et al., 2013; Hussain and Kumaresan, 2014; 
Yonemoto et al., 2014).  
In this present study, two different methods were applied for the successive 
solvent extraction, which were Soxhlet and maceration. Soxhlet extraction applied 
heat in a shorter time while maceration involved prolonged soaking without heat. 
Successive solvent extraction means the leaves were extracted first using hexane, ethyl 
acetate and lastly with methanol, in the manner of increasing polarity index (P’). 
Burdick and Jackson have arranged and listed solvents in order of increasing P’ 
(Barwick, 1997). Hexane has a P’ of 0.1, P’ for ethyl acetate is 4.4 and P’ for methanol 
is 5.1. Meanwhile aqueous has the highest P’ at 10.2. Low P’ solvent will extract 




1-octacosanol was the main compound identified in both extraction by hexane 
Soxhlet or hexane maceration. This compound is a fatty acid alcohol mostly found in 
waxes of leaves and it is chemically similar vitamin E. To be beneficially for health, 
this compound must be taken as supplement because only a small amount of it can be 
ingested in the diet (Taylor et al., 2003). Red-coloured rice of the Korean rice genotype 
presented highest antioxidant activity and contained the highest level of octacosanol 
(Cho et al., 2017). Though not scientifically proven, this compound is used as 
supplement for many things including Parkinson disease, managing high cholesterol 
and atherosclerosis, improving athletic performances and also for amyotrophic lateral 
sclerosis (ALS). A study recently published showed that combined supplement with 
addition of 1-octacosanol can boost the fitness of drug detection dogs physically 
(Menchetti et al., 2019). Another fatty alcohol highly presented in hexane maceration 
extract is heptacosanol (21.80%)  however, only 0.24% was identified in the hexane 
Soxhlet extract. No health benefits or bioactivity has been associated with this 
compound. 1-eicosanol is another fatty alcohol highly presented in hexane Soxhlet 
extract which is mainly used as emollient in the cosmetics industry [PubChem 
CID=12404] (Kim et al., 2018b).  
 Neophytadiene was the main compound found in the ethyl acetate Soxhlet 
extraction. It is an antioxidant compound known for its biological activity as anti-
inflammaroty, antipyretic, good analgesic and antimicrobial (Swamy et al., 2017). 
Neophytadiene belongs to a group of compounds known as sesquiterpenoids, which 
consist of terpenes containing three consecutive isoprene units. This compound was 
not found in the ethyl acetate maceration extract. This might be because the maceration 
technique did not use any heat compared to the Soxhlet extraction method. 
Neophytadiene is possibly occurred by dehydration of phytol (Changi et al., 2012). 
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This also explained the reason that this compound could only be identified in extracts 
obtained via Soxhlet. The main compound found in the ethyl acetate maceration 
extract was 2-hexadecene,3,7,11,15-tetramethyl-(R-(R*,R*-E)-. Neophytadiene 
presence was very little with peak area of 1.54% in hexane Soxhlet extract, and 1.23% 
in hexane maceration extract. This compound was also one of the main compound 
identified in the methanol Soxhlet extract besides hexadecenoic acid, methyl ester.  
Hexadecanoic acid, methyl ester is also known as methyl palmitate belongs to 
a group of fatty acid methyl ester [PubChem, CID=8181]. This compound has been 
reported to significantly induce dilation in aorta (Wang et al., 2018a), reduce the levels 
of tumour necrosis factor-alpha (TNF-a), interleukin-10 (IL-10) and prostaglandin E2 
(PGE2) without jeopardising the levels of ATP in cells. Besides that methyl palmitate 
is also reported to inhibit nitric oxide production and phagocytic activity of certain 
cells (Sarkar et al., 2006; Wang et al., 2018a; Wang et al., 2010b). Methyl palmitate 
is also known as vasodilator which enhance blood flow in cerebral and promote 
neuronal cell survival after cardiac arrest. This therapeutic potential of methyl 
palmitate would lead to improvement of functional learning and memory subsequent 
of cardiac arrest-induced brain injury (Lee et al., 2019b).  
In this current study, extract from the ethyl acetate and methanol obtained by 
Soxhlet exhibited the highest phenolic and terpenoid compounds. 4-vinylphenol was 
the highest phenolic compound identified in the methanol extract (Soxhlet) and 
neophytadiene was the highest terpenoid compound identified in that extract. 
Cirsimaritin is another phenolic compound identified in both ethyl acetate and 
methanol (Soxhlet) extracts. This compound inhibited nitric oxide production and 
exhibited the anti-inflammatory activity (Shin et al., 2017a). Another  compound 
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found in the ethyl acetate (Soxhlet) profile is 3-Methoxy-4,5,7-trihydroxyflavone, also 
known as chrysoeriol. This compound is derived from luteolin, another 
phytocompound widely studied in medicinal plants. Recently it is found that this 
compound exhibited anti-inflammatory (Limboonreung et al., 2019) and anticancer 
activity (Wei et al., 2019).  
 Phytochemicals found in plants are generally known as primary and secondary 
compounds. Primary compounds are generally present as the building blocks of plants 
which includes sugars, proteins, and chlorophyll. Secondary compounds include 
phenolic compounds, alkaloids, terpenoids, steroids and many more (Wadood et al., 
2013). The biggest group of phytochemicals is the phenolic compound and most of 
these compounds are found in plant-based foods mainly fruits and vegetables such as 
cherries, grapes, citruses, tomatoes, apples, peaches and berries (Basli et al., 2017). 
Phenolic compounds are widely studied for its health benefits especially the ability to 
exhibit as an anti-cancer agent.  This ability might be attributed to the antioxidant 
activity poses by phenolic compounds. Oxidative stress is one of the causes in cancer 
occurrences. Phenolic compounds chemopreventive structure are able to induce cell 
cycle arrest thus inhibiting DNA binding and proliferation, and regulate the expression 
of ontogenesis and carcinogen metabolism (Huang et al., 2009). Naringenin, a 
phenolic compound identified in the ethyl acetate extract (Soxhlet), exhibited 
cytotoxic effect on colon carninoma. In this particular study, naringenin was isolated 
from the citrus (Song et al., 2016).  
 Terpenoids is also another compound of interest which have been identified to 
demonstrate the anti-proliferative activity on cancer cells. Subclasses of terpenoids are 
believed to contribute as anti-cancer agents include monoterpenoid, diterpenoid, 
triterpenoid and sesquiterpenoid (Huang et al., 2012). In this current study, A. 
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precatorius leaves extract from ethyl acetate Soxhlet extraction presented the highest 
terpenoids at 36.97%. While the methanol Soxhlet extraction showed the highest 
phenolic compounds presented at 13.88% and terpenoids at 14.08%. Although there 
are a lot of therapeutic potential of the compounds identified in all extracts, our study 
are focusing on compounds promoting anticancer activity. Phenolic compounds found 
in all A. preactorius extracts were 4-methyl-2,5-dimethoxybenzaldehyde, cirsimaritin, 
and 4-vinyl-phenol. While compounds belong in the terpenoids group identified in all 
extracts include neophytadiene, phytol, squalene, and (-)-Loliolide. Neophytadiene 
presented in all extracts except ethyl acetate maceration and methanol maceration 
extracts.  
Previous study of A. precatorius leaves showed that their biological activities 
are also related with their active compounds such as terpenoids and phenolics 
compounds. Yonemoto et al. (2014) found that terpenoids isolated from A. precatorius 
leaves had α-amylase inhibitory effect; one of the therapeutic approaches for 
preventing diabetes mellitus. Phenolic compounds such as flavanoids and phenolic 
acids are well known to have antioxidant and anti-proliferative activities (Gul et al., 
2013). A recent study from Iraq, using 80% aqueous ethanol solvents for A. 
precatorius leaves extraction by Soxhlet revealed the presence of several compounds 
including alkaloids, flavonoids, phytosterols and terpenoids. Three fractions were 
obtained from the crude extract that showed the presence of alkaloids (fraction 1), 








 Presence of phenolic compounds and terpenoids in most of the extracts showed 
that A. preactorius leaves might have effects on cancer cell proliferation and mortality. 
Major compound found consistently in all extract is neophytadiene, a terpenoids. 
However, little is known as to whether these identified compounds work individually 
or as a result of a synergistic effect. Therefore, in this study, we were exploring on the 
usage of A. precatorius leaves extracts in crude form rather than as isolated 
compounds. The ability of A. precatorius leaves extracts to possibly exert the anti-
proliferative activity against selected normal and cancer cell line and its ability to 



























ANTI-PROLIFERATIVE ACTIVITY AND APOPTOSIS INDUCTION  of 
Abrus precatorius LEAVES EXTRACT ON CANCER CELLS 
 
4.1 INTRODUCTION 
Apoptosis is known as programmed cell death and it is the most studied and 
characterized form of cell death. Dying cells are packaged into fragments which later 
are consumed and eliminated by phagocytes. This process needs to occur without 
disturbing the function of surrounding healthy tissues (Green, 2011). Equilibrium 
between cell proliferation and cell death is important to ensure the cellular balance in 
functioning tissues and to avoid cell disruption. Many clinical diseases including 
cancer are developed because of this apoptosis imbalance either deficient or excessive 
(Cao and Tait, 2018). Initiation of apoptosis can occur either by the extrinsic or 
intrinsic pathway.   The intrinsic pathway is also known as the mitochondrial pathway 
and the extrinsic pathway is also known as the death receptor pathway. Apoptosis is 
as important tool in cancer management used as a target by potent chemical or 
biological apoptosis-inducing agents (Sreelatha et al., 2011).  
Advances in the medical field have proven that allopathy treatment to be the 
preferable choice to combat cancer. However, these advances are used with concern 
due to their side effects and limitations. This scenario has generated an impact on the 
increase demand of traditional medicines through utilizing medicinal plants either as 
complementary to the allopathy treatments or as a complete alternative. Medicinal 
plants are widely sought as an alternative in various treatment in traditional medicine 
including cancer. Many issues were raised with this development especially 
concerning the toxicity and efficacy of the medicinal plants extract. Therefore, many 
studies have been conducted to fill in the knowledge gap in order to provide better 
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understanding of the biological activities and mechanism underlying those activities 
of the medicinal plants.  
Among the other popular medicinal plants that is highly studied is the Anonna 
muricata. Ethanol extract of this plant was found to reduce viability and trigger 
apoptosis in liver cancer cell, HepG2 (Liu et al., 2016). The apoptosis was triggered 
through activation of multiple proteins involved in the endoplasmic reticulum stress 
pathway. Another study by Smith et al. (2018), reported that bacopaside II, isolated 
from the plant Bacopa monnieri significantly reduced cell viability in colon cancer 
cells, SW 480, SW 620, Ht-29 and HCT 116. Ixeris dentata induced apoptosis by 
inhibiting p-Akt and p-NF-	κB signaling pathway in MDA-MB-231 cells (Shin et al., 
2017b). Root extract from Dillenia suffruticosa also induced apoptosis, arrest DNA at 
G2/M cell cyle and activation of proapoptotic JNK1 and down regulation of ERK1 
proteins (Foo et al., 2016). Medicinal plants in focus of this thesis is Abrus precatorius. 
As mentioned earlier,  many biological activities of A. precatorius have been reported 
including anticancer. However, pharmacological properties of A. precatorius collected 
from Malaysia need to be further explored.  
Therefore, this chapter reported on the anti-proliferative activity of A. 
precatorius leaves extracts on selected cancer and normal cells. The extract with the 
lowest IC50 with its corresponding cell was selected for further analysis to elucidate 






4.2 MATERIALS & METHODOLOGY 
4.2.1 Cell culture 
Human breast cancer cell lines, MDA-MB-231 and MCF-7; human colon 
cancer cell line, SW480; human cervical cancer cell line, HeLa; human normal breast 
cell, MCF-10A and mouse normal fibroblast cell, NIH(3T3); were obtained from 
American Type Cell Culture Collection (ATCC), Maryland, USA.   Cells were seeded 
in 25cm2 tissue culture flasks and grown at 37°C under humidified 5% CO2 in DMEM 
medium supplemented with 5% of FBS and 1% of penicillin-streptomycin. Confluent 
cells were harvested by trypsinization with trypsin-EDTA (0.25%) for about five 
minutes. Trypsinization was stopped with the addition of 1ml of complete medium. 
All selected cancer and normal cells used DMEM media except for MCF10-A. The 
ingredients for MCF10-A media is as listed in Appendix A. 
4.2.2 Anti-proliferative activity assay of A. precatorius leaves extracts 
Screening of anti-proliferative activity of A. precatorius leaves extract was 
performed on the selected cancer and normal cells. Extract that exhibited the lowest 
IC50 value and its corresponding cell, was used for subsequent analysis in this study. 
Cells were cultured in 25cm2 tissue culture flasks, trypsinized with trypsin-EDTA 
(0.25%)  and seeded into the flat bottom 96-well plate. Cells were seeded at the centre 
of the plate (60 wells) with the concentration of 5 x 104 cells/ml per well. Number of 
cells were determined by trpan blue exclusion assay and counted using hemocytometer 
(Appendix D). Wells at the edges of the plate were filled up with water to prevent the 
plate from drying during the incubation. The next day medium was discarded, then 
200µL of fresh medium was added into the wells. Extracts of A. precatorius leaves 
were added following a serial dilution starting from 99µg/ml until 0.39µg/ml in each 
well. The diluted A. precatorius leaves extracts were added into the wells as according 
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to Table 4.1. Each concentration was added into three wells (triplicates) and each 
extract was tested for three times (n=3).  
 












extract in well 
(µg/ml) 
Log 10 final 
concentrations 
1 10 0.099 99 -1.00 
2 5 0.0495 49.5 -1.31 
3 2.5 0.0248 24.8 -1.61 
4 1.25 0.0124 12.4 -1.91 
5 0.625 0.00618 6.18 -2.21 
6 0.3125 0.00309 3.09 -2.51 
7 0.156 0.00155 1.55 -2.81 
8 0.078 0.00077 0.77 -3.11 
9 0.039 0.00039 0.39 -3.41 
 
Anti-proliferative activity of A. precatorius leaves extracts was measured by 
the MTT (3-[4,5-dimethyl thiazol-2-yl] 2,5-diphenyl tetrazolium bromide) assay, 
which was performed after a 72h incubation post treatment with the extracts, 
tamoxifen (positive control) and DMSO (negative control). Absorbance was read at 
OD of 570nm. The absorption value at this wavelength directly represents the relative 
cell numbers with comparison to the control group (Igarashi and Miyazawa, 2001). 




 The IC50 values of all extracts on each cancer/normal cells were determined by 
plotting a graph of ‘Log10 of the final extracts concentration’ (as depicted in Table 4.1) 
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against ‘Cell Viability’. The extract that induced lowest IC50 values with its 
corresponding cell, was selected for the subsequent analysis of this study.  
 
4.2.3 Morphology of cell death 
 From anti-proliferative assays, it was shown that A. precatorius methanolic 
leaves extract (Soxhlet) showed the lowest IC50 value at 26.4µg/ml on MDA-MB-231 
cells (Table 4.2). This extract was designated as APME for the rest of the report in this 
thesis. In order to visualize the morphological effects of APME on MDA-MD-231 
cells, the APME-treated cells were observed under light microscope and fluorescent 
microscope.  
4.2.3(a) Bright field microscopy   
 Light microscope was used to view morphological effect of APME-treated 
MDA-MB-231 cells and images were recorded with Dino-Eye Eyepiece Camera. Cells 
were seeded in a six-well plate at 5x104 cells/well. Cells were culturre using DMEM 
with 5% of FBS and 1% of penicillin-streptomycin.  Cells were incubated in a 
humidified, 5% CO2 incubator at 37°C, overnight. After cells were confluence, cells 
were treated with APME and further incubated for 24h, 48h and 72h. Untreated cells 
(contains <1% DMSO) at each time point were also observed alongside with 
Tamoxifen-treated cells.  
4.2.3(b) Fluorescent microscopy (Hoechst Staining )  
Hoechst 33258 was used to visualize nuclear changes in apoptotic cells. The 
dye binds to the DNA in the cells, producing fluorescence blue color under 
fluorescence microscope. Cells were firstly seeded in a petri dish containing a sterile 
microscope slide at 5x104 cells. They were incubated in a humidified, 5% CO2 
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incubator at 37°C, overnight. The next day, cells were treated with APME for 24, 48h 
and 72h. After the incubation times, the slides were washed three times with PBS and 
dried. Then they were fixed with 4% paraformaldehyde (30 minutes) at 4°C. All slides 
were then incubated with 30 µg/mL Hoeshct 33258 (Invitrogen, USA) at room 
temperature in a dark condition for 30 minutes. Nuclear morphology of each different 
treatment time was examined under fluorescent microscope at 40X magnification 
(Imaging Source Europe GmbH, Bremen, Germany). For long-term storage, the slides 
were wrap with aluminum foil and kept in 4°C. 
4.2.4 Cell Cycle Assay  
MDA-MB-231 cells were treated with IC50 of the APME and incubated for 24, 
48 and 72h. Cells were harvested by trypsinization and the cell cycle assay was 
performed according to the manufacturer protocol, BD CycletestTM. All samples 
readings were acquired with FACSCANTO II (BD Bioscience). Data obtained was 
analysed with ModFit LT 5.0 software (Becton Dickinson, Franklin Lakes, NJ, USA). 
4.2.5 Apoptosis Assays 
4.2.5(a) AnnexinV and PI staining 
MDA-MB-231 cells were treated with IC50 of the APME and incubated for 
24h, 48h and 72h. Cells were harvested by trypsinization and the apoptosis assay was 
performed according to the manufacturer protocol, AnnexinV-FITC detection kit I 
(BD Bioscience). All samples readings were acquired with FACSCANTO II (BD 




4.2.5(b) Bax, Bcl-2, Caspase-3 and p53 activity 
MDA-MB-231 cells were treated with IC50 of the APME and incubated for 
24h, 48h and 72h. Cells were harvested by trypsinisation following each incubation 
time and washed twice with PBS. Ethanol (70%) was used to fix the cells at 4°C for 
an hour. Cells were washed twice with PBS and then blocked with 2% BSA for 10 
minutes at room temperature. Another cell wash was performed, and cells were 
resuspended in PBS.   
About 100µl of the cell suspension (1x106 cells) were mixed independently in 
different tubes, with antibodies (SantaCruz); Bax-PE (sc-7480), Bcl-2 – Alexa Fluor 
647 (sc-7382), p53 – Alexa Fluor 488 (sc-126) and Caspase-3 – Alexa Fluor 488 (sc-
7272). These cells-antibodies mixtures were incubated for 20 minutes at room 
temperature, then washed once and resuspended in 500µl PBS. All samples readings 
were acquired with FACSCANTO II (BD Bioscience).  Data obtained was analysed 
with FlowJo software.  
4.2.6 Statistical Analysis 
The data were expressed as mean ±SD of three repeated experiments. The level 
of statistical significance was tested using repeated measure one-way ANOVA, 
followed by Dunnett’s multiple comparison test. The difference was considered 






4.3.1 Anti-proliferative activity of A. precatrius leaves extracts 
Anti-proliferative activity of A. precatorius was determined on human breast 
cancer cell lines, MDA-MB-231 and MCF-7; human liver cancer cell lines, SW480; 
human cervical cancer cell line, HeLa; human normal breast cell, MCF-10a and mouse 
normal fibroblast cell, NIH (3T3). The potential anti-proliferative activity of A. 
precatorius extracts was investigated by MTT assay. IC50 values were determined to 
demonstrate the anti-proliferative effects of these extracts, with lower IC50 values 
indicating higher anti-proliferative activity. The US National Cancer Institute and 
Geran Protocol (Geran et al., 1972), listed out the criteria used to categorize 
cytotoxicity of plant extracts against cancer cell line as follows: highly cytotoxic (IC50 
≤ 20μg/ml), moderately cytotoxic (21≤ IC50 ≤ 200μg/ml), weakly cytotoxic (201≤ IC50 
≤ 500μg/ml), and, no cytotoxicity (IC50 ≥ 501μg/ml).  IC50 of all extracts were 
determined by plotting the graph of concentration of the extract(s) or tamoxifen vs 




4.3.2 Determination of the anti-proliferative activity of A. precatorius aqueous 
extract (decoction) on selected normal and cancer cells 
 A. precatorius aqueous leaves extract was prepared by decoction at 50°C. 
Initially the cells were treated with concentration as listed in Table 4.1 (page 88). 
However, no IC50 value was obtained even the cells were treated at the maximum 
concentration of 99µg/ml. Therefore, the aqueous extract concentration was increased 
to 990µg/ml. It was performed in the same manner as explained in section 4.2.2. A log 
concentration vs cell viability was also plotted. Figure 4.1 showed the representative 
points of each concentration, presented in means with ±SD of three independent 
experiments. A. precatorius aqueous extract demonstrated a null toxicity against all 
cells, according to the standard criteria used by The US National Cancer Institute and 











Figure 4.1: Anti-proliferative activity of A. precatorius aqueous leaves extracts on 
selected cancer and normal cells.  
 
The results were expressed as mean, ±SD of three independent 
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4.3.3 Determination of the anti-proliferative activity of A. precatorius solvents 
extract (Soxhlet) on selected normal and cancer cells 
There were two types of extraction methods used for A. precatorius leaves. 
Both methods applied solvents in a successive manner. Anti-proliferative activities of 
A. precatotius successive Soxhlet hexane-, ethyl acetate- and methanol- leaves extracts 





Figure 4.2: Anti-proliferative activity of A. precatorius successive Soxhlet      
hexane-, ethyl acetate- and methanol- leaves extracts on HeLa cells.  
 
The only IC50 values obtained were for methanol extract was 73.6µg/ml 
and 4.32 µg/ml for Tamoxifen, while the rest of the extracts has the IC50 
values of >99 µg/ml.  The results were expressed as mean, ±SD of three 
























Figure 4.3: Anti-proliferative activity of A. precatorius successive Soxhlet 
hexane-, ethyl acetate- and methanol- leaves extracts on MCF7 cells.  
 
The IC50 values obtained for hexane extract was 52.65µg/ml, ethyl acetate 
extract was 99µg/ml and methanol extract was 59.03µg/ml and 1.81µg/ml 
for Tamoxifen.  The results were expressed as mean, ±SD of three 


























Figure 4.4: Anti-proliferative activity of A. precatorius successive Soxhlet 
hexane-, ethyl acetate- and methanol- leaves extracts on MDA MB-
231 cells.  
 
The IC50 obtained for hexane, ethyl acetate, methanol extract and 
tamoxifen were 45.60µg/ml, 54.5µg/ml, 26.4µg/ml and 2.27µg/ml, 
respectively. The results were expressed as mean, ±SD of three 
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4.3.3(d) SW 480 
 
  
Figure 4.5: Anti-proliferative activity of A. precatorius successive Soxhlet 
hexane-, ethyl acetate- and methanol- leaves extracts on SW 480 
cells.  
 
The IC50 obtained for methanol extract is 77.23µg/ml and 2.31µg/ml for 
Tamoxifen, while the rest of the extracts demonstrated the IC50 values of 
>99µg/ml. The results were expressed as mean, ±SD of three independent 



























Figure 4.6: Anti-proliferative activity of A. precatorius successive Soxhlet 
hexane-, ethyl acetate- and methanol- leaves extracts on NIH(3T3) 
cells.  
 
The IC50 obtained for Tamoxifen is 3.78µg/ml, while the rest of the 
extracts demonstrated the IC50 values of >99µg/ml. The results were 


























Figure 4.7: Anti-proliferative activity of A. precatorius successive Soxhlet 
hexane-, ethyl acetate- and methanol- leaves extracts on MCF10A 
cells.  
 
The IC50 obtained for Tamoxifen is 2.78µg/ml, while the rest of the 
extracts demonstrated the IC50 values of >99 µg/ml. The results were 
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4.3.4 Determination of the anti-proliferative activity of A. precatorius solvents 
extracts (Maceration) on selected normal and cancer cells 
 
Another method used for A. precatorius leaves extraction was by maceration. 
The ground leaves were soaked with no heat successively with different solvents 
following their polarity. Initially the concentration of the extracts used were as stated 
in Table 4.1. However, no IC50 was recorded in all extracts even at the maximum 
concentration used. Therefore, the extracts concentration was increased to the 
maximum of 495µg/ml. Anti-proliferative activities of A. precatotius successive 
(maceration) hexane-, ethyl acetate- and methanol- leaves extracts are shown in Figure 







Figure 4.8: Anti-proliferative activity of A. precatorius successive (maceration) 
hexane-, ethyl acetate- and methanol- leaves extracts on HeLa cells.  
 
The IC50 obtained for hexane extract was 325µg/ml, ethyl acetate extract 
was 371µg/ml and methanol extract was 352 µg/ml. The results were 


























Figure 4.9: Anti-proliferative activity of A. precatorius successive (maceration) 
hexane-, ethyl acetate- and methanol- leaves extracts on MCF-7 cells.  
 
The IC50 obtained for hexane extract was 672µg/ml and methanol extract 
was 423µg/ml. While ethyl acetate extract was >495µg/ml. The results 

























Figure 4.10: Anti-proliferative activity of A. precatorius successive (maceration) 
hexane-, ethyl acetate- and methanol- leaves extracts on MDA-MB-
231 cells.  
 
The IC50 obtained for hexane extract was 80.75µg/ml, ethyl acetate 
extract was 207µg/ml and methanol was 255µg/ml. The results were 



























Figure 4.11: Anti-proliferative activity of A. precatorius successive (maceration) 
hexane-, ethyl acetate- and methanol- leaves extracts on SW480 cells.  
 
The IC50 obtained for hexane extract was 301.3µg/ml, ethyl acetate 
extract was 447.5µg/ml and methanol 350.3was µg/ml. The results were 
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4.3.4(e) NIH (3T3) 
 
Figure 4.12: Anti-proliferative activity of A. precatorius successive (maceration) 
hexane-, ethyl acetate- and methanol- leaves extracts on NIH(3T3) 
cells.  
 
No IC50 was obtained even at the maximum concentration of 495µg/ml. 
The results were expressed as mean, ±SD of three independent 
























Figure 4.13: Anti-proliferative activity of A. precatorius successive (maceration) 
hexane-, ethyl acetate- and methanol- leaves extracts on MCF10A 
cells.  
 
No IC50 was obtained even at the maximum concentration of 495µg/ml. 
The results were expressed as mean, ±SD of three independent 
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4.3.5 Summary of the IC50 values of all A. precatorius leaves extracts 
The IC50 values of all extracts in inhibiting the cancer and the normal cells were 
summarized in Table 4.2. Methanol extract (Soxhlet) was identified to have the lowest 
IC50 value among all extracts on MDA-MB-231 cells at 26.4±2.45µg/ml, which is 
categorized it to be moderately toxic. Methanol extract (Soxhlet) also exhibited 
moderate anti-proliferative activity on all cancer cells but not toxic on normal cells. 
Methanol extract (maceration) exhibited low cytotoxic activity on all cancer cells. 
Hexane extract (Soxhlet) exhibited moderate cytotoxicity on MCF-7 and MDA-MB-
231 cells, while the maceration extract showed low anti-proliferative effect on HeLa, 
MCF-7, and SW 480. Ethyl acetate extract (Soxhlet) exhibited moderate anti-
proliferative activity on MCF-7 and MDA-MB-231 cells, while low anti-proliferative 
activity on HeLa, MDA-MB-231, and SW 480 was exhibited by the ethyl acetate 
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4.3.6 Observation on morphological changes upon treatment with APME 
 Morphology of cell death can be observed microscopically. Two methods used 
in this study were direct observation via bright field microscopy and Hoechst staining 
via fluorescence microscopy. From previous anti-proliferative assays, A. precatorius 
methanolic leaves extract (Soxhlet) showed the lowest IC50 value at 26.4µg/ml on 
MDA-MB-231 cells. Therefore, this extract (APME) was selected for further studies. 
 MDA-MB-231 cells were treated with APME for 24h, 48h, and 72h. The cells 
were viewed under inverted light microscope at 20X magnification and the images 
were captured with Dino-Eye Camera. The images are  shown in Figure 4.14 (a) – (i). 
No significant change was observed for the APME-treated cells at 24h comparing to 
the untreated cells. At 48h and 72h, cells grew rapidly, and new cells formed layers, 
while older cells formed clumps on their surface. APME-treated cells were showing 
signs of apoptosis starting at 48h (Figure 4.14-e) post treatment. Longer time exposure 
showed more cells with membrane blebbing and ballooning. Cells were also unable to 
keep its spindle shaped cells. Rounder and shrunken cells signify dead cells and none 
newly formed cells were observed in Figures 4.14 (e), (f), (h) and (i). Tamoxifen-
treated cells started to exhibit apoptotic-like structure at 24h post treatment. More cell 
deaths were observed in tamoxifen-treated cells at 48h and 72h post treatment.  
 MDA-MB-231 treated cells were also observed under fluorescent microscope 
to observe the nucleus changes. Hoechst 32588 was used to stain the cells as shown in 
Figure 4.15. This dye enters the cell and binds to the AT-rich segment of the DNA in 
the nucleus. This staining is important in order to demonstrate the DNA fragmentation 
as the hallmark of apoptosis. The density of the fluorescent was observed higher in 
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APME-treated cells at 48h and 72h which indicated that the DNA in those cells started 
to lose its integrity thus allowing more dye to bind to the exposed AT-regions.  
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4.3.6(b) Hoechst Staining  
 
Figure 4.15 Hoechst staining of MDA-MB-231 treated with APME. 
 
(A) Non-treated MDA-MB-231 cells; (B) MDA-MB-231 cells treated 
with APME at 24h; (C) MDA-MB-231 cells treated with APME at 48h 
(D) MDA-MB-231 cells treated with APME at 72hMagnification: 40X. 












4.3.7 Cell Cycle Analysis 
The ability of the APME to reduce cell viability could be due to cell death 
mediated by cell cycle arrest. Cell cycle arrest was investigated using flow cytometric 
analysis of propidium iodide stained DNA. Representative profiles of the cell cycle 
progression are presented in Figure 4.16 and percentage of each phase of cell cycle is 
presented in Figure 4.17. Significant increment of the arrest was seen at G0/G1 phase 
of the cell cycle, suggestive of cell death consistent with the reduction of cell growth 





Figure 4.16: Effects of APME on cell cycle progression in MDA-MB-231 cells. 






Figure 4.17: Effects of APME on cell cycle progression in MDA-MB-231 cells. 
Graph represents the percentage of each phase of the cell cycle. Data are 
expressed as mean ±SD of three repeated experiments. P<0.05 is 




































4.3.8 Apoptosis Assay Analysis 
4.3.8(a) Annexin-V vs PI Staining 
An apoptosis staining assay was performed using the AnnexinV-FITC 
detection kit I (BD Bioscience) to determine the ability of the APME to induce 
apoptosis. Representative profiles of the apoptosis assays are presented in Figure 4.18 
and percentage of each phase of cell death progression is presented in Figure 4.19. 
Live cells did not uptake any stain and represented at Q3 (quadrant 3). AnnexinV 
bound to the phosphatidylserine of the plasma membrane which was exposed in early 
apoptosis (Q4; annexinV positive, PI negative). Late apoptotic cells lost their cell 
integrity thus allowing the penetration of PI (Q2; annexinV positive, PI positive), 
while necrotic cells were stained with PI only (Q1; PI positive). APME induced early 
apoptosis in MDA-MB-231 cells at 48h following treatment and late apoptosis at 72h 




Figure 4.18: The representative dot plot of the apoptosis assay in a time-
dependent manner. 
(A) Non-treated MDA-MB-231 cells; (B) MDA-MB-231 cells treated 
with APME at 24h; (C) at 48h and (D) at 72h. Quadrants represent the 
percentage of cell populations; Q1- Necrosis, Q2- Late apoptosis, Q4-















Figure 4.19: Graph of the percentage of each phase of the MDA-MB-231 cell death 
following treatment with APME. 
Data are expressed as mean ±SD of three repeated experiments. P<0.05 




































4.3.8(b) p53, Bax, Bcl-2, and Caspase-3 protein expression 
p53, Bax, Bcl-2 and Caspase-3 proteins expression levels in APME–induced 
apoptosis in MDA-MB-231 cells were measured by flow cytometry (Figure 4.20) at 
24, 48, and 72h. Treatment of the MDA-MB-231 cells with the APME increased pro-
apoptotic protein, Bax (Figure 4.22) and reduced anti-apoptotic protein, Bcl-2 (Figure 
4.23) expressions in time dependant manner. No significant changes were observed on 
the p53 protein expressions (Figure 4.21). Caspase-3 protein expressions (Figure 4.24) 
were also increased in time dependant manner. These findings indicated that APME 
induced apoptosis in MDA-MB-231 cells by up regulating Bax protein and 
downregulating Bcl-2 protein. Increase in Caspase-3 expression also signifies the 
occurrence of apoptosis in MDA-MB-231 cells induced by APME. Combination of 
these findings might suggest that the apoptosis in MDA-MB-231 cells was triggered 





Figure 4.20: Apoptosis proteins expression of Bax, Bcl-2, p53, and Caspase-3, 










Figure 4.21: Protein expressions of p53, following the treatment of MDA-MB-231 
cell with APME by flow cytometry. 
Data are expressed as mean ±SD of three repeated experiments. P<0.05 





































Figure 4.22: Protein expressions of Bax, following the treatment of MDA-MB-231 
cell with APME by flow cytometry. 
Data are expressed as mean ±SD of three repeated experiments. P<0.05 








































Figure 4.23: Proteins expressions of Bcl-2, following the treatment of MDA-MB-
231 cell with APME by flow cytometry. 
 
Data are expressed as mean ±SD of three repeated experiments. P<0.05 




































Figure 4.24: Protein expressions of Caspase-3, following the treatment of MDA-
MB-231 cell with APME by flow cytometry. 
Data are expressed as mean ±SD of three repeated experiments. P<0.05 




































A very large number of plant extracts have been screened for cytotoxic effects 
against cancer cell lines over the last 25 years and the traditional use of a considerable 
number of plants for cancer has been justified to some extent by the findings that have 
shown that their extracts are cytotoxic, especially if selectivity is demonstrated, either 
between different cancer cell lines or between cancer and non-cancer cell lines. 
Cytotoxicity is the common method to determine the anti-proliferative activity of an 
extract towards a cancer cell line. This method identifies the inhibitory effect of the 
extract on the cell that are actively undergoing mitotic division. The growth rate is 
indirectly measured by the formation of a colour, which also indicates the number of 
cells present. This is the basic principle applied in the MTT assay that was used in this  
study. In MTT, the mitochondria of the viable cells will reduce the tetrazolium salt 
into a coloured product called formazan. The instensity of this coloured product is 
measured spectrophotometrically with a plate reader. Such method can be used to 
determine whether the cytotoxicity of the cells is cytostatic or cytocidal (Houghton et 
al., 2007). Thus, it will give an idea whether the extracts really affect the cells or 
merely just inhibit the growth.  
This chapter reported on the potential of A. precatorius leaves to induce cell 
deaths in cancer cells.  Previous chapter has highlighted the phytochemicals identified 
in A. precatorius leaves extracts and its possible compounds that contribute to the anti-
proliferative activity in A. precatorius leaves. Previous study on various cancer cell 
lines showed that various phytocompound isolated from A. precatorius demonstrated 
inhibitory effects and these properties should be able to induce apoptosis on various 
types of cancers (Hickman, 1992). Extraction with water (aqueous) by decoction was 
performed to be as closely to the traditional practise as possible. Initially, the extracts 
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showed no anti-proliferative effect on any of the cells even at the highest concentration 
of 99µg/ml. Therefore, the extract was tested again on the cells with the maximum 
concentration at 990µg/ml. This was done to ensure whether A. precatorius aqueous 
leaves extract has any anti-proliferative effect because according to The US National 
Cancer Institute and Geran Protocol, plants extracts that are more than 501μg/ml is 
considered to not exhibit any cytotoxicity activity (Geran et al., 1972).   
A. precatorius aqueous leaves extracts could be categorized as non-toxic to 
cells. The lowest IC50 values was 573µg/ml on MDA-MB-231 cells. This value is more 
than 501μg/ml, and this is definitely categorized as non-toxic. Lebri et al. (2015) 
performed a different aqueous extraction on A. precatorius leaves and discovered that 
it was able to inhibit 50% growth of murin mastocytoma cells (P815) at 200µg/ml. 
Sofi et al (2013) demonstrated anti-proliferative activity of the aqueous leaves extract 
of Abrus precatorius at 98µg/ml when tested against MDA-MB 231 cell line. 
Maximum inhibition of the cells at 75% was obtained at 600µg/ml after 48h of 
incubation (Sofi et al., 2013). Their extract was obtained by longer maceration time 
(overnight) of sonicated powdered leaves in double distilled water, whereby in this 
study the aqueous extract was obtained by decoction at 50°C. In the GCMS report of 
A. precatorius aqueous leaves extract in Chapter 3, b-ionone was identified. This 
compound was reported to exhibit anti-proliferative effects on human leukemia cell 
line (Faezizadeh et al., 2016). However, in this study, this extract was not able to show 
anti-proliferative effect below the standard range stipulated by The US National 
Cancer Institute and Geran Protocol, despite the presence of b-ionone in the extract.   
Two different successive solvent extraction methods were applied this study. 
One was with the Soxhlet and the second one was by prolonged soaking or known as 
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maceration. The differences between these two methods are time and heat. Soxhlet 
took a shorter time with heat while maceration took a longer time without heat. Both 
started with hexane, followed by ethyl acetate and lastly with methanol. Extracts 
obtained by Soxhlet exhibited a better anti-proliferative activity against the selected 
cancer and normal cells compared to extracts obtained by maceration. The lowest IC50 
values was exhibited by the A. precatorius methanol leaves extract on MDA-MB-231 
cells. In fact, this extract also has a moderate anti-proliferative effect on other cancer 
cells, HeLa, MCF7, and SW 480. On normal breast cell, MCF10A, and normal 
fibroblast cell, NIH(3T3), this extract failed to display any anti-proliferative activity 
at the maximum concentration of 99µg/ml. A. precatorius methanol leaves extract by 
maceration demonstrated weakly anti-proliferative effects on all cancer cells, and 
definitely exhibited non-cytotoxic on the normal breast cell, MCF10A and normal 
fibroblast cell, NIH(3T3). The presence of (-)-Loliolide may contribute to the better 
anti-proliferative effect of the A. precatorius methanol leaves extract by Soxhlet 
because of its anti-cancer ability (Samanta et al., 2018). The GC-MS analysis also 
revealed that this extract contained high content of phenolic and terpenoid compounds. 
As discussed in Chapter 3, 4-vinylphenol exhibited antiangiogenesis and reduced the 
size of the tumour (Yue et al., 2015), and this is the highest phenolic compound present 
in the extract. Both methanol extracts were able to display their anti-proliferatve 
activity on all cancer lines moderately by the Soxhlet extraction and lowly by the 
maceration extraction. These results indicate that A. precatorius methanol leaves 
extract both by Soxhlet extraction or maceration have the potential to induce cell 




A. precatorius ethyl acetate leaves extract by Soxhlet was able to moderately 
inhibit the growth of MDA-MB-231 cells at 54.50µg/ml and MCF7 at 99µg/ml. On 
the other hand, the maceration extracts exhibited weak cytotoxic on HeLa, MDA-MB-
231 and SW 480. No activity was observed in MCF7, MCF10A and NIH(3T3) cells. 
Similar to methanol extract (Soxhlet), (-)-Loliolide was also identified in the ethyl 
acetate extract by Soxhlet. This compound was not identified in the maceration 
extracts. (-)-Loliolide was also presence in the A. precatorius leaves hexane extract 
(Soxhlet) and not detected in the maceration extract. Soxhlet A. precatorius leaves 
hexane extract exhibited moderate anti-proliferative activity on MDA-MB-231 cells 
at 45.60µg/ml and MCF7 cells at 52.65µg/ml. No cytotoxicity was observed on this 
extract on both MCF10A and NIH(3T3) cells at the maximum concentration of 
99µg/ml. While the maceration extracts showed moderate anti-proliferative activity 
only on MDA-MB-231 cells at 80.75µg/ml, it also exhibited weak anti-proliferative 
activity on MCF7, HeLa, and SW480. Another study by Gul et al. (2013) claimed to 
have stronger anti-proliferative activity of the hexanol and ethanol leaves extracts of 
Abrus precatorius both in human colon adenocarcinoma cells (Colo-205) and human 
retinoblastoma cancer cells (Y79), while milder anti-proliferative activities were 
observed in human hepatocellular carcinoma cells (HepG2) and leukemia cells 
(SupT1). These two studies were different with the current study on the incubation 
time of the treated cells. They treated their cells for 48 h while ours was 72 h. From 
these findings, the Soxhlet A. precatorius methanol extract (APME) was identified as 
the most potent anti-proliferative extract on the MDA-MB-231 cells.  
From this anti-proliferative experiment, both breast cancer cell lines showed 
high sensitivity towards all A. precatorius leaves extract, except for ethyl acetate 
extract by maceration. However, not all extracts were able to exclusively exhibit the 
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anti-proliferative activity in all cancer cell lines. All extracts were also unable to 
induce cytotoxicity on normal cells. This provide an inclination of the selectivity of A. 
precatorius leaves extracts which also conclude that MDA-MB-231 cells was the most 
sensitive cells towards those extracts.  
Cytotoxicity activity alone could not conclude the anticancer properties of the 
extracts. Further studies are needed to determine the mechanism of the cell death. 
Some natural products are found to act by novel mechanism. For example, paclitaxel 
from species of yew (Taxus), inhibited mitosis by stabilizing microtubules and thus 
preventing the formation of tubulin, which in contrast to other anticancer agents that 
inhibit the formation microtubules since the beginning (da Rocha Dias and Rudd, 
2001).  APME was used to treat MDA-MB-231 cells in all subsequent assays to 
explore more on the activity of this extract. First, the APME-treated cells were 
observed for its morphological changes by light microscopy and fluorescence 
microscopy. APME-treated cells started to show signs of cell deaths starting at 48h. 
At 24h APME-treated cells did not exhibit significance difference with the untreated 
cells. Tamoxifen-treated cells started to demonstrated signs of apoptosis as early as 
24h post treatment. Cells undergoing apoptosis were identified with the presence of 
membrane blebbing and ballooning, indicating that the plasma membrane started to 
lose its integrity. Apoptotic bodies were also observed in the APME-treated cells at 
48h post treatment.  
Further evaluation of the morphological changes of the apoptosis events, 
APME-treatted cells were also observed under fluorescence microscope following 
staining with Hoechst. This dye is generally used to observe nuclear changes in the 
cell. Besides Hoechst, another typical dye used for the same reason is 4’,6-diamidino-
2-phenylindole (DAPI). DNA becomes condensed and fragmented during apoptosis 
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and this event is the hallmark for cells undergoing apoptosis that distinguish them from 
necrosis cells and healthy cells. DNA fragmentation can be clearly observed in APME-
treated cells after 72h post treatment.  
For better understanding of the ability of APME to induce cell death, cell cycle 
analysis assay was performed. Cell growth and proliferation of mammalian cells 
occurs through cell cycle; thus, the inhibition of the cell cycle progression is the ideal 
target for anticancer agents (Kim et al., 2008; Li and Blow, 2001). APME exhibited 
growth inhibitory effects on the MDA-MB-231 cells, inducing cell cycle arrest at 
G0/G1 phase. Increase percentage of cell population in G0/G1 phase and reduction of 
the population in S-phase, in time dependant manner proved this claim. On a contrary, 
a recent study showed that kaempferol, a flavonoid compound, induced cell cycle 
arrest at G2/M phase in MDA-MB-231 cells (Zhu and Xue, 2019).  In S-phase, genetic 
information is transferred from one cell generation to another. Genome replication in 
S-phase is important to segregate two daughter cells during mitosis or the M-phase. 
Mitosis only occurs when S-phase is completed. Two gaps separate between M- and 
S-phase. Between M- and S-phase, there is the G1, and between S- and M-phase, there 
is G2. DNA damage activates these checkpoints. When growth arrest occurs at any 
checkpoints, cells will repair the damage. If the damage is repaired, cell progression 
will successfully resume, otherwise the cell will be eliminated through apoptosis (Li 
and Blow, 2001).   DNA arrest occurred during G0/G1 phase in this current study, 
indicated that the cell proliferation was inhibited, thus showing reduction of the cell 
percentage in S-phase and G2/M phase. At this point, it is clear that cell proliferation 
was halted by DNA arrest at G0/G1 phase.  Furthermore, it is important to establish if 
the cell inhibition was caused by apoptosis.  
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Apoptosis induction is regarded as the best strategies in cancer treatment. It is 
an important programmed cell death to eliminate unnecessary cells and thus became 
the common mode of action for most chemotherapeutic agents (Cao and Tait, 2018). 
Induction of apoptosis signifies the success of plant products as anticancer agents and 
it is the optimal way in cancer treatment.  In order to confirm whether the inhibition 
of cell proliferation induced by APME is due to apoptosis, rather than necrosis, 
apoptosis assay using AnnexinV-FITC and PI staining was performed following the 
treatment with the extract. AnnexinV stains the phosphatidylserine of the inner cell 
membrane which is exposed during the early stage of apoptosis. Our results 
demonstrated that the APME promotes cell death via apoptosis. Early apoptosis 
occurred after 48h and eventually led to late apoptosis following 72h of treatment. 
These findings are in coherent with the morphological observation of the APME-
treated MDA-MB-231 cells, where signs of cells undergoing apoptosis started to show 
at 48h post treatment. These signs explained the shrinkage of cells and eventually lead 
to rounded cells and detachment from the well surface.  
Apoptosis occurs through a series of events, either by extrinsic pathway or 
intrinsic pathway, or both.  One of the important proteins in inducing cell cycle arrest 
or apoptosis is the p53. This protein is encoded by the TP53 gene. p53 is found mostly 
mutated or silence in cancer where about 50% to 55% of human cancers have loss of 
wild type p53 activity (Wang et al., 2015). In normal condition, p53 is lowly expressed 
even undetectable, however, upon activation, p53 provides significance defence 
against tumour development by inducing cell cycle arrest or apoptosis. MDA-MB-
231, a triple negative breast cancer (ER-) is known to express mutant p53 (Gartel et 
al., 2003; Hui et al., 2006), which enable the survival of the cells and contribute to 
suppressing apoptotic events. In ER+ breast cancer, though expressing wild type p53, 
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apoptosis responses by p53 are prevented because of the estrogen directly interacts 
with the wild type p53 (Bailey et al., 2012a). p53 responses can be blocked in tumours 
with wild type p53 by downregulation of its activity or its protein effector activity. In 
our study, p53 expression was relatively high in MDA-MB-231 cells, however 
significant increment was observed at 24h post APME treatment. The level started to 
decrease insignificantly at 48h and significantly at 72h. Even though the level of p53 
expression decreased at 72h, it was still significantly higher in comparison to the 
untreated cell. Thus, indicating that increased p53 levels contributed to the cell cycle 
arrest and/or apoptosis events in APME-treated MDA-MB-231 cells.  
Decrease of mitochondrial outer membrane permeability (MOMP) indicated 
the irreversible events of early apoptosis. MOMP is highly regulated by anti-apoptotic 
and pro-apoptotic proteins (Czabotar et al., 2014). Bax is a pro-apoptotic protein and 
Bcl-2 is an anti-apoptotic protein (Bai and Wang, 2014).  Upon stimuli in the intrinsic 
pathway, Bax is activated which induce MOMP. In this pathway, Bcl-2 prevented 
MOMP by inhibiting the activity of the BH3-only proteins that are responsible to 
activate Bax. MOMP allows the release of intermembrane space proteins, such as 
cytochrome c and SMAC. Cytochrome c forms an apoptosome complex after binding 
to the APAF-1 protein. This complex is responsible to activate caspase-3 and caspase-
7 which eventually lead to apoptosis.  
Our results indicated that the expression of Bax proteins increased while Bcl-
2 proteins decreased. Chien et al. (2009) demonstrated that quercetin induced 
apoptosis in MDA-MB-231 cells also by reducing Bcl-2 and increasing Bax protein 
levels. Overexpression of Bcl-2 like proteins such as Bcl-2, Bcl-xL and MCL-1 were 
detected in various cancers including lymphoma (Pepper et al., 1998), lung cancer 
(Beroukhim et al., 2010), neuroblastoma(Castle et al., 1993) and breast cancer 
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(Olopade et al., 1997). MOMP is an important event of apoptosis because once it is 
activated, cell will face death sentence regardless of caspase activation (Tait and 
Green, 2010).  
Caspase-3 increased protein expression signified the apoptosis events in the 
MDA-MB-231 cells treated with the APME. Caspase-3 activation can occur both in 
the extrinsic or intrinsic pathway. Upon activated, caspase-3, which is also known as 
the executioner, cleaves hundreds of other proteins, that subsequently lead to the 
biochemical and morphological signals of apoptosis. These hallmark events include 
DNA fragmentation, plasma membrane blebbing and phosphatidylserine exposure 
(McIlwain et al., 2015). As shown in the apoptosiss staining assay, exposure of 
phosphatidylserine was detected by AnnexinV-FITC and this indicates the early 
apoptosis event.  
4.5 Conclusion 
The results of this current study exhibited that APME inhibited MDA-MB-231 
cell proliferation by causing DNA arrest at G0/G1 and inducing apoptosis cell death 
through upregulation of p53 and Bax, down regulation of Bcl-2 and increase 
expression of caspase-3 protein. These findings suggest that APME successfully 
promotes cell death in breast cancer cell, MDA-MB-231 via apoptosis possibly 
through mitochondria mediated pathway. Further analysis was perfomed to evaluate 





INDUCTION  of NATURAL KILLER (NK) CELL ACTIVITY ON MDA-MB-
231 CELLS BY  Abrus precatorius METHANOL LEAVES EXTRACT (APME) 
 
5.1 INTRODUCTION 
 Elimination of cancer cells by the immune system is the desirable strategy to 
combat cancer naturally. This process utilises the highly specific coordinated immune 
system to remove cancerous cells from the host without interfering or damaging the 
surrounding cells. However, cancerous cells also have their own “mechanism” to delay 
or evade this immune surveillance and therefore remain active. Any anti-cancer agents 
that would augment the cytotoxicity of the immune cells in particular the Natural Killer 
cells (NK) is highly demanded and many researchers are currently looking into the 
insight of deeper understanding of these NK cells (Hu et al., 2019). NK cells are innate 
immune cells which are able to eliminate various stressed or abnormal cells and even 
kill target cells without preliminary sensitization (Grossenbacher et al., 2016; 
O’Sullivan et al., 2015; Vivier et al., 2011). NK cells are the preferred focus for the 
use in immunotherapy due to its independency on antigen specific T cells and its rapid 
proinflammatory cytokines secretion that initiate the adaptive immune response 
(Sconocchia et al., 2014). NK cells release the cytolytic granules upon bridging 
immune synapses with target cells, including perforin and granzymes. These proteins 
function to induce target cell lysis and this process leading to their expressions is 
known as degranulation. NK cells degranulation is referred as indirect measurement 
of NK cells cytotoxicity (Topham and Hewitt, 2009) 
 Plant-derived medicines have an important role in influencing the effects on 
immune system. Discoveries of plant containing immunomodulatory properties is still 
relevant and in demand especially to enhance current practices in immunotherapy. 
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Several studies have been conducted to grasp the better understanding of how plant 
extracts or isolated phytocompounds affect the immunomodulation of NK cells. 
Studies on revasterol suggested that it promotes target cell apoptosis via caspase 
signalling pathway in high concentration ranges (Leischner et al., 2015). Another 
study identified a fraction from Caesalpinia spinosa, rich with gallotannin as an anti-
tumour agents in breast carcinoma and melanoma (Gomez-Cadena et al., 2016). Lee 
and Cho (2018) demonstrated that curcumin augments the cytotoxicity effect of NK-
92 on MDA-MB-231. For Abrus precatorius, to date most reported studies are on the 
seeds, particularly on lectin and abrin. NK cells activity in tumour-bearing mice was 
enhanced significantly by abrin (Ramnath et al., 2006). A. precatorius  seeds peptides 
AGP and ABP exerted immunostimulants response in Dalton’s Lymphoma (DL) 
bearing mice (Bhutia et al., 2009). Another study conducted on another species of 
Abrus known as Abrus agglutinin (seeds) also successfully demonstrated the ability of 
the seeds to stimulate spleen derived NK in vitro to exhibit cytotoxicity effect against 
Dalton’s lymphoma ascites cells (DLAC) (Ghosh and Maiti, 2007). 
 Previous experiment has described the ability of A. precatorius methanol 
leaves extract (APME) to induce apoptosis in MDA-MB-231 cells. Therefore, the 
ability of APME to induce NK cells activity was investigated in this current Chapter. 
This was measured by the ability of APME-treated NK cells to promote cell death, 
measured by apoptosis staining of the target cell with AnnexinV/PI, and the production 
of interleukin-2 (IL-2), interferon gamma (IFN-g), perforin (PRF-1) and granzyme B 





5.2 MATERIALS & METHODS 
5.2.1 Healthy and Cancer Donor Criteria 
 Three donors were chosen for both healthy and cancer individuals. 10ml of 
blood was obtained from each donor. All healthy donors were female with the age 
between 18 – 45 years old, no chronic disease, not consuming any immunosuppressive 
drugs, non-smokers, and not pregnant. For cancer donors, the selected donors were 
female between the age of 18 – 45 years old, diagnosed with breast cancer, not 
receiving any treatment yet including chemotherapy and radiotherapy or consuming 
any herbal and medicinal plants, non-smokers and not pregnant. Non-smokers were 
preferable because smoking impacts immune cells including the NK cells (Qiu et al., 
2017).  
5.2.2 Isolation of human peripheral blood mononuclear cells (PBMC) 
 Whole blood sample from donors was collected in an EDTA vacutainer. The 
collected blood was diluted in PBS with ratio of 1:3 (v/v). The diluted blood was 
layered carefully on Lymphocyte Separation Media, LSM (Capricorn Scientific), and 
centrifuged at 400xg for 30 minutes at room temperature. After centrifugation, four 
layers were formed started with the blood plasma phase, interphase, LSM phase and 
erythrocyte phase (pellet), as illustrated in Figure 5.1. The interphase layer was 
collected carefully and transferred into a new 15ml tube. About 30ml of PBS was 
added to the tube and was centrifuged at 300xg for 10 minutes. This process was 
repeated twice. The pellet collected was the lymphocyte and it was resuspended in 
complete RPMI 1640 medium. The lymphocyte was transferred into the 75cm3 flask 
and was incubated overnight in a humidified 5% CO2  incubator at 37°C. This process 
was necessary to remove the monocyte by adherence to the flask plastic surface (Bose 
et al., 2009).  The next day, the supernatant was decanted into a new 15ml tube and 
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centrifuged at 400xg for 10 minutes. Washing with PBS was performed twice at 300xg 
for 10 minutes. The resulting pellet was resuspended in the RPMI media and the cell 
count was determined by the Trypan Blue exclusion assay.  
 
Figure 5.1: Isolation of peripheral blood mononuclear cells (PBMC) 
 
5.2.3 NK Cell Isolation  
 Human NK Cell Isolation Kit (Miltenyi Biotec) was used to isolate the NK 
cells. The experiment was performed according to the manufacturer’s protocol. This 
experiment was performed in cold and using pre-cooled solutions and buffers. After 
removal of monocyte by adherent to the plastic as described previously, the cell 
suspension was centrifuged to collect remaining lymphocytes. The cell pellet was 
resuspended in 40µl of buffer (refer Appendix B) for 107 of the total cells. 10µl of NK 
Cell Biotin-Antibody Cocktail was added per 107 of the total cells and mixed well. 
This mixture was incubated in the refrigerator (2-8°C) for 5 minutes. Then, 20µl of 
NK Cell Microbead Cocktail was added per 107 of the total cells, mixed well and 












this suspension. Then, this suspension was proceeded to the subsequent magnetic cell 
separation.  
 First the column was placed onto the magnetic field of the MACS separator. 
The column was rinsed with 3ml of buffer then the suspension prepared earlier was 
applied into the column. The collected flow-through was the unlabelled cells which 
would represent the NK cells. The column was washed with the 3ml of buffer twice 
and was combined with the effluent collected earlier. This suspension was centrifuged 
at 300xg for 5 minutes and resuspended in 1ml PBS. The NK cells counts was 
determined using the Trypan Blue exclusion assay. Flow cytometry was used to verify 
the percentage of CD56+/CD3- cells population after the separation.  
5.2.4 NK Cell Proliferation Assay (MTT) 
 Isolated NK cells were seeded into the 96 wells plate. A. precatorius 
methanolic leaves extract (APME) was added in serial dilution with DMSO into each 
well starting from 200µg/ml until 1.56µg/ml. Untreated-NK cells and DMSO (<1%) 
were added into the wells as controls. The culture was incubated for 24h, 48h and 72h 
in a humidified 5% CO2 incubator at 37°C. After each incubation point, 20µl of MTT 
(5mg/ml) was added into the well and incubated for 4h. After 4h, 100µl of DMSO was 
added into the wells to dissolve the formazan and the plate was read at absorbance 
570nm. The absorption value at this wavelength directly represents the relative cell 
numbers with comparison to the control group (Igarashi and Miyazawa, 2001). The 
percentage of cell viability was determined by dividing the absorbance of the treated 
cells with the absorbance of the control and multiply by a hundred. Besides the diluted 
extract, the APME IC50 (26.4µg/ml) obtained from previous experiment in Chapter 4 
was also tested individually. This was done to ensure the effect of that concentration 
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on the NK cell proliferation. This part of the experiment in general was performed to 
determine the ideal concentration of APME needed to be used in the subsequent NK 
co-culture with MDA-MB-231 cells. 
5.2.5 NK Cell Co-culture with MDA-MB-231 
 Graphical summary of this experiment is shown in Figure 5.2. This experiment 
was performed to evaluate the ability of APME in inducing NK cells activity on MDA-
MB-231 cells.  
5.2.5(a) Cell Culture 
MDA-MB-231 were seeded in 25cm2 tissue culture flask and grown at 37°C 
under humidified 5% CO2 in DMEM medium supplemented with 5% of FBS and 1% 
of penicillin-streptomycin. Confluent MDA-MB-231 cells were harvested by 
trypsinization.  
5.2.5(b) Co-cultutring of NK cells with MDA-MB-231 cells 
This experiment was performed to evaluate the APME potential to induce 
anticancer immune response by activating the NK cells. Freshly isolated NK cells 
(effector) from each donor were pre-incubated for four hours according to the 
experimental design as described in Table 5.1, before being added into the pre-seeded 
(overnight) MDA-MB-231 (target) cell culture. The ratio of effector cells to target 
cells was set at 20:1 following the methods detailed in Ismail et al. (2012) and 
Nishimura et al. (2017) with given consideration of NK cells co-cultured with adherent 
cells (Surayot and You, 2017) and specifically with MDA-MB-231 cells (Fu et al., 
2015). Following the incubation, the medium was collected into a fresh tube and the 
adhered MDA-MB-231 cells were harvested  by trypsinization. The trypsinized cells 
were combined with the collected medium and centrifuged at 300xg to separate the 
 
 143 
cell pellet from the supernatant. The medium (supernatant) was transferred into a fresh 
1.5ml tubes and kept at -80°C for further analysis. The collected pellet containing both 
NK cells and MDA-MB-231 cells were resuspended with RPMI 1640 complete 
medium and divided into two fresh tubes for further analysis.  
5.2.5(c) NK Cell Staining 
The number of NK cells in the culture was determined by staining the cells 
with PE-conjugated anti-CD56 (Santa Cruz) antibody and acquired by flow cytometry. 
The collected cells (100µl) following the co-culture experiment, was washed twice 
with 1XPBS. One mililitre of Bovine Serum Albumin (BSA) was added to the cells 
and incubated for 10 minutes at room temperature. Five microlitre (5µl) of the PE-
conjugated anti-CD56 and FITC-conjugated anti-CD3 antibodies were added and 
mixed well. This suspension was incubated for about 30 minutes on ice. Then, the cells 
were washed with PBS (centrifuged at 300xg) twice to remove excess antibodies. The 
resulted pellet was resuspended with 500µl PBS and the number of NK cells was 
determined by flow cytometry FACSCANTO II (BD Bioscience). Data obtained was 
analysed with FCS 7 software (De Novo). 
5.2.5(d) Apoptosis Detection 
Determination of the percentage of apoptotic cells of MDA MB 231 in the 
culture was done by apoptosis staining of the target cells using the AnnexinV-FITC/PI.  
The apoptosis assay was performed according to the manufacturer protocol, 
AnnexinV-FITC detection kit I (BD Bioscience). The collected cells (100µl) following 
the co-culture experiment, was washed twice with 1xPBS and then, 100µl of 1X 
binding buffer was added prior to mixing with 5µl of AnnexinV and 5µl of PI.  This 
suspension was incubated for 15 minutes, at room temperature in dark. After the 
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incubation period, 500µl of 1X binding buffer was added into the tube. All samples 
readings were acquired with FACSCANTO II (BD Bioscience). Data obtained was 
analysed with FCS 7 software (De Novo). Percentage of NK cells cytotoxicity for each 
donor category was determined by the following formula: ([percentage of cell deaths 
by effector – percentage of cell deaths without effector] / [100 – percentage of cell 
deaths without effector]) x 100 (Nishimura et al., 2017).  
Table 5.1: Experimental design for NK cells co-culture with MDA-MB-231 cells 
No Treatment Groups Details 
1 NK/MDA-MB-231/APME NK cells were incubated with APME prior to 
treatment on MDA-MB-231 cells 
2 NK/MDA-MB-231 NK cells were incubated on MDA-MB-231 cells 
3 NK/MDA-MB-
231/DMSO 
NK cells were incubated with DMSO prior to 
treatment on MDA-MB-231 cells 
4 NK ONLY NK cells were incubated on its own 




5.2.5(e) ELISA (IL-2, IFN-g, PRF-1, GzmB) 
 ELISA was performed to quantify the expression level of the cytokines, 
interleukin-2 (IL-2)  and interferon gamma (IFN-g); and cytotoxic granules protein, 
perforin (PRF-1) and granzymeB  (GzmB). This assay was performed according to the 
manufacturer’s protocol (Elabscience). In general, 100µl of sample/standard was 
added into a pre-coated ELISA plate and incubated for 90 minutes at 37°C. The 
samples or standards were diluted accordingly as needed. After the first incubation 
period, liquid from each well was removed and 100µl of Biotinylated Detection Ab 
was added into each well and incubated for 1h at 37°C. Then the liquid from each well 
was aspirated and washed with 350µl of wash buffer was added. The washing step was 
performed three times. 100µl of HRP conjugate was added after the washing steps and 
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the plate was incubated for 30 minutes at 37°C. Another five times of washing steps 
were performed after the incubation. Then, 90µl of substrate reagent was added into 
each well and was incubated for 15 minutes at 37°C in dark. 50µl of stop solution was 
added after the incubation time ended and the optical density (OD value) of each well 
was determined with a micro-plate reader at absorbance of 450nm.  
5.2.6 Statistical Analysis 
The data were expressed as mean ±SD of three repeated experiments. The level 
of statistical significance among the group was tested using repeated measure one-way 
ANOVA, followed by Tukey’s multiple comparison test. Level of significance 
between two main groups were tested using paired or unpaired t-test. The difference 
was considered significant if P<0.05.The normality of each data set was determined 
by Shapiro-Wilk normality test. Analyses were all done using GraphPad Prism7 . 





Figure 5.2: Graphical summary of the co-culture experiment of APME-treated NK 




































5.3.1 NK Purification 
NK cells were isolated from healthy and cancer donor using the Human NK 
cell isolation kit (Miltenyi Biotec). Isolated NK cells were stained with CD56 (NCAM 
(ERIC) - PE, Santa Cruz Biotechnology). Dot plot graph of the cell distribution events 
after acquiring by flow cytometry were as shown in Figure 5.3. About 85.04% of NK 
cells were successfully isolated using this NK isolation kit.  
 
Figure 5.3: Dot plot graphs representing the isolated NK cells using the Human 
NK cell isolation kit (Miltenyi Biotec). 
 
(A) The cell population gated as NK cells.  







5.3.2 Isolated NK Cell in Healthy and Cancer Donor 
 In this experiment, NK cells were isolated from three healthy donors and three 
cancer donors (breast cancer). Trypan blue exclusion assay was used to count the cells. 
These isolated NK cells were used in the subsequent analysis following the isolation. 
The average counts of NK cells isolated from healthy donor was significantly higher 




Figure 5.4: NK cells counts isolated from healthy and cancer donor. 
The results were expressed as mean, ±SD of three independent donor for 
each group. P<0.05 is considered significance when comparing NK counts 
between healthy donor and cancer donor using unpaired t-test. 






5.3.3 Ability of APME to induce NK cells proliferation 
 The ability of APME to induce NK cells proliferation, was analysed in this 
experiment. This was carried out in order to identify the optimum concentration of 
APME needed to be used in the subsequent analysis. APME with concentrations from 
200µg/ml until 1.56µg/ml were added in the medium containing NK cells in order to 
observe the ability of the extract to induce NK proliferation. The APME  at 26.4µg/ml 
was also added because it was the IC50 value that was identified in previous chapter 
which was able to induce apoptosis in MDA-MB-231 cells. Isolated NK cells were 
seeded in a 96 wells plate and were incubated for 4h before adding the extract. Then, 
the cells were incubated for 24h, 48h and 72h. From Figure 5.5, it was found that the 
proliferation of NK cells was stable at 24h, and the proliferation pattern rate was 
fluctuating at 48h and 72h. This is because this NK cells were primary cells isolated 
from donors and no other stimulant was added to expand the cell line. The results also 
showed that at 24h, NK cells proliferation increased until 25µg/ml and 26.4µg/ml and 
started to decline at 50µg/ml and increase again at 100µg/ml. Since the cells 
proliferated well at APME IC50 value, this concentration was chosen for the 
subsequent experiments since it was also used in the previous apoptosis experiments 




Figure 5.5: NK cells proliferation treated with APME  
(A) 24h, (B) 48h, and (C) 72h. The results were expressed as mean, ±S.D 




































































5.3.4 Effects of APME-induced NK cells on apoptosis of breast cancer cell 
MDA-MB-231; and measurement of cytokines and cytotoxic granules 
protein levels 
 
 NK cells from both healthy and cancer donor were treated in the same manner 
as listed in Table 5.1. NK Cells was incubated with APME (26.4µg/ml) for 4h prior to 
treatment on the MDA-MB-231 cells. Then this culture was further incubated for 20h. 
After the incubation period, the media were collected for cytokines and cytotoxic 
granules protein assay by ELISA and the remaining cells were harvested for 
CD56/CD3 staining and apoptosis assay with Annexin-V/PI staining. Figure 5.6 
demonstrated the forward and side scatter of the MDA-MB-231 cells and NK cells 
population in the sample following co-culture experiment, acquired by flow 
cytometry. The size of the MDA-MB-231 cells were bigger compared to the size of 
the NK cells.  
 
Figure 5.6: The forward and side scatter of NK cell co-culture with MDA-MB-
231 cells . 
 
Gating of the NK cell population and MDA-MB-231 cell population 
were marked in the circles.  
 
- FSC (Forward Scatter) 






5.3.4(a) NK Cell Counts of Healthy and Cancer Donor after co-culture with 
MDA-MB-231 cells  
Figure 5.7(A) showed the representative profiles of dot plot of NK cells counts 
in healthy donor and Figure 5.7(B) showed the results of the NK cells counts in 
different treatments in healthy donor. In healthy donor, NK cell count in Group 1 
(NK/MDA-MB-231/APME) is 50.5±8.7%, Group 2 (NK/MDA-MB-231) is 
37.6±5.5%, Group 3 (NK/MDA-MB-231/DMSO) is 40.0±9.7% and Group 4 (NK-
Only) is 39.3±7.9%. NK cell count in Group 1 is significantly higher statistically when 
comparing to the rest of the groups. In cancer donor (Figure 5.8), the NK cell counts 
for all groups were slightly similar among each other except for Group 4 (NK-Only) 
which has a slight increase at 45.2±5.5%. NK cell counts for Group 1 (NK/MDA-MB-
231/APME) is 41.9±5.0%, Group 2 (NK/MDA-MB-231) is 42.7±6.6% and Group 3 
































Figure 5.7(A): Healthy donor NK cell counts in NK cell co-culture with MDA-MB-231 cells . 
 
The representative dot plots where (G-1) NK/MDA-MB-231/APME, (G-2) NK/MDA-MB-231 (G-3) NK/MDA-MB-










Figure 5.7(B): Healthy donor NK cell counts in NK cell co-culture with MDA-
MB-231 cells . 
 
Graph representing the NK cell counts in Healthy Donor from the co-
culture with MDA-MB-231 cells in different treatment groups. The 
results were expressed as mean, ±SD of three independent donor for 





























































Figure 5.8 (A): Cancer donor NK cell counts in NK cell co-culture with MDA-MB-231 cells. 
 
The representative dot plots where (G-1) NK/MDA-MB-231/APME, (G-2) NK/MDA-MB-231 (G-3) NK/MDA-MB-















Graph representing the NK cell counts in Cancer Donor from the co-
culture with MDA-MB-231 cells in different treatment groups. The 
results were expressed as mean, ±SD of three independent donor for 






















































5.3.4(b) Apoptosis Assay of MDA-MB-231 cells treated with APME-
induced NK cells 
The ability of APME-induced NK cells to promote apoptosis and cell death in 
MDA-MB-231 cells was assessed by staining with Annexin-V/PI. Figure 5.9(A) 
represents the dot plot of the treated MDA-MB-231 cells in healthy donor acquired by 
flow cytometry. Figure 5.9(B) shows the graph plotted from tabulated results of the 
apoptotic MDA-MB-231 cells following co-culture with NK cells from healthy donor. 
As presented in Figure 5.9(B), Group 1 (NK/MDA-MB-231/APME) showed 
46.28±2.2% apoptotic cells, Group 2 (NK/MDA-MB-231)  showed 30.50±1.8%, 
Group 3  (NK/MDA-MB-231/DMSO) showed 29.4±1.5% and Group 4 
(APME/MDA-MB-231) showed 27.55±0.8%. These results showed that there were 
significantly higher apoptotic cells in Group 1 in the healthy donor category comparing 
to the rest of the groups in that category.  
Figure 5.10(A) represents the dot plot of the treated MDA-MB-231 cells in 
cancer donor and  Figure 5.10(B) shows the graph plotted from tabulated results of the 
apoptotic MDA-MB-231 cells following co-culture with NK cells from cancer donor. 
As presented in Figure 5.9(B), apoptotic cells in Group 1 (NK/MDA-MB-231/APME) 
was 26.32±6.0%, Group 2 (NK/MDA-MB-231)  was 26.84±56.1%, Group 3  
(NK/MDA-MB-231/DMSO) was 24.28±4.3% and Group 4 (APME/MDA-MB-231) 
was 20.68±2.0%. Group 1, 2 and 3, demonstrated higher apoptotic cell percentage 
comparing to Group 4. However, these differences were not statistically significant.  

















Figure 5.9(A): MDA-MB-231 apoptotic cells from NK cell co-culture with MDA-MB-231 in Healthy Donor.  
 
The representative dot plots where (G-1)NK/MDA-MB-231/APME, (G-2) NK/MDA-MB-231 (G-3) NK/MDA-MB-
231/DMSO and (G-4) NK- ONLY.Quadrants represent the percentage of cell populations; Q1- Necrosis, Q2- Late 











Figure 5.9(B):  MDA-MB-231 apoptotic cells from NK cell co-culture with MDA-
MB-231 in Healthy Donor.  
 
Graph representing the apoptotic cells of MDA-MB-231 co-culture 
with NK cells from healthy donor. The results were expressed as mean, 
±SD of three independent donor for each group  and (p<0.05) is 













































































Figure 5.10(A) :MDA-MB-231 apoptotic cells from NK cell co-culture with MDA-MB-231 in Cancer Donor.  
 
The representative dot plots where (G-1) NK/MDA-MB-231/APME, (G-2) NK/MDA-MB-231 (G-3) NK/MDA-MB-
231/DMSO and (G-4) NK- ONLY.Quadrants represent the percentage of cell populations; Q1- Necrosis, Q2- Late 












Figure 5.10(B): MDA-MB-231 apoptotic cells from NK cell co-culture with MDA-
MB-231 in Cancer Donor.  
 
Graph representing the apoptotic cells of MDA-MB-231 co-culture 
with NK cells from cancer donor. The results were expressed as mean, 
±S.D of three independent donor for each group  and (p<0.05) is 

































































Figure 5.11 showed the comparison of the target cell deaths between healthy 
and cancer donor. Percentage of the target cell death by APME-treated NK cells from 
the Healthy Donor were significantly higher than the cancer donor. This data inserted 
into the NK cell cytotoxicity formula gave the percentage of NK cell cytotoxic activity 
as shown in Figure 5.12. APME-treated NK cells from the healthy donor significantly 
showed higher percentage comparing to the other treatment groups and also between 



















Figure 5.11: MDA-MB-231 apoptotic cells from NK cell co-culture with MDA-
MB-231 cells.  
 
Graph showing the comparison of MDA-MB-231 cell deaths between 
Healthy Donor and Cancer Donor. The results were expressed as mean, 
±SD of three independent donor for each group  and (P<0.05) is 
considered statistically significant, when comparing between healthy 

































































Figure 5.12: Percentage of NK cells cytotoxic activity  
 
Graph showing the comparison of NK cells cytotoxic activity between 
Healthy Donor and Cancer Donor. The results were expressed as mean 
±SD of three independent donor for each group  and (P<0.05) is 



































































5.3.4(c) IL-2, IFN-g, PRF-1 and GzmB protein expression level following 
AMPE-induced NK cells co-culture with MDA-MB-231 cells 
ELISA was performed to quantify the production of cytokines, interleukin-2 
and interferon gamma (IFN-g); and cytotoxic granule proteins (PRF-1 and GzmB) in 
the media collected following NK cells co-culture with MDA-MB-231 cells. Figure 
5.13 presents the expression of interleukin-2 (IL-2), Figure 5.14 presents the 
expression of interferon gamma (IFN-g), Figure 5.15 shows the expression of  perforin 
(PRF-1) and Figure 5.16 presents the expression of granzyme B (GzmB).  
In healthy donor, as presented in Figure 5.13(A), the IL-2 expression in Group 
1 (NK/MDA-MB-231/APME) was 388.7±80.6pg/ml, Group 2 (NK/MDA-MB-231) 
was 353±56.5pg/ml, Group 3 (NK/MDA-MB-231/DMSO) is 356.9±57.33pg/ml, and 
Group 4 (NK-Only) is 8.13±0.8pg/ml. IL-2 expression in Group 1 was slightly higher 
but not significant than the expression in Group 2 and 3. In cancer donor, as presented 
in Figure 5.13(B), the IL-2 expression in Group 1 (NK/MDA-MB-231/APME) is 
427.5±82pg/ml, Group 2 (NK/MDA-MB-231) is 436.9±118pg/ml, Group 3 
(NK/MDA-MB-231/DMSO) is 439.1±71.7pg/ml, and Group 4 (NK-Only) is 
9.09±0.8pg/ml. Figure 5.13(C) showed the comparison of IL-2 expressions between 
healthy donor and cancer donor in al treatment groups. The IL-2 expressions in cancer 
donor were higher but not significant in all treatment groups comparing to healthy 
donor. 
Quantification of IFN-g in healthy donor, as presented in Figure 5.14(A), in 
Group 1 (NK/MDA-MB-231/APME) was 812.5±82.3pg/ml, Group 2 (NK/MDA-MB-
231) was 656.5.7±88.3pg/ml, Group 3 (NK/MDA-MB-231/DMSO) was 
607.9±98.6pg/ml, and Group 4 (NK-Only) was 8.34±0.5pg/ml, however the value 
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obtained in Group 4 is below the lower cut-off point of the minimum concentration 
detected by the kit. Therefore, expression level in Group 4 is considered null or no 
expression. The expression level of IFN-g was significantly higher in Group 1 of both 
healthy and cancer donor categories. In cancer donor, as presented in Figure 5.14(B), 
the expression of IFN-g in Group 1 (NK/MDA-MB-231/APME) was 
2.5x103±2.3x102pg/ml, Group 2 (NK/MDA-MB-231) was 1.5x103±1.7x102pg/ml, 
Group 3 (NK/MDA-MB-231/DMSO) was 1.4x103±4.5x102pg/ml, and Group 4 (NK-
Only) is 87.33±2.6pg/ml The expression IFN-g  in cancer donor for all treatment 
groups were significantly higher comparing to the expressions in healthy donor, as 
depicted in Figure 5.14(C).  
Similarly to the cytokines expression analysis, the cytotoxic granule protein, 
perforin (PRF-1) and Granzyme B (GzmB)  were all quantified using the ELISA. In 
healthy donor, as presented in Figure 5.15(A), the expression of PRF-1 in Group 1 
(NK/MDA-MB-231/APME) is 5.7x103±3.3 x102pg/ml, Group 2 (NK/MDA-MB-231) 
is 4.6x103±8.5x102pg/ml, Group 3 (NK/MDA-MB-231/DMSO) is 
4.7x103±6.7x102pg/ml, and Group 4 (NK-Only) is 248.8±12.6pg/ml, however, the 
value obtained in Group 4 was below the lower cut off point of the minimum 
concentration. Therefore, expression level in Group 4 is considered null. The 
expression level of PRF-1 was the highest in Group 1 and statistically significant 
comparing to the rest of the groups.  In cancer donor, as presented in Figure 5.15(B), 
the expression of PRF-1 in Group 1 (NK/MDA-MB-231/APME) was 
8.4x103±9.0x102pg/ml, Group 2 (NK/MDA-MB-231) was 8.0x103±1.1x103pg/ml, 
Group 3 (NK/MDA-MB-231/DMSO) was 7.7x103±7.5x102 pg/ml, and Group 4 (NK-
Only) is 299pg/ml, however, the value obtained in Group 4 was below the lower cut 
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off point of the minimum concentration of the standard curve. Therefore, expression 
level of PRF-1 in Group 4 is considered null. The expression level of PRF-1 was the 
highest in Group 1 from the cancer donor category however it was not statistically 
significant. The expression level of PRF-1 in cancer donor was overall significantly 
higher comparing to the corresponding expression level of the healthy donor as shown 
in Figure 5.15(C).  
Another cytotoxic granule protein measured was the GranzymeB (GzmB). In 
healthy donor, as presented in Figure 5.16(A), the expression of GzmB in Group 1 
(NK/MDA-MB-231/APME) was 14.82±1.7pg/ml, Group 2 (NK/MDA-MB-231) is 
13.02±0.7pg/ml, Group 3 (NK/MDA-MB-231/DMSO) was 13.58±1.1pg/ml, and 
Group 4 (NK-Only) was 10.33±0.7pg/ml. In this category (healthy donor) Group 1 has 
the highest GzmB protein expression but it was not statistically significant. In cancer 
donor, as presented in Figure 5.16(B), the expression of GzmB in Group 1 (NK/MDA-
MB-231/APME) was 12.57±2.4pg/ml, Group 2 (NK/MDA-MB-231) was 
14.12±3.2pg/ml, Group 3 (NK/MDA-MB-231/DMSO) was 15.35±1.1pg/ml, and 
Group 4 (NK-Only) was 11.74±1.8pg/ml. In this category (cancer donor) Group 3 has 
the highest GzmB protein expression, followed by Group 2, Group 1 and Group 4.  
Nevertheless their GzmB protein concentration were all statistically insignificant. 
Similarly, the GzmB expression between healthy and cancer donor were all slightly 







Figure 5.13: The expression level of IL-2 in the co-culture experiment of NK cells 
with MDA-MB-231 cells. 
 
(A) The IL-2 expression level in Healthy Donor. (B) The IL-2 expression 
level in Cancer Donor. (C) General comparison of IL-2 expressions 
between Healthy and Cancer Donor. The results were expressed as mean, 




Figure 5.14: The expression level of interferon gamma (IFN-g) in the co-culture 
experiment of NK cells with MDA-MB-231 cells. 
(A)The IFN-g expression level in Healthy Donor. (B) The IFN-g 
expression level in Cancer Donor. (C) General comparison of IFN-g 
expressions between Healthy and Cancer Donor. The results were 
expressed as mean, ±SD of three independent donor for each group  and 
(P<0.05) is considered statistically significant, when comparing between 
groups in (A) and (B), and within the groups between healthy and cancer 









































































































































Figure 5.15: The expression level of perforin (PRF-1) in the co-culture 
experiment of NK cells with MDA-MB-231 cells. 
(A) The PRF-1 expression level in Healthy Donor. (B) The PRF-1 
expression level in Cancer Donor. (C) General comparison of PRF-1 
expressions between Healthy and Cancer Donor. The results were 
expressed as mean, ±SD of three independent donor for each group  and 
(p<0.05) is considered statistically significant, when comparing between 
groups in (A) and (B), and within the groups between healthy and cancer 







































































































































Figure 5.16: The expression level of granzyme B (GzmB) in the co-culture 
experiment of NK cells with MDA-MB-231 cells. 
(A) The GzmB expression level in Healthy Donor. (B) The GzmB 
expression level in Cancer Donor. (C) General comparison of GzmB 
expressions between Healthy and Cancer Donor. The results were 
expressed as mean, ±S.D of three independent donor for each group  





































































































































 Previous chapter have reported that A. precatorius methanol leaves extract 
(APME) was able to induce apoptosis in MDA-MB-231 cells. NK cell activation can 
be measured by cytototoxic analysis of the target cell death, quantification of soluble 
target cell death markers, quatification of cytokine relased upon NK cell activation and 
finally the evaluation of the degranulation indicators (Baran et al., 2001; Blom and 
Albers, 2009; Rudnicka et al., 2015; Wang et al., 2010a). This chapter reported on the 
ability of APME to activate the NK cells activity upon co-culture with MDA-MB-231 
cells. NK cells used in this study were freshly isolated from donors, three from healthy 
and three from cancer patients. This was done to observe if APME would have any 
effect on NK cells activation, thus only three healthy donors and three cancer donors 
were chosen. These donors were selected in accordance with the ethics approval 
guideline.  
In the previous apoptosis study, APME was found to induce apoptosis in 
MDA-MB-231 cells, a breast cancer cell line, hence the donors chosen for this NK 
study were all females. Healthy donors must not have any known disease and must be 
healthy at the time of blood withdrawal. While cancer donors were females with 
diagnosed breast cancer but have not undergone any treatments. These three cancer 
donors were on the waiting list to undergo chemotherapy at the time of blood donation. 
They were at different stages of the disease where two of the donors were at stage 4 
and one was at stage 3. NK cells were isolated from the peripheral blood using the 
negative sorting NK isolation kit from Miltenyi Biotec. This kit applied the concept of 
negative sorting that allows the tagging of non-NK cells and collect NK cells in the 
flow through. The collected NK cells were tested for purity by staining with CD56-PE 
conjugated and CD3-FITC conjugated, measured by flow cytometry. NK cells are 
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known to express CD56+ and CD3-. Lacking of CD3 expression differentiate NK from 
T lymphocyte (Grudzien and Rapak, 2018).  By using this kit, about 85% of sample 
purity was achieved. A group recently published the acquisition of their isolated NK 
cells from PBMC was around 86% (Sugita et al., 2018). Other study reported to obtain 
purification of NK cells up to 90% - 95% (Kanevskiy et al., 2013), while another study 
managed to obtain around 60.6% (Klingemann and Martinson, 2004). By using the 
same kit, another study suggested the addition of MACS CD15 microbeads in order to 
reach purification until 98% by improving further depletion of granulocyte (Pesce et 
al., 2017). In the study by Wang et al. (2017), only 34.4% of NK cells were able to be 
recovered and more granulocytes were present when using the kit. They also suggested 
addition extra microbeads in order to obtain higher sample purity.  
As shown by Figure 5.2, the amount of NK cells isolated from the healthy 
donor were two folds higher than the amount of NK cells obtained from the cancer 
donor. An experiment on NK cells expansion from healthy and cancer donor showed 
that the NK cells counts in healthy donor was also higher than from cancer donor. The 
same trend was also reported where reduced numbers of NK cells from breast cancer 
patients were observed comparing to the healthy donor (Mamessier et al., 2011; 
Shenouda et al., 2017). Another study by Yunusova et al. (2018) also reported lower 
number of NK cells in the peripheral blood of ovarian cancer patients. Low NK cells 
counts in cancer patients could be the cause of tumour cells escape which eventually 
led to metastasis (Gulubova et al., 2009). Other studies also revealed that cancer 
patients exhibiting advanced disease progression exhibited lower number of NK cells 
in their peripheral blood and normally have lower chance of survival (Ishigami et al., 
2000; Li et al., 2016; Peng et al., 2017; Tang et al., 2020). NK cells from cancer 
patients exhibited inhibitory phenotype which is characterized by decreased activating 
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markers expression such as NKG2D and natural cytotoxicity receptors (NCRs). On 
the contrary, the inhibitory markers such as killer-cell immunoglobulin- like receptors 
(KIRs) and NKG2A were upregulated. These phenotype leads to the inability of NK 
cells from the cancer patients to exhibit cytotoxic activity comparing to the NK cells 
from healthy donors (Costello et al., 2002; Pasero et al., 2015).  
 Lymphocytes activation, survival, proliferation and differentiation are 
regulated by cytokines. Interleukin in particular IL-2, IL-15, IL-12, IL-18 and IL-21 
are known to promote NK cells proliferation and improve their anti-tumour ability 
(Floros and Tarhini, 2015; Hu et al., 2019; Srivastava et al., 2013). However, in this 
study, freshly isolated unstimulated NK cells from healthy and cancer donor were used 
for the co-culture assay to measure the NK cells cytotoxicity with the target cells in 
the presence of plant extract or compound only (Ismail et al., 2012). Therefore, prior 
to the co-culture assay with the target cell, the optimal concentration which APME 
could induce proliferation of NK cells was determined. The ability of APME to 
proliferate NK cells was evaluated by MTT assay (Lu et al., 2016; Shpakova et al., 
2000; Zhang et al., 1996). The experiment showed that the proliferation trends were 
stable at 24h and were unstable at 48h and 72h. At 24h, NK cell proliferation trend 
was seen to increase as the concentration increased. Thus IC50 value of APME was 
chosen for the NK cells co-culture with MDA-MB-231 cells.  
 The ability of APME to induce NK cell cytotoxicity was assessed in the 
experiment of NK cells co-culture with MDA-MB-231 cells, in the presence of APME. 
NK cells were the effector and MDA-MB-231 cells were the target. The ability of 
APME to promote effector to induce cytotoxicity on the target cell was the main aim 
for this experiment. Three parameters were measured in this experiment, the first one 
was the effect on NK counts following the incubation; secondly the effect on cell death 
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measured by apoptosis AnnexinV/PI assay; and thirdly the concentration of 
interleukin-2 (IL-2), interferon gamma (IFN-g), perforin (PRF-1) and granzyme B 
(GzmB).   
 Following the co-culture incubation, percentage of NK cells was determined 
by observing CD56/CD3 expression. In healthy donor, percentage of NK cells was 
significantly higher in the APME-treated NK cells comparing to the rest. However, no 
significant differences can be seen in the percentage of NK cells from cancer donor. 
At this point, the difference between APME-treated and untreated NK cells was only 
observed in the healthy donor. To evaluate the ability of APME to induce cytotoxicity, 
the cell death was measured by the apoptosis  staining with AnnexinV/PI. The 
advantage of this staining is that the NK cytotoxic activity that caused target cell 
apoptosis or death could be determined.  
In this study, APME-treated NK cells from healthy donor was able to induce a 
significant MDA-MB-231 cell death comparing to the non-treated NK cells. While in 
cancer donor, the percentage of cell deaths in all treatment groups were indifference. 
Especially the APME-treated NK cells from healthy donor exhibited significant 
cytotoxicity comparing to APME-treated NK cells from cancer donor. This is 
supported by the percentage of NK cytotoxicity which was calculated based on a 
formula as described previously (Mhatre et al., 2014; Nishimura et al., 2017). These 
values were obtained simply by deducting the value presented by non-effector 
treatment, which was the APME incubation with MDA-MB-231 cells only. 
 Overall, from these values, APME-treated NK cells from the healthy donor 
definitely has the highest percentage of NK cell cytotoxic activity comparing to the 
rest of the treatment groups, and the percentage of NK cells cytotoxic activity from 
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healthy donor were higher comparing to the NK cells from cancer donor. This 
demonstrated that APME was able to further promote NK cell cytotoxic activity in NK 
cells obtained from the healthy donor but not from the cancer donor. NK cells count 
from cancer patients were not only lesser comparing to the healthy donor as previously 
described (Mamessier et al., 2011; Shenouda et al., 2017), but these endogenous NK 
cells also have less cytotoxic activity might be due to the alteration of the NK cells 
receptors including decreased inhibitory receptors or/and increase activating receptors 
(Guillerey et al., 2016). Because of that, in immunotherapy treatment involving NK 
cells, immune activation is facilitated by addition of cytokines and antibodies to 
sensitize the NK cells to assist its modulation towards the anti-tumour response (Hu et 
al., 2019) 
 Medium from the co-culture experiment was collected to quantify the secretion 
of interleukin-2 (IL-2), interferon gamma (IFN-g), perforin (PRF-1) and granzyme B 
(GzmB). Levels of IL-2 secretion in all treatment groups from both healthy and cancer 
donor showed insignificance differences. Presence of IL-2 indicated that the isolated 
NK cells were contaminted with other IL-2 secreting lymphocytes because the purity 
of NK cells obtained in this study was less than 90%. IL-2 is a 15K-kDa cytokine 
mainly produced by activated CD4+/ CD8+ T cells, however, there were reports on the 
scretion of IL-2 by dendritic cells, and NK cells (Gaffen, 2001; Granucci et al., 2001). 
Nevertheless, the relevance of the IL-2 production by these cells remains ambiguos 
(Malek, 2008).  
The results obtained showed that the level of IFN-g production was 
significantly increased in APME-treated NK cells. These production of IFN-g marked 
the activation of NK cells. IFN-g, is the cytokine that mainly important in modulating 
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host immune response in particular controlling the spread of pathogen infection and 
defence against cancers.  IFN-g is also released by activated TH1 cells, CD8+ T cells, 
and NK T cells, besides NK cells (Mah and Cooper, 2016; Schoenborn and Wilson, 
2007). NK cells producing high level of IFN-g exhibited low cytotoxicity while on the 
contrary, cytotoxic NK cells demonstrated low level of IFN-g production (Björkström 
et al., 2016; Caligiuri, 2008). This coincide with the results of this current  study where 
even in extremely high level of IFN-g expression found in cancer donor comparing to 
healthy donor, the cytotoxicity activity of NK cells from healthy donor were higher. It 
was also reported that CD56dimCD16+ NK cells were able to produce IFN-g during 
their cytolytic activity. Activated NK cells producing intrinsic cytokines such as IFN-
g and TNF-a promotes target cell lysis and neutralization of these cytokines caused 
impaired function of the cell lysis (Wang et al., 2012). From these results, APME was 
found to be able to stimulate NK cells from both healthy and cancer donor by 
producing higher IFN-g levels comparing to non-tretated NK cells.  
 Perforin (PRF-1) and granzyme B (GzmB) are two granule proteins released 
by NK cells upon activation by stimuli from the target cells. The synergistic effect of 
PRF-1 and GzmB leads to the lysis of the target cell. PRF-1 is a potent pore-forming 
protein that allows the entrance of cytotoxic proteases such as GzmB  into the target 
cell cytoplasm. This pore-forming process by PRF-1 is crucial in order to ensure the 
granzyme proteases able to enter the cytoplasm of the target cells. Defects in this 
pathway, particularly lacking of the perforin molecule will result in human disorder 
termed as perforinopathies, which include immunoproliferative disease Familial 
Haemophagocytic Lymphohistocytosis (FHL) type 2, haemotological malignancies 
and protracted viral infections (Spicer et al., 2017).  In this current study, the PRF-1 
expression was significantly high in the APME-treated NK cells from healthy donor 
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and similar trend can be seen with its counterpart from the cancer donor, however this 
slight difference was insignificance. Nevertheless, the expression of PRF-1 in NK cells 
from the cancer donor were overall significantly increased comparing to the healthy 
donor. Even though the NK cells cytotoxic activity from cancer donor was lesser 
comparing to the NK cells from the healthy donor, their PRF-1 expression were 
extremely high. This was parallel to the production of the IFN-g levels, where they 
were higher in NK cells from the cancer donor. This phenomena was probably caused 
by NK cells isolated from cancer donors have “memory” and were activated upon 
stimulation with the target cells. The review by Fehniger and Cooper (2016) mentioned 
that enhanced NK cells function was observed in antigen-specific stimulation and this 
is termed as “memory” or “memory-like” depending on how the NK cells were 
activated. NK cells memory would be beneficial use for anitumour immunotherapy, 
especially in vitro expansion capability (Capuano et al., 2019).  
GzmB induces cell deaths either through caspase-dependant or independent 
manner (Martinvalet, 2019). GzmB initially is expressed as an inactive pre-cursor 
protein that bears an N-terminal signal peptide. This terminal direct packaging of 
GzmB into secretory granules followed by removal of dipeptide Glysine and 
Glutamate by cysteine protease cathepsin C. Upon removal of those peptides, GzmB 
becomes activated and kept together in a lytic granules together with other granzymes 
and perforin. GzmB enters target cells after the activation of perforin, and instantly 
induce apoptosis either by caspase-dependant or independent manner (Afonina et al., 
2010). In this current study, it was found that GzmB were lowly expressed in both 
healthy and cancer donor. No conclusive remarks could be deduced from this finding 
because the detected GzmB expression levels in all groups were very low. Comparison 
between healthy and cancer donor also showed indifference expressions of GzmB. 
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AMPE-treated NK cells were unable to exhibit any significance differences in GzmB 
expression from this co-culture experiment. This experiment conducted in vitro might 
be the reason that very low amount of GzmB expressions were detected. Madakkannu 
and Ravichandran (2017) have successfully demonstrated that Indigofera tinctoria and 
Scoparia dulcis aqueous extracts were able to exhibit immunopreventive role in noise-
stress rats by elevation of GzmB in vivo. Another study involving a plant known as 
sea buckthorn or Hippophae rhamnoides L. exhibited elevated level of GzmB and 
PRF-1 expression in chronic-stress rat model (Diandong et al., 2016).  
 These results have demonstrated that APME was able to increase the 
proliferative capacity of NK cells, induce NK cell cytotoxic activity thus promoting 
cell death via apoptosis, and exhibited increased levels of IFN-g and PRF-1 protein 
expressions by NK cells isolated from healthy donor. As for the cancer donor, although 
higher expressions of IFN-g and PRF-1 were observed in comparison to the healthy 
donor, the NK cells cytotoxicity was impaired and APME was unable to further 
stimulate or better the activity of NK cells isolated from cancer donor. Therefore it is 
believed that in healthy individuals, APME could help promote their NK cells activity 
and this would benefit if A. precatorius could be introduce in their diet occasionally. 
Thus helping them to combat the emergence of cancer cells. However, this assumption 









 In conclusion, it was found that APME was able to activate and promote better 
NK cells cytotoxic activity from healty donor but not in NK cells from cancer donor. 
It is suggested that more sample could be acquired especially from cancer donor in 
order to have better observation and conclusion. Probably details analysis of the donor 
such as their specific type of cells (example: breast – triple negative) will provide better 
understanding on this matter. Expansion of NK cells is also recommended to ensure 
better NK cells stability and viability. A better protocol to enhance NK purtity is also 
recommended such as using another specific microbeads tag to eliminate as much 
contaminant as possible. If screening a large number of donors, it is impossible to 
acquire large volume of blood. Therefore, another robust and simple method using 
MACSxpress® (Miltenyi) would solve this issue because isolation of NK cells is 













GENERAL DISCUSSION, CONCLUSION AND FUTURE DIRECTION 
 
6.1 GENERAL DISCUSSION 
 Since many decades or even centuries ago, human depends on medicinal plants 
for treatment of various health issues such as, high blood pressure, diabetes mellitus, 
infections, arthritis, and cancers. With advancement of the science and technology, the 
efficacy and mechanisms of the medicinal plants to treat these illnesses can be proven. 
Furthermore, scientific findings has also provided the identifications of bioactive 
compounds from these plants that have been tested in vitro, in vivo and even some are 
successfully tested in clinical settings and practices (Ortega and Campos, 2019). In 
this modern world, with high throughput research and technologies, many powerful 
drugs and treatment for cancer are established. However, many cancer patients are also 
relying on medicinal plants to help them battling with cancers and the side effect of 
chemotherapy. For that matter, it is crucial that more information on medicinal plants 
need to be studied in order to understand their effect and mechanisms of action.  
 The GC-MS phytochemical analysis of A. precatorius leaves extracted by 
different methods and different solvents in this current studies have exhibited various 
groups of phytocompounds including phenolic compound, terpenoid, sterols, vitamin, 
lipids, and carbohydrates. GC-MS is an interesting tool to use for the analysis of 
chemical compounds from medicinal plants, foods, cosmetics, drugs and 
pharmaceutical products (Kolb et al., 2019). It is robust because the information 
obtained are based on identified compound in their libraries. Different solvents used 
in this study have different ability to extract different type of phytocompounds, and 
have also affected the extraction yield and the bioactive compound content. These 
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differences would affect the biological activity of the extract (Ngo et al., 2017). 
Information of these phytochemicals profile is desirable because it can facilitate 
researcher to further explore any particular compound in relation to the bioactivity. 
Acknowledging these profiles in the beginning of any study on medicinal plants will 
avoid random sampling and selection of the plant organs and parts (Dirar et al., 2019).  
In this current study, the extracts obtained from different extraction processes 
were evaluated for their ability to inhibit cell proliferation. This was done by 
performing the MTT assay. Among the tested extracts, the A. precatorius methanol 
leaves extract (APME) obtained from Soxhlet extraction have exhibited the lowest 
IC50 value on all cancer cells tested. This may be due to the presence of high phenolic 
and terpenoid compounds (Basli et al., 2017; Huang et al., 2012). Many other studies 
have demonstrated that the methanolic extract of the leaves of the medicinal plants 
tested showed high level of  phenolic, flavonoid, alkaloid and terpenoid compounds 
(Kuppusamy et al., 2015; Ruiz-Ruiz et al., 2017; Truong et al., 2019).  Many dietary 
phenolics may block carcinogenesis through induction of apoptosis through different 
mechanisms. In vitro studies showed that curcumin, a phenolic compound, induced 
apoptosis through the modulation of the extrinsic pathway (Shankar et al., 2007). 
Another phenolic compound, resveratrol, induced apoptosis via the intrinsic pathway 
in prostate cancer-derived cell lines by activation of caspase-9 and -3 (Benitez et al., 
2007).   The anti-proliferative effect of this extract was the lowest on the MDA-MB-
231 cells. However, this extract showed no toxicity on the normal cells used in this 
study.  
Further confirmation of the anti-proliferative effect of APME was analysed by 
evaluating the cell cycle arrest and the ability to induce apoptosis. Various apoptosis 
protein markers have been evaluated in many studies to evaluate the ability of an 
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extract or compound to induce apoptosis. These proteins are involved in the cell cycle 
progression and apoptosis pathways and they include c-Myc, p53, Ras, pRb, protein 
kinase A (PKA), protein kinase C (PKC), CDK, Bcl-2 family proteins, cyclins and 
CK1. With stimulation, these proteins will able to promote or halt the  proliferation of 
cells, induce cell cycle arrest or apoptosis (Vermeulen et al., 2003). Most studies are 
looking into the ability of medicinal plants and their derived compound to induce 
cancer cell deaths but not the normal cell deaths. In this current study, APME has 
demonstrated to promote cell deaths through up regulation of p53 and Bax, which 
activated the apoptosis by increase Caspase-3 expression. APME were able to 
selectively induce cell deaths in cancer cells but not the normal cells.  
Immunomodulation is a process of the immune system response to stimulation 
to prevent or suppress diseases.  Immunomodulation mechanisms occur by 
macrophage activation, lymphoid stimulation, phagocytosis stimulation, enhancement 
of cellular immune function, increasing the production of antigen-specific 
immunoglobulin, increasing the non-specific immunity mediators and stimulation of 
the natural killer (NK) cells. Medicinal plants extracts that are able to facilitate the 
immunomodulation is desirable. Medicinal plants have not only demonstrated their 
ability to effect the target cells, but can also modulate, stimulate and activate the 
immune system. This ability is depending on the phytocompounds such as terpenoid, 
phenolics, polysaccharides, alkaloids, peptides, nucleotides and glycoproteins (Utami, 
2019). As such, vitamin E has shown the ability to modulate the immune system 
especially the NK cells. Higher vitamin E content will increase the NK cells activity 
and lower vitamin E caused decrease NK cells activity (Mutalip, 2018).  
In this study, the APME has shown the ability to increase NK cells activity 
from the healthy donor, while insignificance differences were observed with the NK 
 
 184 
cells from the cancer donor. As outlined by (Hanahan and Weinberg, 2016) cancer cell 
exhibited eight hallmarks in order to survive, grow, proliferate, and metastasis. 
Therefore maintaining a healthy lifestyle might help our immune system to be able to 
perturb the formation of cancer. This includes eating foods that are rich in beneficial 
phytochemical. NK cells from healthy donor were able to be stimulated to induce cell 
deaths but not from the cancer donors. This shows that ingested phytochemical could 
halt the progression of cancer cells and tumour formation by stimulating the immune 
systems responses. Similarly as shown by Takeda and Okumura (2019), in a group of 
ten volunteers consuming 1000mg of ginseng per day for 14 days, showed no 
difference in NK cell size or CD56 expression but the cytotoxicity of the NK cells was 
significantly increased.  
6.2 CONCLUSION 
 From the results obtained in this study it can be concluded that A. precatorius 
leaves extract possessed beneficial phytochemicals that are able to induce the anti-
proliferative activity on cancer cells. It is found that the A. precatorius methanol 
extract from Soxhlet extraction showed the highest phenolic and terpenoid compounds 
while the ethyl acetate demonstrated the highest terpenoid compound. The methanol 
extract (APME) has shown the ability to moderately inhibit cancer cell proliferation 
in all cancer cells tested. APME was able to induce cell deaths in MDA-MB-231 cells 
via apoptosis. p53, Bax and Caspase-3 were activated and Bcl-2 protein was down-
regulated. Finally, APME was also found to significantly promote NK cells (from 
healthy donor) cytotoxicity on MDA-MB-231 cells. NK cells activation was observed 
by the production of INF-g and PRF-1. However, APME was unsuccessful to modulate 
NK cells activity obtained from the cancer donors in vitro.  
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 These findings provide a better understanding of A. precatorius as an 
anticancer agent or better as chemopreventive agent. Different parts of A. precatorius  
have been widely studied for this bioactivity, especially the seeds. This current study 
adds the portfolio of the A. precatorius leaves. Since A. preactorius leaves has also 
exhibited higher sweetness profile than sucrose, it is recommended to utilise this plant 
as sugar substitute. Therefore, besides maintaining the “sweetness of life”, A. 





















6.3 FUTURE RECCOMENDATION 
 Due to limited budget, this current study possesses many limitations therefore 
better approaches would give better findings of the study. Here are some future 
recommendations to improve the understanding of A. precatorius as an anticancer 
medicinal plant. 
1. Study on the mechanism of cell death and NK activation of other extracts of A. 
precatorius exhibiting anti-proliferative effect.  
2. Study on the ability of APME as a chemopreventive agent in animal models. 
3. Study on other apoptosis proteins and markers such as cytochrome-c, caspase-
9, and Fas ligand.  
4. Increase the number NK cell donors especially from cancer patients in order to 
better understand the NK cell activity and provide a broader perspective.  
5. Expand the isolated NK cells in order to have more stable NK cells. 
6. Measure the effect of A. precatorius on NK cells directly in human by oral 
intake. Therefore, optimisation of the safe dosage per body weight need to be 
explored or the plant can also be consumed in the dosage as practised in 
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Expansion, subculturing and cryopreservation of MCF10a cells 
Complete growth medium reagents 
1. DMEM F-12  
2. 5% (v/v) horse serum 
3. 10 µg/mL recombinant human insulin 
4. 20 ng/mL recombinant human epidermal growth factor (hEGF) 
5. 0.5 µg/mL hydrocortisone 
6. 1% penicillin streptomycin 
Subculturing reagents 
1. Trypsin-EDTA (0.05% % (w/v) Trypsin/ 0.02% EDTA) 
2. PBS: modified without calcium chloride and without magnesium chloride 
Cryopreservation medium reagents 
1. DMEM F-12  
2. 5% (v/v) horse serum 
3. 10 µg/mL recombinant human insulin 
4. 20 ng/mL recombinant human epidermal growth factor (hEGF) 
5. 0.5 µg/mL hydrocortisone 
6. 10% (v/v) DMSO  
Preparation of complete growth medium 
• (DMEM F-12 + 5% (v/v) horse serum + 10 µg/mL recombinant human insulin + 20 ng/mL hEGF 
+ 0.5 µg/mL hydrocortisone + 1% penicillin streptomycin) 
 
The complete growth medium (500 mL) is prepared by aseptically combining: 
 
• 25 mL horse serum, 1.25 mL recombinant human insulin (stock 4 mg/mL in 5 mL), 10 µl hEGF 
(stock 1 mg/mL), 5 ml hydrocortisone (stock 50 µg/mL) and 5 mL penicillin streptomycin to 





Appendix B: LIST OF CHEMICALS / REAGENTS / KIT 
 
FITC-Annexin V Apoptosis Detection Kit 1 BD Biosciences 
BD Cyclotest Plus DNA BD Biosciences 
Lymhocyte Separation Media Capricorn 
Human IL-2 ELISA Kit Elabscience 
Human IFN-g ELISA Kit Elabscience 
Human PRF-1 ELISA Kit Elabscience 
Human GzmB ELISA Kit Elabscience 
Trypsin EDTA Gibco 
Penicillin Strepromycin Gibco 
DMEM, powder, high glucose medium Gibco 
RPMI 1640  medium Gibco 
Horse Serum Gibco 
DMEM F12 Gibco 
Insulin human recombinant Gibco 
Hoechst 33258 Invitrogen 
Recombinant human epidermal growth factor  Invitrogen 
MTT Formazan Merk Milipore 
n-hexane Merk Milipore 
Ethyl acetate Merk Milipore 
Methanol Merk Milipore 
MACS® BSA Stock Solution (NK Buffer*) Miltenyi Biotec 
autoMACS® Rinsing Solution (NK Buffer*) Miltenyi Biotec 
NK Cell Isolation Kit (human) Miltenyi Biotec 
Bax-PE (sc-7480) SantaCruz 
Bcl-2- Alexa Fluor 647 (sc-7382) SantaCruz 
p53- Alexa Fluor 488 (sc-126) SantaCruz 
Caspase-3 - Alexa Fluor 488 (sc-7272) SantaCruz 
NCAM (ERIC 1) - PE for CD56 SantaCruz 
CD3 - FITC SantaCruz 
PBS Tablets Sigma 
DMSO Sigma 
Hydrocortisone  Sigma 
 
*NK Buffer:  




Appendix C :CELLS USED IN THIS STUDY 
 










Tissue: Marmary gland, breast; derived from 
metatastic site 





Tissue: Marmary gland, breast; derived from 
metatastic site 











Tissue:Marmary gland, breast 










Appendix D: CELL COUNTING USING HEMOCYTOMETER 
 
Cells were counted using the trypan blue exclusion assay. Following trypsinization, 
cells were centrifuged to obtain the cell pellet. The supernatant was discarded and the 
pellet was resuspended in 1ml complete medium. Then, 10µl of the cell culture was 
mixed with 10µl of 4% (w/v) trypan blue dye. 10µl of this mixture was decanted into 
the gap of the edge between the  hemocytometer chamber and a cover slip. The cell 






Live cells were counted from each chamber I, II, III, and IV. Only live cells located 
in each chamber (16 small grid squares) were counted. Live cells can be differentiated 








Cell counting was performed under a light microscope at a 10X magnification. Total 
live cells were determined using the calculation formula as below:  
 
C =[(I + II + III + IV) x ¼ ] x df x 104 
 
C = number of cells in 1ml (cells/ml) 
df= dilution factor  
¼ = to obtain the mean of the cells in one area 
104 = volume of improved hemocytometer chamber 
 
Therefore, to prepare A x 104 cells, N = [(d x 104 x V)] / C  
 
A x 104 = number of cells needed for seeding  
N = volume of cells needed from the cell suspension to obtain A x 104 
V = Volume of medium + cell suspension needed for seeding  
C = number of cells in 1ml (cells/ml)  
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Dr. Norzila Ismail 
Department of Pharmacology 
School of Medical Sciences 
Universiti Sains Malaysia 
16150 Kubang Kerian, Kelantan. 
JEPeM Code : USM/JEPeM/17100566 
I 
Jawatankuasa Etika 
Penyelidikan Manusia USM (JEPeM) 
Human Research Ethics Committee USM (HRECJ 
Universiti Sains Malaysia 
Kampus Kesihatan. 
16150 Kubang Kenan. Kelantan. Malaysia 
T : (6)09-767 3000/2354/2362 
F : (6)09-767 2351 
E : jepem@usm.my 
L : www.jepem.kk.usm.my 
INWW.usm.my 
Protocol Title : Understanding the Cytotoxic Effect of Natural Killer Cells towards Selective 
Cancer Cells Modulated by Pereskia bleo, Abrus precatorius and Liposomes. 
Dear Dr., 
We wish to inform you that your study protocol has been reviewed and is hereby granted approval 
for implementation by the Jawatankuasa Etika Penyelidikan Manusia Universiti Sains Malaysia 
(JEPeM-USM). Your study has been assigned study protocol code USM/JEPeM/17100566, which 
should be used for all communication to the JEPeM-USM related to this study. This ethical clearance 
is valid from 13'" June 2018 until12'" June 2019. 
Study Site: Kubang Kerian, Kota Bharu, Kelantan. 
The following researchers also involve in this study: 
1. Prof. Dr. Armando Acosta 
2. Dr. Ramlah Kadir 
3. Dr. Rohimah Mohamud 
4. Dr. Rahimah Rahim 
5. Dr. Wan Zainira Wan Zain 
6. Mrs. Mazni Yusoff 
The following documents have been approved for use in the study. 
1. Research Proposal 
In addition to the abovementioned documents, the following technical document was included in 
the review on which this approval was based: 
1. Patient Information Sheet and Consent Form (Malay version) 
Attached document is the list of members of JEPeM-USM present during the full board meeting 
reviewing your protocol. 
While the study is in progress, we request you to submit to us the following documents: 
1. Application for renewal of ethical approval 60 days before the expiration date of this 
approval through submission of JEPeM-USM FORM 3(8) 2017: Continuing Review 
Application Form. Subsequently this need to be done yearly as long as the research goes on. 
2. Any changes in the protocol, especially those that may adversely affect the safety of the 
participants during the conduct of the trial including changes in personnel, must be 
submitted or reported using JEPeM-USM FORM 3(A) 2017: Study Protocol Amendment 
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Dr. Norzila Ismail 
Department of Pharmacology 
School of Medical Sciences 
Universiti Sains Malaysia 
16150, Kubang Kerian, Kelantan. 
JEPeM USM Code: USM/JEPeM/17100566 
Jawatankuasa Etih 
Penyelidihn Manusia USM (JEPeM) 
Human Research Ethics Comm~ttee UsM IHRECI 
Universiti Sa ins Malaysia 
Kampus Kesihatan 
16150 Kubang Kerian. Kelaman, Malaysia 
Tel. : • 6 09·767 3000/2354/2362 
fa<. : ·6 09·767 2311 
Emel : jepem@usm.my 
Laman Web : www.jepem.kk.usm.my 
www.usrn.my 
Study Protocol rrtle: Understanding the Cytotoxic Effect of Natural Killer Cells towards 
Selective Cancer Cells Modulated by Pereskia bleo, Abrus precatorius and Uposomes. 
Dear Dr.: 
We wish to inform you that the Jawatankuasa Etika Penyelidikan Manusia, Universiti Sains 
Malaysia (JEPeM-USM) acknowledged receipt of Continuing Review Appl ication dated 261• June 
2019. 
Upon review of JEPeM-USM Form 3(8) 2019: Continuing Review Application Form, the 
committee's decision for the EXTENSION OF APPROVAL IS APPROVED (start from 7th July 2019 
till 6th July 2020). The report is noted and has been included in the protocol file. 
JEPeM USM has noted that there is no research activity took place during the period of n•• June 
2019 until 6'• July 2019. The report is noted and has been included in the protocol file. 
Principle Investigator (PI) should aware and concern about the ethical expiration of the study 
in the future. 
Thank you for your continuing compliance with the requirements of the JEPeM-USM. 
"ENSURING A SUSTAINABLE TOMORROW" 
Very truly yours, 
~ 
(PROF. DR. HANS AMIN VAN ROSTEN BERG HE) 
Chairperson 
Jawatankuasa Etika Penyelidikan (Manusia), JEPeM 
Universiti Sains Malaysia 
c.c Secretary 
Jawatankuasa Etika Penyelidikan (Manusia). JEPeM 










JAWATANKUASA ETIKA PENYELIDIKAN (MAN USIA)- JEPeM USM 
UNIVERSITI SAINS MALAYSIA 
TEMPLATE BORANG MAKLUMAT DAN KEIZINAN PESERTA 
TEMPLATE OF PARTICIPANT INFORMATION SHEET AND CONSENT FORM 
(PROJEK PENYELIDIKAN) 
(RESEARCH PROJECT) 
Borang Maklumat dan Keizinan Peserta yang digunakan dalam Projek Penyelidikan mestilah mengikuti 
format maklumat berikut. Namun begitu pernyataan dan ayat yang digunakan hanyalah sebagai panduan 
sahaja. 
The Participant lnfomation and Consent Form used in the Research Project must be according to these 
information formats. However, statements and phrases used only as a guide. 
Tajuk Kajian I Topic of the Research 
Pengenalan I Introduction 
Tujuan Kajian I Purpose of the Study 
Kelayakan Penyertaan I Participants Criteria 
Prosedur-prosedur Kajian I Study Procedures 
Rislko I Risks 
Melaporkan Pengalaman Kesihatan I Reporting Health Experiences 
Penyertaan dalam Kajian I Participation in the Study 
Manfaat yang Mungkin Diperolehi I Possible Benefits 
Soalan I Questions 
Kerahsiaan I Confidentiality 
Tandatangan I Signatures 
Sebagal CONTOH, sila rujuk Borang Maklumat dan Keizinan Peserta yang dilampirkan. 
As an EXAMPLE, please refer to the attached Participant lnfomation Sheet and Consent Form. 
(Versl Bahasa Malaysia) I (Bahasa Malaysia Version/ 
1. LAMPIRAN A 
<Sila masukkan TAJUK KAJIAN> 
2. LAMPIRAN S (Borang Kelzlnan Peserta) 
3. LAMPIRAN G (Borang Keizinan Peserta- Sampel Genetik) 
4. LAMPIRAN P (Borang Keizinan Penerbitan Bahan yang Berkaitan dengan Peserta) 
!Versi Bahasa lnggerisl I (English Version/ 
1. ATTACHMENT B 
<Please add in the RESEARCH TITLE> 
2. ATTACHMENTS (Participant Information and Consent Form) 
3. ATTACHMENT G (Participant Information and Consent Form- Genetic Sample) 
4. ATTACHMENT P (Participant's Material Publication Consent Form) 
















Kajian ini akan melibatkan individu yang mempunyai ciri-ciri berikut: 
Bagi Peserta sihat: 
Tiada penvakit berat 
Tidak mengambil dadah immunosupresif 
Umur 18-45 tahun 
Tidak merokok 
Tidak hamil 
Kajian ini tidak akan melibatkan individu yang : 
Bagi peserta sihat: 
resif 
Bagi peserta pesakit kanser: 
Disahkan mengidap kanser oleh doktor 
Masih bel urn mendapat apa-apa 
rawatan 
Umur 18-45 tahun 
Tidak merokok 
Tidak hamil 
Bagi peserta pesakit kanser: 
Tidak didiagnos mempunyai kanser 
Mengambil dadah immunosupresif 
Mempunyai kanser dengan ko-morbiditi 
*Tidak mengambil dadah immunosupressif 
sekurang-kurangnya 3 bulan yang lepas. 
la in 
Enggan memberi kebenaran consent 
• ko-morbiditi adalah kewujudan penyakit lain oada pesakit kanser, seperti tekanan 
darah tinggi, penyaki t buah pinggang dan lain-lain. 
PROSEDUR-PROSEDUR KAJIAN 
Peserta (yang boleh berbahasa melayu) hanya perlu mengisi borang maklumat yang diperlukan untuk 
mengetahui sama ada peserta termasuk dalam kriteria yang diperlukan. Jika peserta memenuhi kriteria, 
darah peserta akan diambil oleh individu terlatih sebanyak 10 mi. Setelah selesai, peserta akan diberi 
honorarium. Sisa buangan saripada sampel kajian (sisa klinikal biohazard) akan dilupuskan dengan 
cara yang slstematlk. 
RISIKO 
Secara umumnya. pesakit tidak akan mengalami sebarang masalah atau risiko dalam proses 
pengambilan darah sebanyak 10 mi. Sila ikut arahan kakitangan yang mengambil darah dan hanya 
meninggalkan makmal selepas darah kering. Sila maklumkan kepada kakitangan kajian sekiranya 
anda menghadapi sebarang masalah atau mempunyai sebarang maklumat panting yang mungkin 
mengubah persetujuan anda untuk terus menyertai kajian ini. 
MELAPORKAN PENGALAMAN KESIHATAN (Jika Kajian Melibatkan Kesihatan SAHAJA) 
Sila hubungi kakitangan berikut pada bila-bila masa sekiranya anda mengalami sebarang masalah kesihatan, 
samada berkaitan atau tidak berkaitan dengan kajian ini. 
Dr Wan Zainira Wan Zain (No. Pendaftaran Penuh Majlis Perubatan Malaysia: 38667 ] di talian 019-
9216789 atau Dr Rahimah Rahim [No. Pendaftaran Penuh Majlis Perubatan Malays ia: 38338 ] di talian 
012-8330274 secepat mungkin. 
PENYERT AAN DALAM KAJIAN 
Penyertaan anda dalam kajian ini adalah secara sukarela. Anda berhak menolak untuk menyertai kajian ini 
atau menamatkan penyertaan anda pada bila-bila masa, tanpa sebarang kehilangan manfaat yang 
sepatutnya anda perolehi. Hasil kajian ini t idak akan dimaklumkan kepada peserta kerana ia merupakan hasil 
dari kombinasi set darah putih dari beberapa peserta dan bukan berorientasikan individu. 





















Borang Keizinan Peserta untuk Pengambilan Sampel Genetik 
(Halaman Tandatangan) 
Tajuk Kajian: Memahami kesan sitotoksik sel Pembunuh Semulajadi (Natural killer cell) ke alas sel 
kanser payudara dan serviks yang dimodulasi oleh ekstrak Pereskia bleo, Abrus precatorius and liposom 
Nama Penyelidik: Dr. Norzila Ismail, Dr. Ramlah Kadir, Dr. Rohi mah Mohamud, Prof 
Armando Acosta, Dr Wan Zaini r a Wan Z ain (Surgery , No MMC 38667). Dr Rah lmah 
Rahim (O&G , No MMC 38338),Puan Maz ni Yusoff (Unit Perubatan lntegrat if ) 
Untuk menyertai kajian ini, anda atau wakil sah anda mesti menandatangani mukasurat ini. Dengan 
menandatangani mukasurat ini, saya mengesahkan yang berikut: 
Saya Ieiah membaca semua maklumat da lam Borang Ma klumat dan Ke iz inan 
Pesakit ini te rmasuk apa-apa maklumat berka i tan r is iko yang ada dalam 
kajian dan saya te lah pun diberi masa yang mencukupi untuk 
mempertimbangkan maklumat tersebut. 
Semua soalan-soalan saya te lah dijawab dengan memuaskan . 
Saya, secara sukarela , bersetuju menyertai kajian penyel idikan ini , 
mematuhi sega la prosedur kaj ian dan memberi makl umat ya ng diperlukan 
kepada doktor, para jururawat dan juga kakitangan lain yang berkaitan 
apab il a diminta. 
Saya boleh menamatkan penyertaan saya dalam kajia n ini pada bila-bila 
mas a . 
Saya Ie iah pun menerima satu sa l inan Borang Maklumat dan Ke iz inan 
Peserta untuk simpanan peribad i saya . 
Nama Peserta 
No. Kad Pengenalan Peserta 
Tandatangan Peserta atau Wakil Sah 
Nama & Tandatangan lndividu yang Mengendalikan 
Perbincangan Keizinan 
Nama Saksi dan Tandatangan 
Tarikh (dd/MM/yy) 
Masa Uika perlu) 
Tarikh (dd/MM/yy) 
Tarikh (dd/MM/yy) 
Nota: i) Lebihan sampel kajian ini akan dilupuskan dan tidak akan digunakan untuk tujuan lain kecuali setelah mendapat 
kebenaran daripada Jawatankuasa Etika Penyelidikan (Manusia), USM. 
ii) Semua peserta yang mengambil bahagian dalam projek penyelidikan ini tidak dilindunoi insuran. 














Borang Keizinan bagi Penerbitan Bahan yang berkaitan dengan Peserta Kajian 
(Halaman Tandatangan) 
Tajuk Kajian: Memahami kesan sitotoksik sel Pembunuh Semulajadi (Natural killer cell) ke atas sel 
kanser payudara dan serviks yang dimodulasi oleh ekstrak Pereskia bleo, Abrus precatorius and liposom 
Nama Penye/idik: Dr. Norzila Ismai l, Dr. Ramlah Kad ir, Dr. Rohimah Mohamud , Prof 
Armando Acosta , Dr Wan Zainira Wan Zain (Surgery, No MMC 38667) , Dr Rah imah 
Rahim (O&G , No MMC 38338),Puan Mazni Yusoff ( Un it Perubatan lntegratif) 
Untuk menyertai kajian ini, anda atau wakil sah anda mesti menandatangani mukasurat ini. 
Dengan menandatangani mukasurat ini, saya memahami yang berikut: 
Bahan yang akan diterbitkan tanpa di lampirkan dengan nama saya dan set iap 
percubaan yang akan dibuat untuk memastikan ketanpanamaan saya . Saya 
memahami, walaubagaimanapun, ketanpanamaan yang sempurna ti dak 
dapat dijam in. Kemungkinan sesiapa yang menjaga saya di hospital atau 
saudara dapat mengena l i saya . 
Ba han yang akan d iterbitkan dalam penerb itan 
mingguan/bulanan/dwibulanan/suk u tahunan /dwi tahunan merupakan satu 
penyebaran yang luas dan tersebar ke se luruh dunia . Kebanyakan 
penerbitan in i akan tersebar kepada doktor-doktor dan juga bukan doktor 
termasuk ahli sains dan ahl i jurnal. 
Bahan tersebut jug a akan di lampirkan pada Ia man web jurnal d i seluruh 
dun ia . Sesetengah Iaman web ini bebas d ikunjung i ole h semua o rang . 
Bahan tersebut juga akan d igunakan sebaga i penerbitan tempatan dan 
disampaikan oleh rama i doktor dan ah l i sa ins di se luruh dun ia . 
Bahan tersebut juga akan d igunakan sebagai penerbitan buku oleh penerbit 
jurnal. 
Bahan tersebut tidak akan digunakan un tu k pengiklanan ataupun bahan 
untuk membungkus. 
Saya juga memberi keizinan bahawa bahan tersebut boleh d igunakan sebaga i 
penerbitan lain yang diminta oleh penerbit dengan kriteria ber ikut : 
Bahan tersebut tidak akan digunakan untuk pengiklanan atau bahan untuk 
membungkus . 
Bahan tersebut tidak akan digunakan di luar konteks - contohnya : Ga mbar 
tidak akan d igunakan untuk menggambarkan sesuatu artikel yang tidak 
berka itan dengan subjek dalam to to tersebut. 
Nama Peserta 
No. Kad Pengenalan Peserta T/tangan Peserta 
Nama & Tandatangan lndividu yang Mengendalikan 
Perbincangan Keizinan 
JE Pe M USM T emplate for PIS and CF updated 10/05/2017 
Tarikh (dd/MM/yy) 
Tarikh (dd/MM/yy) 
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t.:~:NIKA TROPICAL AGRICULTURAL SCIENCE 
GC-MS Analysis of Phytochemical Compounds in Aqueous Leaf 
Extract of Abrus Precatorius 
\Van Slll"iyani Wan-lbrahim', Tuan Nadrah .'laiDll Tuan Ismail', 
Siti Famanah \lohd-Sall~h' and .'lorlila Ismail'* 
1 DtpartmDJt of Plw.nJJtrolog\·. Sdroo/ of AlniKal Snmcrs Unn·t!t"SStr Saau M.u/oysw../6150 VSJt, 
Kubang Kenan. Kdaattm.. Jlaltn'SUJ 
!ScJtooJ ofDentol Sclt'ncn., Lim·IY7ih Stuns Ma/a,-sw.. 16150 m.\1~ K.ubang Kn-wn. Krlankm, Ma/a,-sw 
ABSTRACT 
Abrus precmOJius is a flowering plant that belongs to the l~ume family, Fabaceae. In 
Malaysia. the lea,·es of Abrus fJI"<'atoriu.t are tL~ed traditionally to treat :Uiments such 
as fever. ulcer and mouth cancer. These traditional practices. however. have never been 
documented and usage oftbe plaru is based on popular beliefs held by the loc-.U people. 
This work doeumemed the phytoeompounds that are present in the aqueous extract of 
Abrus prectJtoriu.r lea,·es collected from a local area. in Kota Bh&rtL Kelantan, Malaysia. 
The leaves were dried and then subjected to extraction using the decoction technique. The 
compounds \\ere identified by gas chromatography with mas.~ spectromeuy analysi~ and 
characterised by comparison through the N1ST02 and Wiley275 library search software. 
The GC-MS analysis showed that the cla~ses of compounds identified in aqueous extracts 
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1:-ITRODUCTIO:"< 
Medicinal plantsarewidelyused as food and 
medicine in traditional practice. In Malaysia, 
such plants are consumed as an alternati\•e 
treatment for illness or to maint:Un a healthy 
lifestyle. A huge reservoir of bioactive 
con1p0undsexiSlS in o'-er 400.000 species of 
plants on Earth. but only a small percentage 
of these compounds have been examined 
in research. In many de\-eloped countries, 
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